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The early stages of development are characterised by profound transcriptional and 
epigenetic reprogramming. The most striking example is the global loss of DNA methylation 
patterns on the maternal and paternal genomes that is precipitated upon formation of the 
zygote. This is coincident with the establishment of the inner-cell mass, a pluripotent 
population of cells that give rise to the embryo. The necessity to reset the epigenetic 
landscape to attain this state however requires further investigation, as are the mechanisms 
that lead to these changes. Using a mouse embryonic stem culture media, referred to as 2i, 
that models this developmental period, I set out to uncover mechanisms that may contribute 
to the remodelling of DNA methylation. In contrast to traditional serum-based mouse 
embryonic stem cell culture media, 2i maintains DNA methylation at a significantly lower 
level. The use of 2i and serum cultures therefore provided a means to investigate the 
regulation of the different DNA methylation landscapes. The overarching focus has been to 
understand how the mediators of DNA methylation, the DNA methyltransferases, are 
regulated at the level of the protein in response to the stimuli of the media. The differential 
makeup of the protein complexes of Dnmt1, referred to as the main DNA methyltransferase, 
and of its obligate co-factor, Uhrf1, were characterised in a proteomic screen. This led to the 
identification of several candidates and their potential roles in mediating DNA methylation 
have been postulated to build a case for future investigation. Furthermore, the influence of 
citrullination, a relatively understudied post-translational modification detected throughout 





DNA can be viewed as a sequence of the letters A, T, G and C, bundled into one of the smallest 
units the human body can be divided into, a cell. These letters can be arranged into specific 
sequences termed genes. In turn, genes are read by machinery in a cell to produce proteins, 
the fundamental building blocks of life. A full complement of these letters is initially provided 
equally by sperm and egg cells from biological males and females, respectively. These two 
cells each have half of the DNA required for a new organism to develop. When they come 
together by a process known as fertilisation, a full set of genes is present. Having a full set of 
genes is in itself not sufficient and the precise reading of these at certain times or in different 
types of cells is also crucial for life. One way this is controlled in adults is through the use of 
small chemical marks that can directly decorate DNA. These can dictate if and when a gene 
produces a protein in any certain cell. One example of these marks is DNA methylation. This 
is present on the male and female DNA in sperm and eggs, however it is nearly completely 
removed after fertilisation, before it is added back again later. The necessity for this initial 
erasure and the way it happens is still not clear. This study has set out to identify the 
mechanisms that promote this loss by focussing on the machinery that regulates DNA 
methylation levels. This machinery may be modified directly or controlled by other 
machinery in the cell to keep regulating DNA methylation. When these mechanisms have 
been identified, they can be promoted or prevented from happening before their effects on 
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Methylated cytosine is described in the classic Riggs, Pugh and Holliday papers as an 
epigenetic factor that regulates and constrains cellular fates (Holliday and Pugh, 1975; Riggs, 
1975). Epigenetic programs act in concert with spatiotemporally coordinated interactions 
between transcription factors and DNA to give rise to specialised cells (Baubec and Schübeler, 
2014). Gene regulation is primarily encoded in cis whilst DNA methylation is a mitotically 
heritable modification that does not alter the underling sequence of DNA. These marks are 
essential in mammalian development and as such, DNA methylation has spurned a field into 
elucidating its roles (Smith and Meissner, 2013). 
Although present in organisms as diverse as plants, animals and prokaryotes, DNA 
methylation is not an essential requirement for life and is absent from common model 
organisms, such as adult Drosophila melanogaster, Caenorhabditis elegans and 
Saccharomyces cerevisiae (Kumar et al., 1994; Hendrich and Tweedie, 2003). 
The mammalian genome is densely methylated at cytosine bases in a palindromic CpG 
context. This is to such an extent in humans that 70-80% of CpGs are modified, which equates 
to 1% of total DNA bases (Bird, 2002). Methylation has also been observed at very low levels 
in a CHG and CHH configuration in oocytes and neurones, where H represents any other 
nucleotide base, which may represent the fidelity of the enzymes that deposit the mark (Li, 
Dai, Suzanne N Martos, et al., 2015; C. Li et al., 2018).  
The landscape in most invertebrates is markedly different. For example, in the sea squirt 
Ciona intestinalis, methylation is present as blocks interspersed with stretches of 
unmethylated DNA in equal proportions. Gene bodies of highly expressed genes and 
transposable elements, described later in more detail, are marked in accordance with the 
pattern of surrounding DNA. The fungi Neurospora crassa exhibits a similar mosaic pattern 
however methylation is targeted specifically to transposable elements. This is also the case 
for plants such as Arabidopsis thaliana wherein marks are enriched over gene bodies of many 
housekeeping genes too. On the contrary, plants with relatively larger genomes have a broad 
global distribution of DNA methylation, potentially owing to the abundance of transposable 
elements embedded in the genome that are targeted to maintain a transcriptionally 
repressive state (Suzuki and Bird, 2008).  
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The shift from a mosaic to a global pattern in mammals has been presented as necessary for 
the development of an immune system that could detect the DNA of bacterial pathogens, 
which is replete with unmethylated CpG. The Toll-like receptor 9 expressed by immune cells 
in vertebrates has an affinity for this motif and is absent in invertebrates. This notion is 
certainly provocative as it suggests that the majority of DNA methylation is redundant and is 
present largely in a global configuration to obscure actual functional blocks, such as across 
gene bodies or transposable elements, that would otherwise trigger an autoimmune 
response. The implication therefore is that outside of specific targets, DNA methylation has 
no role (Suzuki and Bird, 2008). However, this would ignore the selectivity of the enzymes 
that initially set up the DNA methylation patterns and the influence of co-factors and histone 
marks that can direct them. 
As our understanding is enhanced by the development of a plethora of sequencing 
technologies, the initial importance attributed to DNA methylation has been slowly eroded. 
Nonetheless, DNA methylation is irrefutably vital for post implantation embryonic 
development. This is illustrated by the lethality of knockout mouse models for the enzymes 
which set up and maintain the patterns across cell division (Li, Bestor and Jaenisch, 1992; 
Okano et al., 1999).  
 
1.2 DNA Methyltransferases     
DNA-(cytosine-5) methyltransferases (Dnmts) catalyse and maintain DNA methylation. They 
are defined by ten conserved motif blocks that are invariably ordered along the protein and 
punctuated with non-conserved variable sequences that can determine target specificity (see 
Figure 1.1) (Kumar et al., 1994). These fold into a characteristic ‘AdoMet-dependent MTase 





Figure 1.1 – Domains of the mammalian DNA methyltransferases. Present in all are important motifs 
that constitute the catalytic domain (I, IV, VI, VIII, IX, X). Two of these motifs (IX, X) are notably absent 
in Dnmt3l, which renders it catalytically inactive. Details of other domains labelled are discussed later 
in the text.  Values to the right of each schematic refer to the number of residues in the mouse 
methyltransferase. Adapted from (Goll and Bestor, 2005; Jurkowska, Jurkowski and Jeltsch, 2011) 
Motif IV PCQ contains a nucleophilic cysteine residue that reacts with the C6 position in a 
cytosine ring. The nitrogenous base is also transiently protonated at the N3 position, a state 
stabilised by motif VI ENV of the MTase fold. This results in the formation of a transient 
covalent protein-DNA complex and the activation of C5 in the cytosine ring, leading to a 
nucleophilic attack on the donor S-adenosyl-L-methionine (AdoMet) methyl group. 
Subsequent deprotonation at the C5 position, followed by β-elimination, regenerates the 
aromatic ring and the by-product S-adenosyl-L-homocysteine (see Figure 1.2) (Kumar et al., 




Figure 1.2 – Cytosine methylation is catalysed by DNA methyltransferases in a multi-step process as 
outlined above. See main body of text for further details (Adapted from Vilkaitis et al., 2001; Jeltsch, 
2006) 
 
Mammalian DNA methylation patterns are initially deposited by de novo methyltransferases 
Dnmt3a and -b which act on DNA devoid of pre-existing marks. The maintenance 
methyltransferase Dnmt1 meanwhile has an affinity for hemi-methylated sites that arise 
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during cell division. It semi-conservatively copies these patterns onto nascent daughter 
strands using the parental strand as a template (see Figure 1.3) (Smith and Meissner, 2013).    
 
 
Figure 1.3 – When DNA is initially synthesised, it is devoid of methyl groups.  Marks are added through 
the action of the de novo methyltransferases, typically at CpG sequences. During DNA replication, the 
parental strand is used as a template by Dnmt1 to semi-conservatively copy the methylation marks 
onto the newly synthesised strand, thus the pattern is maintained in daughter cells. Adapted from: 
Moore, Le and Fan, 2012. 
 
Underscoring the significance of DNA methylation for development are mouse models. 
Homozygous Dnmt1-null mice die by E10.5 with apparent limb-bud defects, impaired 
organogenesis, open neural pore, increased cell death and no yolk sac vasculature (Li, Bestor 
and Jaenisch, 1992). A compound heterozygote null/catalytically dead mouse model has an 
indistinguishable phenotype and arrests developmentally at the same stage as a null line 
(Takebayashi et al., 2007). In both instances this has been partially explained by the aberrant 
expression of imprinted genes and transposable elements which will be discussed later 
(Walsh and Bestor, 1999; Takebayashi et al., 2007). Depletion of Dnmt1 in mouse embryonic 
fibroblasts (MEFs) results in apoptosis within 5-6 days and this can be partially attenuated by 
the knockdown of p53 (Jackson-Grusby et al., 2001).    
The effects of deleting de novo transferases varies: Dnmt3b-null mice die by E9.5 which 
contrasts with Dnmt3a-null mice that survive until after birth. These are however runted in 
size and succumb within four weeks. Recovered Dnmt3b-/- embryos are characterised by 
growth impairment and a variety of developmental defects (Okano et al., 1999). Noteworthy 
is that heterozygotes from the single knockout of either the maintenance or de novo 
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transferases are phenotypically indistinguishable from wild-type (WT) mice (Li, Bestor and 
Jaenisch, 1992; M Okano et al., 1999).  
Mouse embryonic stem cells (mESCs) exhibit a high expression of Dnmts in addition to 
components not yet introduced, Dnmt3l and the highly specific Dnmt2 enzyme. Despite this, 
they are tolerant of epigenetic perturbations and can be cultured in perpetuity in appropriate 
conditions, as exemplified by Dnmt single or triple knockout models (TKOs) (Tsumura et al., 
2006; Meissner, 2010). This contrasts with human ESCs from which DNMT1-homozygous null 
models cannot be derived, whilst single and double DNMT3A and -B clones can. This disparity 
may be a consequence of the different cell-doubling times which is substantially longer for 
hESCs. Nevertheless, like the mouse equivalents, early passage DNMT3A and -B knockouts 
can form teratomas (Liao et al., 2015). A tolerance to genetic deletions and response to 
rescues, coupled with an ability for multilineage differentiation, mean mESCs have been used 
extensively to grapple with questions surrounding the importance of methylation in 
development and regulation of the Dnmts. Consequently, they are the model of choice 
throughout this project and are referred to extensively herein.  
 
1.3 Roles of DNA methylation 
DNA methylation is highly associated with transcriptional regulation. This function may be 
direct, through the occlusion of transcription factors, or secondary whereby methylated 
CpGs act as docking sites for methyl-CpG binding proteins (MBPs). These serve as recruitment 
factors and bring about a transcriptionally repressive state that inhibits initiation, typically 
through hypoacetylation of neighbouring histones (Schübeler et al., 2000; Fournier et al., 
2012). MBPs are expressed ubiquitously in somatic cells and also have tissue specific isoforms 
(Wade, 2001).  
For example, MeCP2, an X-linked gene from the MBP family, transiently recruits the Sin3-
histone deacetylase (HDAC) repressor complex and regulates spacing of linker histones 
(Fournier et al., 2012). MeCP2 is highly abundant in post-natal neuronal tissue and 
conditional deletion in mice leads to the development of a phenotype that is comparable to 
human patients with Rett syndrome, a disorder stemming from mutations in MeCP2 that 
abolish its DNA methylation binding capabilities. The phenotype is characterised by post-
natal neurological defects (Chen et al., 2001; Guy et al., 2001; Wade, 2001). Alternative 
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mutations in MeCP2 can disrupt interactions with ATRX, a SWI/SNF DNA helicase that 
cooperates with cohesin and the transcription factor CCCTC-binding factor (CTCF) to maintain 
the imprint status of a subset of genes in the mouse brain (Fournier et al., 2012). Despite this, 
only a small number of genes are miss-expressed by 10-20% in Rett syndrome patients and 
MBP knockout models only produce modest effects (Hendrich and Tweedie, 2003). The 
association with DNA methylation is complicated by observations that MeCP2 can bind to 
unmethylated DNA and compact nucleosome arrays in vitro and assemble oligomeric 
suprastructures (Georgel et al., 2003). 
Kaiso and Kaiso-like proteins similarly work to repress transcription by altering histone states. 
Their methyl-dependent binding instigates hypoacetylation through recruitment of CtBP1 
and CtBP2 complexes (Sasai and Defossez, 2009).  
That methylation inhibits transcription factor binding however has proven to be 
generalisation and is motif, context and transcription factor dependent. Although it is 
instructive at highly dense CpG regions with respect to transcriptional activity, as discussed 
below, the effect of DNA methylation is variable within other promoters (Baubec and 
Schübeler, 2014).  
Using DNAseI hypersensitivity as a surrogate for transcription factor binding, accessible sites 
were shown to be largely comparable between mESCs in which the three main Dnmts have 
been knocked-out, TKOs, and the WT counterpart (Domcke et al., 2015). A number of sites 
did emerge however that were distal to transcriptional start sites (TSS). These had a notably 
low CpG content and were enriched for motifs of the transcription factors GABPA, MYCN and 
most prominently, NRF1. The subsequent binding of NRF1 was coincident with increased 
transcription of the nearest gene. In WT cells, the engagement of NRF1 was shown to be 
directed by other adjacently binding transcription factors insensitive to methylation, such as 
REST, that act in trans to promote local demethylation of NRF1 motifs (Domcke et al., 2015).  
A similarly minimal effect on CTCF redistribution was also found in a colorectal carcinoma cell 
line (HCT116) null for Dnmt1 and Dnmt3b (DKO) (Maurano et al., 2015). In excess of 98.5% 
of unoccupied CTCF sites in the WT HCT116 line remained depleted of the transcription factor 
in the DKO line. Whilst over 3000 sites were found to arise exclusively with demethylation, 
only 50% of sites methylated in WT lines and depleted in the DKO lines displayed this novel 
binding. This suggests that methylation contributes but is not the sole determinant of 
transcription factor binding (Maurano et al., 2015).  
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Techniques such as methylation-sensitive SELEX and EpiSELEX-seq have begun to unravel the 
complex relationship between transcription factor binding and DNA methylation 
(Kribelbauer et al., 2017; Yin et al., 2017). 
A systematic analysis of the interplay between DNA methylation and the binding affinities of 
542 human transcription factors was performed with methylation-sensitive SELEX (Yin et al., 
2017). Over a third of transcription factors were shown to not be influenced by methylation 
due the absence of a CpG sequence in the primary binding motif, whilst others were not 
affected regardless of a methyl group. A further third of transcription factors, enriched for 
examples involved in development, displayed a preference for the methylated motif that 
likely interacts via hydrophobic interactions to the DNA binding domain. Around a quarter, 
typically involved in cell proliferation and differentiation, preferred an unmethylated 
substrate due to steric clashes that would otherwise arise with a methyl-group. As a single 
motif is recognised by multiple transcription factors that are either positively or negatively 
influenced by DNA methylation, this property can select the factors that bind and this may 
impose different outcomes on gene expression (Yin et al., 2017).  
The positional effects of methylation must also be considered if more than one CpG 
dinucleotide in a transcription factor binding motif is present. Transcription factors can also 
form complexes with co-factors and recruit enzymes that remodel the 5-methylcytosine 
(5mC) levels and alter binding affinity (Feldmann et al., 2013; Kribelbauer et al., 2017). 
Furthermore, motifs that lack a CpG site may be indirectly regulated by DNA methylation if 
MBPs are recruited to a neighbouring methylated sequence and their activity encroaches, 
inhibiting transcription factor binding (Baubec and Schübeler, 2014).  
Examples of genes that are causally regulated by DNA methylation and exhibit no interplay 
with other epigenetic regulatory mechanisms have been identified (Hackett et al., 2012).  
Exposure of NIH 3T3 fibroblasts to the demethylating agent 5-aza-2’-deoxycytidine (5-aza-
CdR) resulted in a significant over 6-fold upregulation of 344 genes and 49 remained 
expressed after a period of recovery. These were distinguished as possessing a CpG Island 
(CGI) promoter, a high density CpG promoter as explained below. Cross referencing this set 
of 49 genes with transcripts upregulated in Dnmt1 hypomorphic MEFs produced 26 genes 
that are likely bona fide examples of DNA methylation dependent genes. Half of these were 
germ-line specific genes, with a number involved in transposable element suppression. Their 
silencing occurred in parallel with their methylation during ESC differentiation and 
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conversely, expression of these genes was detected during the wave of DNA methylation loss 
that occurs in vivo during primordial germ cell (PGC) specification (Hackett et al., 2012). That 
most genes remain silent when DNA methylation is removed shows that regulation is 
primarily determined by the presence of a transcription factor in the cell or alternative 
epigenetic modifications that act at the level of histones (O’Neill et al., 2018).  
1.3.1 CpG Islands 
Exceptions to when CpGs dyads are typically methylated can be found at high density clusters 
termed CGIs, which are refractory to methylation. Various calculations agree that over two-
thirds of mammalian promoters could be defined as such, particularly housekeeping and key 
developmental genes and lineage specific microRNAs. Consequently, there is considerable 
interest in them as they are potential elegant illustrations of the inhibitory function of DNA 
methylation on gene expression (Meissner et al., 2008; Illingworth and Bird, 2009; Lienert et 
al., 2011). The description of a CGI, and therefore the parameters inputted into genome 
browsers to quantify them, often varies in terms of the length however, there is consensus 
that the G + C content is ≥ 50% and an observed/expected CpG ratio of ≥0.6 (Illingworth and 
Bird, 2009). Compared to low CpG density promoters, CGI associated promoters in mESCs 
display higher transcriptional activity. This appears to be due to an intrinsic property of CpG-
dense sequences that reside in and that flank transcription factor motifs (Hartl et al., 2019).   
Why these sequences remain largely unmethylated under a potential onslaught of Dnmt 
activity is likely due to the presence of bound transcription factors, hence the relationship 
between house-keeping genes and hypomethylated CGIs. Transcription factor binding may 
occlude Dnmts or bring about a loss of any DNA methylation that is added by an active 
process, introduced later (Brandeis et al., 1994; Feldmann et al., 2013; Marchal and Miotto, 
2015; Yin et al., 2017). The binding of transcription factors alone was shown to be insufficient 
to cause transcription and therefore this hypothesis could also account for the unmethylated 
status of CGIs in other gene classes (Spitz and Furlong, 2012). However, as CGIs largely remain 
depleted of 5mC regardless of transcriptional activity, this points to additional regulatory 
mechanisms that enforce the typical hypomethylated state (Brandeis et al., 1994; Weber et 
al., 2007). Indeed, H3K4me3 enrichment at CGIs, the mechanistic reasons for which are 
addressed later, occludes binding of the de novo methyltransferases (Mikkelsen et al., 2007; 
Weber et al., 2007; Meissner et al., 2008; Illingworth and Bird, 2009). A component of the 
Setd1 H3K4 transferase, Cfp1, was identified as having a high affinity for CGIs, thus providing 
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a link between the underlying DNA and perepuation of a DNA methylation resistant region 
(Thomson et al., 2010).  
Exploiting the affinity of the CXXC zinc-finger domain for unmethylated and clustered CpG 
sites, CXXC affinity purification (CAP)-seq was developed to identify CGIs in human tissue. 
The total number found (~25,200) exceeded the number of known genes (~20,000) whilst 
gene rich chromosomes, such as chromosome 19, had more CGIs compared to gene poor 
chromosomes, for example chromosome 18. This demonstrated that CGIs are not exclusively 
localised to canonical promoters (Illingworth et al., 2008). CGIs that lay outside of these units 
were termed orphan CGIs. Typically, the GC content of murine CGIs is lower than humans but 
are equally abundant in number and distributed throughout the gene, including at annotated 
promoters and inter- and intra-genic positions (Illingworth et al., 2010).   
Data from the CAP-seq study in brain, blood, muscle and spleen tissue showed that tissue-
specific methylation of CGI associated promoters is enriched at genes encoding transcription 
factors and key developmental genes. In general, the presence of methylation was shown to 
be a poor predictor of gene expression (Illingworth et al., 2008). In a different study using 
human primary fibroblasts however, whilst there was no significant correlation with 
methylation at low CpG content promoters and polymerase II (PolII) binding, indicative of 
transcription, decreased PolII occupancy was shown at hypermethylated CGIs (Weber et al., 
2007). These findings suggest caution when considering CGI methylation as regulating a 
dichotomy of silencing or expression. Studies into orphan-CGIs have been more resolute and 
have shown that ~40% of human and mouse units display transcriptional activity and these 
are more likely to become methylated and silenced during cell specification, compared to 
those overlapping an annotated promoter (Illingworth et al., 2010).   
1.3.2 Imprinting 
The influence of DNA methylation at CGIs is less ambiguous in the context of genomic 
imprinting. Differential methylation at CGI containing imprint control regions (ICRs), giving 
rise to a differentially methylated regions (DMRs), in conjunction with histone modifications 
and non-coding RNA binding, ensures expression in a parental-origin-specific manner from 
either the maternal or paternal chromosome. These DMRs regulate multiple genes in a 
cluster and result in functional non-equivalence of the genomes, showing maternal and 
paternal genomes provide unique reciprocal functions. Likewise, perturbing individual 
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imprinted genes on the chromosomes from which they are expressed leads to developmental 
defects (Ferguson-Smith, 2011).   
Although imprinting has been described as a useful paradigm for exploring interactions 
between gene expression and epigenetics, the arrangement of imprinted genes at clusters 
and the influence of neighbouring elements ensures methylation confers differential effects 
on expression. This may be expected as over 100 imprinted genes have been confirmed so 
far in the mouse (Ferguson-Smith, 2011). One of the best studied paternally methylated ICRs 
is that which controls H19-Igf2 reciprocity. In females, a shared enhancer upstream of the 
genes engages with H19 as CTCF insulates Igf2 situated downstream. Conversely, deposition 
of methylation blocks CTCF binding in males, which is concomitant with Igf2 expression 
(Leighton et al., 1995; Thorvaldsen, Duran and Bartolomei, 1998).  
Germline-acquired methylation represents the canonical method for the establishment of 
imprints. The inability of rescued Dnmt1 -/- mESCs to restore imprint status demonstrates 
this (Tucker et al., 1996). However, tissue specific imprinting can emerge in the adult. For 
example, at the Dlk1-Dio3 locus, methylation is present at the ICR on the paternal 
chromosome in almost all tissues where it drives the expression of Dlk1. In neural stem cells, 
it also found on the maternal chromosome which was experimentally determined to be 
essential for the self-renewal property in adult male mice (Ferrón et al., 2011).  
1.3.3 X-chromosome inactivation 
X-chromosome inactivation in eutherian females describes the random silencing of genes on 
one X-chromosome, thus achieving parity with males which only inherit one X-chromosome. 
This is initiated by Xist, a non-coding RNA expressed from an X-inactivation centre. Coating 
of the X-chromosome from which it was expressed in cis accumulates to an extent that by 
E8.5, all female somatic cells have this feature. A correlation between methylation at a CpG-
rich promoter region upstream of Xist and silencing is observed on the active X-chromosome, 
in contrast to a methylation free domain on the inactive X, demonstrates a regulatory role of 
DNA methylation (Panning and Jaenisch, 1996). Perversely, the active X-chromosome is 
relatively hypermethylated. However, this can be accounted for by the prevalence of the 
mark over gene bodies whereas the inactive X-chromosome is solely enriched at promoters 
(Weber et al., 2005).  
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Although initially expressed in both male and female mESCs in culture, Xist is extinguished in 
differentiated male cells. However, cells from a Dnmt1 -/- background maintain expression 
and this temporally correlates with apoptosis (Panning and Jaenisch, 1996). X-chromosome 
inactivation can nevertheless be initiated normally in the absence of Dnmt3a and -b, with 
female embryos at E9.5 exhibiting monoallelic expression of Xist that is capable of repressing 
transcription from the chromosome in cis. The implication therefore is that DNA methylation 
does not instigate the differential silencing of Xist however, it is required for stable silencing 
(Sado, 2004). Binding of Mbd2 to 5mC has shown to contribute to the enforcement of a 
transcriptionally inert state by recruiting the NuRD complex which mediates histone 
hypoacetylation (Barr et al., 2007).  
1.3.4 Repression of DNA repeats 
The majority of the mammalian genome is composed of non-coding sequences yet in some 
instances, it is essential that DNA methylation is still present. Regulating the potential 
transcriptional activity and stability of repetitive sequences has been regarded as the 
function for which DNA methylation first evolved (Yoder, Walsh and Bestor, 1997). This 
notion is strengthened by the apparent conservation of this role in diverse organisms (Walsh, 
Chaillet and Bestor, 1998; Zemach et al., 2010; Bewick et al., 2016). Like in other instances of 
transcriptional repression, DNA methylation may impair the expression of repetitive 
sequences through steric hindrance or recruitment of repressive MBPs (Crichton et al., 2014).  
A repetitive sequence can refer to satellite DNA or transposable elements. Satellite DNA is 
concentrated at centromeres and may possess a structural role, as evinced in ICF syndrome 
(discussed below). It can be further classified as major or minor satellite DNA, in accordance 
with length (Du, Lianna M. Johnson, et al., 2015). Transposable elements meanwhile are 
sequences found in most organisms that have the potential to move independently 
throughout the genome, possibly through an RNA intermediate. Strikingly, these 
compromise ~40% of sequenced mammalian genomes (International Human Genome 
Sequencing Consortium, 2001; Mouse Genome Sequencing Consortium et al., 2002) and 
derivations are frequently associated with gene promoters (Jordan et al., 2003).  
The burden of regulating a class of these transposable elements, endogenous retroviruses 
(ERVs), is less in humans in which they are rarely mobile. This contrasts with mice wherein 
10% of spontaneous mutations are directly caused by their mobilisation and deleterious 
insertion into the genome. These events have the potential to cause ectopic activation, as 
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the element can serve as a promoter, or insertional mutagenesis. One of the best studied 
elements of this class is the intracisternal A-particle (IAP), up to 2000 copies of which have 
been estimated to reside in the murine genome (Walsh, Chaillet and Bestor, 1998). In a classic 
experiment, induced demethylation of an IAP element residing upstream of an agouti gene 
was sufficient to breed a higher proportion of yellow-coated mice, owing to a greater 
expression of the gene. This demonstrated the capacity of dysregulated IAP elements to 
modulate gene expression (Gaudet et al., 2004).  
Elements that are potentially active in both humans and mice are exemplified by long 
interspersed element class 1 (LINE-1). Proteins required to promote the activity of these are 
encoded within the elements and can be subsequently utilised by short interspersed 
elements (SINEs) that are present throughout mouse and human genomes also (Garcia-
Perez, Widmann and Adams, 2016). Whereas SINEs follow the general rule of non-repetitive 
sequences, irrespective of CpG density LINEs are hypermethylated (Meissner et al., 2008). 
The correlation between DNA methylation and LINE-1 activity is witnessed in the 
hypomethylated placental tissue, which derives from the trophectoderm of the developing 
blastocyst, and neuronal precursor cells that are moderately hypomethylated relative to 
somatic tissue. Notably, LINE-1 reporters indicate that retrotransposition occurs more 
frequently in these tissues and activity in neurones may contribute to the mosaicism 
observed in brain tissue (Garcia-Perez, Widmann and Adams, 2016).   
The acute removal of DNA methylation in mESCs can be induced with culture in media 
referred to as 2i, as discussed later. In one study, the 2i media was further supplemented 
with vitamin C and the effects on transposable element methylation status and expression 
were examined (Walter et al., 2016). It was noted that loss of methylation progressed at 
differing rates for different classes of elements: ERVs were most resistant as 5mC was 
maintained across the element, whilst there was only a retention at the 5’ untranslated 
region (5’UTR) of LINE-1 elements. Nevertheless, this coincided with a burst in transcription 
of a proportion of intact elements. In contrast, there is only a modest increase of a subset of 
ERVs in TKO mESCs (Karimi et al., 2011; Walter et al., 2016). In 2i + vitamin C media, elements 
became suppressed almost universally at the same time. Exceptions to this trend included 
IAPs and some SINEs which remained consistently derepressed. Re-silencing was shown to 
be largely driven by histone 3 lysine 9 trimethylation (H3K9me3) and H3K27me3 
accumulation at adjacent genomic sequences and across or at flanking regions of the 
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transposons. The extent and combination of H3K9me3 and H3K27me3 acquisition were 
element and family specific. The compensation by suppressive histone marks therefore 
provides an explanation for the disparity between acute DNA methylation removal in 2i + 
vitamin C and long-term cultured TKO cells on transposable element expression (Karimi et 
al., 2011; Walter et al., 2016). Nevertheless, transcriptional repression in Dnmt3a -/-
;Dnmt3b-/- mESCs harbouring murine stem cell virus (MSCV) and human immunodeficiency 
virus type 1 (HIV-1) vectors suggests that DNA methylation is a secondary event to silencing 
and therefore the conditions used in the study above may impose additional effects not 
accounted for (Pannell et al., 2000).  
With respect to IAP, the direct relationship between demethylation and derepression has 
been resolved with an additional intermediate step. This was initially borne from observing 
a discrepancy between Dnmt1- and Uhrf1-null mESCs. Uhrf1 (Ubiquitin-like, containing PHD 
and RING finger domains 1) is an obligate co-factor of Dnmt1 and is discussed in depth later. 
Here however, it is important to note that it recruits Dnmt1 to chromatin by binding to hemi-
methylated sites that arise during cell division and these would therefore persist in the 
absence of Dnmt1. In a Dnmt1-null mESCs, there is a transient increase in the expression of 
an IAP subgroup whereas in the corresponding Uhrf1-null line, methylation is reduced to 
levels comparable to the Dnmt1 mutants and IAP expression is only modestly and transiently 
promoted. This was accounted for by the maintained binding of Uhrf1 to hemi-methylated 
sites across IAP that arise in Dnmt1-null cells. This subsequently inhibited the recruitment of 
Setd1, a H3K9me3 transferase, and the silencing of IAP. As cell division progresses, 
hemimethylated sites are diluted, permitting Setd1 binding. That this only affects a specific 
subclass of IAP elements was explained by the fact that they are more enriched for CpGs and 
could therefore sequester Uhrf1 more efficiently (Sharif et al., 2016).  
Nevertheless, transient derepression of repeats in the germline is beneficial with respect to 
genome diversification and evolution, in contrast to events in somatic cells which cannot be 
inherited and could ultimately lead to the development of disease (Crichton et al., 2014). In 
this regard, the dynamic rate at which DNA methylation can be controlled represents a 
suitable tool for organisms to employ in order to balance the beneficial and detrimental 
effects of retrotransposition (Hackett et al., 2012).  
Methyl marks outside of these contexts, such as within gene bodies, may also have a function 
in genome regulation. 
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Transcription initiated from internal exons, particularly of highly expressed genes, is 
increased in globally hypomethylated Dnmt3b-null mESCs, relative to WT cells. This 
expression was attributed to the use of alternative promoters in some cases but was 
principally due to the loss of intragenic methylation that would otherwise prevent spurious 
PolII entry. Furthermore, these new transcriptional start sites are enriched for Dnmt3b 
binding and DNA methylation in WT cells, in addition to H3K36me3 upon which Dnmt3b 
recruitment depends (Neri et al., 2017). This observation is particularly intriguing as the 
evolutionary ancient organism Arabidopsis thaliana exhibits a mosaic methylation pattern, 
so called as the modification is concentrated across gene bodies and depleted elsewhere 
(Suzuki and Bird, 2008). Whether in this instance this also contributes to repressing spurious 
transcription would be indicative of its importance. 
Methylation at exons can also influence their splicing into mRNA. This is illustrated during the 
maturation of T-cell lymphocytes, wherein the binding of CTCF to exon 5 promotes PolII 
pausing and its subsequent inclusion in CD45 pre-mRNA. DNA methylation is detected across 
exon 5 in lines irrespective of its inclusion however, it is denser in mature lines within which 
exon 5 is excluded in the pre-mRNA as CTCF binding is inhibited (Shukla et al., 2011). This 
raises the possibility that a secondary effect, such as the recruitment of 5mC binding proteins 
may also influence this pathway.  
 
1.4 Interplay between DNA methylation and the histone code 
In vivo, Dnmts must contend with accessing substrates in a nucleosome structure, in which 
146bp of DNA are wrapped around an octamer of histones. In vitro studies complemented 
with in vivo analyses indicate that these units are refractory to methylation and as such, 
accessibility is regulated by nucleosome remodelling proteins such as the SNF helicases 
Lymphocyte-specific helicase (Lsh) and ATRX that likely generate accessible loops of DNA 
(Geiman and Robertson, 2002; Becker and Workman, 2013; Lyons and Zilberman, 2017). Lsh 
is particularly important for methylation at LINEs, satellite repeat sequences and ERVS in 
embryonic and somatic tissues in early development. Interestingly, derepression of satellite 
and ERVs that is observed in Lsh-knockout somatic lines is coincident with DNA 
hypomethylation, reduction of H3K9me3 and a gain of H3K4me3, suggesting that Lsh 
recruitment influences multiple levels of epigenetic regulation (Dunican et al., 2013).  
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As alluded to earlier, there is an interplay between DNA methylation and the so-called 
histone code. The protrusion of histone tails makes them amenable to a panel of 
modifications, providing an additional layer of epigenetic regulation. An association has been 
postulated whereby modified histone tails facilitate or inhibit the methylation of DNA (Du et 
al., 2015).  
Insightful studies using N. crassa and A. thaliana model organisms have provided evidence 
of the crosstalk between the epigenetic marks (Freitag and Selker, 2005). In the latter case, 
a feedback loop between histone and DNA methylation is observed for some DNA 
methyltransferases (Du et al., 2015). In the mouse, the relationship between the two 
epigenetic signatures may be mediated on two levels: through a physical interaction between 
constituent proteins of the pathways and by the mark deposited by one pathway influencing 
the activity of the other. Furthermore, histone modifications influencing DNA methylation is 
unidirectional with N. crassa yet the literature using mammalian cell lines is potted with 
inconsistencies. This becomes more apparent in the discussion of Dnmt1 interactors later 
that have a role in reading histone signatures (Du et al., 2015).    
A genome-wide analysis of DNA methylation in mESCs noted that patterns could be explained 
by vicinal histone methylation marks (Meissner et al., 2008). Generally, promoters of a high 
CpG density were unmethylated and associated with either house-keeping genes that were 
expressed and marked by H3K4me3 or silent developmental genes bivalently marked with 
H3K4me3 and H3K27me3. Meanwhile, low CpG density promoters were mostly methylated, 
with the exception of those marked by H3K4me2/3. At ICRs, the elements associated with 
imprinted genes as discussed above, a correlation with H3K9 methylation and DNA 
hypermethylation was noted. The relationship between these marks and DNA methylation is 
explored below (Meissner et al., 2008) (see Figure 1.4).    
Methylation of H3K9 in mammalian cells is conducted largely by the Suv39 subfamily of 
‘Suv39, Enhancer of Zeste, Trithorax’ domain containing proteins (Dillon et al., 2005; Wu et 
al., 2010). Despite their differential nuclear localisations, knockout studies and subsequent 
analyses of the global levels of methylated H3K9 suggests there is some compensation 
between different Suv39 members, but not sufficient to prevent lethality or adverse effects 
on viability (Esteve et al., 2006). 
The most dominant Suv39 is G9a, which acts in a complex with another transferase GLP, 
primarily at genic regions. The activity of this heterodimer accounts for the majority of 
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methylated H3K9, specifically H3K9me and H3K9me2, and is essential for embryonic 
development (Tachibana et al., 2002). The remainder of H3K9 methylation is accounted for 
by Suv39h1 and Suv39h2 that act at pericentric heterochromatin and Setd1 which marks 
ERVs with H3K9me3 (Matsui et al., 2010).  
Pericentric heterochromatin is distinguished by minor satellite repeats, which are bound by 
centromeric proteins. These proteins form complexes that have affinities for Suv39h1/2 and 
Dnmt3b that will then establish a transcriptionally inert state, mediating deposition of 
H3K9me3 and DNA methylation respectively. As Dnmt3b recruitment here is not directly 
dependent on H3K9me3, but rather on the binding of a centromeric protein, it follows that 
Suv39h1/2 knockouts do not result in DNA methylation loss at centromeric heterochromatin. 
However, a correlation is observed at major repeats, at which Dnmt3a can be recruited 
directly by Suv39h1/2 (Du, Lianna M. Johnson, et al., 2015). Suv39h1/2 appear to propagate 
H3K9me3 marks deposited in mESCs by Eset which silence intact and potentially functional 
ERVs and LINEs. The double knockout of Suv39h1/2 in mESCs can also promote a reduction 
in DNA methylation at specific LINE-1 families. In neuronal progenitor cells and MEFs, there 
was shown to be a handover from histone-based mechanisms of repeat repression by 
Suv39h1/2 and Eset to DNA methylation (Arand et al., 2012; Bulut-Karslioglu et al., 2014).  
Although H3K9me2 can independently regulate transcription, it also cooperates with DNA 
methylation in this capacity. 
The accumulation of H3K9me2 occurs rapidly upon exit from naïve pluripotency, following 
blastocyst implantation and gastrulation, coinciding with an increase in G9a and GLP protein. 
This can be modelled to an extent in vitro through the induction of mESCs to an epiblast-like 
cell (EpiLC) and eventual epiblast stem cell (EpiLSC) state, respectively (Zylicz et al., 2015). 
Application of retinoic acid to mESCs in vitro promotes differentiation and using this model, 
pursuant de novo methylation in a WT and G9a-null mESC line were compared to identify 
genes whose methylation is driven by G9a. Of the 126 genes identified, Oct3/4 was selected 
for further analysis, given its association with maintaining pluripotency. Interestingly, rescue 
of a G9a null line with a catalytically dead protein was sufficient to direct DNA methylation 
to the Oct3/4 promoter and prevent its expression upon withdrawal of retinoic acid. This is 
contrasted with the G9a knockout line within which Oct3/4 was re-expressed in a time 
dependent manner. However, that the gene was initially silenced demonstrates that histone 
modifications and DNA methylation are mechanisms that act downstream of other events at 
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this locus, serving to reinforce, rather than instigate, the silencing of the gene (Epsztejn-
Litman et al., 2008).  
In a separate study, numerous other genes that were demethylated and subsequently 
expressed upon the knockout of the G9a/GLP heteromer were shown to become 
remethylated and silenced following the introduction of a catalytically impaired complex. 
Conversely, H3K9me2 was present at the promoter region of some of these genes in separate 
Dnmt1 and Dnmt3a and -b-null cells lines, within which they were silent. This result would 
suggest therefore that at these loci, redundant mechanisms operate to silence the genes 
(Dong et al., 2008; Tachibana et al., 2008). A similar catalytically independent effect of G9a 
on DNA methylation was also observed at imprinted genes. This study identified the 
H3K9me1/2 binding ankyrin domain of G9a recruited the de novo transferases to deposit 
DNA methylation (T. Zhang et al., 2016).  
In contrast to endogenous sequences, it was shown that the silencing of a virally-transduced 
leukaemia sequence in mESCs is initially dependent on G9a catalytic activity and Dnmt3a. 
Directing the suppression after multiple passages however was Eset, provoking the need to 
consider the influence of transcription upon directing initial epigenetic silencing mechanisms 
and epigenetic switches when investigating DNA methylation (Leung et al., 2011). Work in 
other cell line lines has shown that there is an independent recruitment of G9a and DNMTs. 
For example, G9a knockdown or depletion of DNA methylation did not exert a reciprocal 
effect in HCT116 cells, suggesting early development represents a unique case. The disparity 
may reflect the epigenetic plasticity of mESCs, compared to the definitive state adopted by 
committed cells (S. Sharma et al., 2012).  
The above observations demonstrate that knockout studies can belie the role of histone 
methyltransferase proteins in regulating DNA methylation patterns. Overall, it is evident that 
the G9a protein, in conjunction with GLP, is important for the deposition of DNA methylation 
through the recruitment of Dnmts directly or indirectly through H3K9me1/2. To delineate 
the association further, it is apparent that global analyses of G9a/GLP knockout and 
catalytically dead cell-lines should be considered alongside loci specific effects. The validity 
of these studies would be enhanced if conducted in both pluripotent and differentiated cells 
as during this transition, transcription, DNA and histone methylation patterns are altered, as 
does the crosstalk between these.  
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Methylation of histones can also impede DNA methylation, specifically that of H3K4. 
Mechanistic studies showed that the addition of methyl groups at this position occludes the 
interaction between carboxylate groups of the ADD (alpha thalassaemia/mental retardation 
syndrome X-linked homologue (ATRX)–DNMT3–DNMT3L) domain within Dnmt3l, abolishing 
an interaction with the histone in the context of H3K4me2/3. Dnmt3l is an important co-
factor of Dnmt3a and -b in undifferentiated cells (Ooi et al., 2007). Furthermore, an isolated 
ADD domain within Dnmt3a was also shown to directly respond to H3K4 methylation, with 
binding affinities being reduced up to 10-fold in vitro (Otani et al., 2009).    
DNA methylation can also act instructively by dictating the distribution of H3K27me3. In 
mammalian tissue, DNA methylation and H3K27me3, modulated by Polycomb Group 
Repressor complex activity, are generally mutually exclusive at CpG rich sequences. 
Promoting DNA hypomethylation through DNMT impairment or knockout redistributes 
H3K27me3. Consequently, gene promoters and enhancer elements are differentially marked 
compared to hypermethylated controls, with only a minimal increase in global H3K27me3 
levels observed. The regions that gain H3K27me3 in a hypomethylated state are associated 
with high levels of DNA methylation in normal controls and conversely, regions that lose 
H3K27me3 typically have low levels of DNA methylation in controls. This effect imposes 
changes on gene expression and those associated with bivalent H3K4me3/H3K27me3 marks 
in WT cells are typically upregulated, which may be attributed to the loss the H3K27me3 and 
the subsequent gain of H3K27ac in some cases. In a MEF model at the HoxC cluster, upon 
loss of H3K27me3 there was accompanying increase in transcription and H3K4me3 across 
the region that became mostly strongly derepressed. The accumulation of H3K4me3 upon 
DNA demethylation at the same element however is not observed in mESCs (Reddington et 
al., 2013; King et al., 2016). 
Redistributed H3K27me3 is partly relocalised to gene promoters of a low CpG content and 
across gene bodies previously devoid of either H3K4me3 or H3K27me3 (Reddington, 
Pennings and Meehan, 2013). In contrast to the association with H3K9 methyltransferases, 
the relationship with DNA methylation and H3K27me3 is dependent wholly on the catalytic 
activity of the Dnmts as rescue of H3K27me3 patterns is only observed with genes that 
encode catalytically competent Dnmts. Interestingly however, reconstitution of Dnmt3a1 
and Dnmt3a2 imparts a greater overall but specific effect, compared to the introduction of 
Dnmt3b (King et al., 2016).  These observations demonstrate the indirect effects of DNA 
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methylation upon transcriptional regulation and should also be considered when accounting 
for changes in expression upon global demethylation (Reddington, Pennings and Meehan, 
2013).  
 
Figure 1.4 – A relationship between the methylation of DNA and histones has been observed. For 
example, DNA methylation is inhibited at regions vicinal to H3K4me3 whereas there is a strong 
relationship with H3K9me2/3. In this case, G9a can also recruit the de novo methyltransferases 
independently of its catalytic function. DNA methylation can also act instructively towards H3K27me3 
deposition and the marks are generally mutually exclusive on chromatin.  
 
1.5 Dnmt3  
The activities of Dnmt3a and -b are the means through which DNA is methylated de novo (Lei 
et al., 1996; Okano, Xie and Li, 1998).  
In E7.5 ectodermal tissue, expression of Dnmt3b, which is also uniquely found in mesoderm 
and endoderm, is considerably greater than Dnmt3a.  In E8.5 tissues however, Dnmt3b is 
detected weakly throughout the embryo and concentrates in the eyes and forebrain, whilst 
Dnmt3a by comparison is ubiquitous. Double homozygous mutant embryos die before E11.5, 
which is earlier than the single mutants, thus suggesting some functional redundancy in early 
development (Okano et al., 1999). Knockout studies in mESCs have shown that whilst 
Dnmt3a and -b have overlapping targets in some contexts, such as IAPs and several single 
copy genes, there is specificity at satellite regions for Dnmt3b. Meanwhile Dnmt3a has a 
preference for SINEs, Xist and the H19 imprinted gene (Okano, Xie and Li, 1998; Okano et al., 
1999; Chen et al., 2003; Arand et al., 2012). 
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Dnmt3b is also particularly enriched across gene bodies. Here, there is an overlap with RNA 
PolII binding, mRNA and H3K36me3 which are indicative of actively transcribed genes. A 
possible functional role is to regulate splicing or the silencing of cryptic promoters as 
discussed earlier (Illingworth et al., 2010; Reddington, Pennings and Meehan, 2013; Baubec 
et al., 2015).  
In mESCs, the major catalytically active isoform of Dnmt3a is Dnmt3a2, which is expressed 
from an alternative promoter and is ubiquitous in its localisation at chromatin. Upon 
differentiation, a longer form is expressed, albeit lowly, and is concentrated at 
heterochromatin in somatic cells. Variants of Dnmt3b arise from alternative splicing and 
similarly one particular isoform, Dnmt3b1, is more highly expressed in the pluripotent state. 
This is subsequently undetectable in somatic cells wherein -3b2, -3b4, -3b5 and the 
catalytically inactive -3b3 isoforms are expressed (Chen et al., 2003; Jurkowska, Jurkowski 
and Jeltsch, 2011).  
Dnmt3a is essential for spermatogenesis throughout which paternal imprints are established. 
Crosses between WT males and Dnmt3a conditionally deleted females, within which the 
transferase is not expressed in the germline, results in aberrant maternal imprinting, reduced 
repeat methylation and lethality by E10.5 (Kaneda et al., 2004).    
These phenotypes are comparable to the effects of disrupting the Dnmt3l allele, an obligate 
cofactor of Dnmt3a and -b. This lacks catalytic activity and a portion of the ADD regulatory 
domain (Bourc’his et al., 2001). In males, Dnmt3l is first expressed in spermatogonial stem 
cell precursors before birth and assists Dnmt3a in establishing methylation patterns at some 
imprints and transposable elements. Defects can be inherited in the spermatogonia, 
triggering aberrant expression of repeats that contributes to meiotic arrest prior to the 
pachytene stage of spermatogenesis and therefore infertility (Bourc’his et al., 2001; Hata et 
al., 2002; Kaneda et al., 2004; Webster et al., 2005). Similarly, Dnmt3l is necessary to 
establish imprints at regulatory regions in oocytes, with offspring exhibiting biallelic 
expression of unmaintained imprinted genes and lethality by E9.5 (Hata et al., 2002; 
Bourc’his and Bestor, 2004).  
In mESC models cultured in conventional medium, deletion of Dnmt1 predictably results in a 
global loss of methylation. Combinatorial knockouts of de novo transferases however 
demonstrate that these are required to top-up patterns that are not faithfully maintained by 
Dnmt1 alone and therefore offset the dilution of 5mC that would otherwise occur during cell 
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proliferation. The CpG periodicity of the sequences Dnmt3a and -b methylate is relatively less 
than those stretches maintained by Dnmt1 alone (Liang et al., 2002; Chen et al., 2003). 
Another study has shown that high density CpG promoter regions of LINE elements are also 
dependent on perpetual de novo activity (Li, Dai, Suzanne N. Martos, et al., 2015). That 
recombinant Dnmt3a and -b proteins have equal activity on hemi- and un-methylated 
substrates in vitro strengthens the case that they can act in combination with Dnmt1 (Okano, 
Xie and Li, 1998). Nascent chromatin capture is a process wherein biotinylated nucleotide 
analogues are incorporated into replicating DNA and then used as bait to identity interactors 
in nascent and mature DNA. Data obtained using this technique in HeLa cells supports the 
observations that latent de novo methylation occurs as Dnmt3a was enriched on mature 
chromatin (Alabert et al., 2014).  
Serial passage of Dnmt3a and -b-null mESCs is therefore associated with diminishing 5mC 
levels. This also likely impacts the recruitment of MeCP2 as there is a corresponding increase 
in H4Kac levels. The change in both of these epigenetic marks therefore contributes to the 
relationship between passage of the Dnmt3-null lines and the block in the ability to form 
teratomas and impaired differentiation capacity (Chen et al., 2003; Jackson et al., 2004). In 
haematopoietic stem cells, the inverse is observed; Dnmt3a and Dnmt3b are readily detected 
yet methylation levels are lower than lineage committed hematopoietic cells. When Dnmt3a 
and -b are deleted conditionally, cells are capable of differentiation into various lineages, as 
shown with in vitro assays, yet are unable to repopulate the bone-marrow of irradiated mice. 
Therefore, DNA methylation is unnecessary for lineage commitment from differentiated 
multipotent HSCs but is indispensable for self-renewal. Of note is that singularly deleting a 
de novo transferase had no effect, providing evidence of redundancy in this system 
(Tadokoro et al., 2007).  
That DNA methylation reaches a nadir in Dnmt3a, Dnmt3b -/- mESCs suggests that a 
minimum amount of DNA methylation is required before Dnmt1 recruitment falters genome-
wide. As differentiated cells have lower Dnmt3a and -b levels compared with mESCs cultured 
in traditional fetal calf serum (FCS)-based media, this would suggest the targeting of Dnmt3a 
and -b is highly efficient to minimise a progressive loss in DNA methylation in somatic cells 
(Liang et al., 2002; Baubec et al., 2015). 
De novo methylation during spermatogenesis in rodents is also mediated by Dnmt3c, a 
Dnmt3b paralogue that contains all the functional methyltransferase motifs and the N-
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terminal domain required for H3K4 binding. This specifically methylates the promoters and 
supresses activity of young and transcriptionally active LINEs and ERVs, which partially 
overlaps with the elements derepressed in Dnmt3l-null germ cells (Barau et al., 2016).   
In addition to the influence of histone modifications, de novo methylation anticorrelates with 
CpG density and transcription factor occupancy of a defined region within the promoter of a 
gene, even in the absence of active transcription (Lienert et al., 2011). Data also supports the 
notion that de novo methylation may occur in a feed-back loop whereby pre-existing 
methylation at an ERV increases the likelihood that it will be maintained in a clonal 
population whereas contrarily, intermediate levels result in a stochastic gain or loss of 5mC. 
Whilst this was observed in Murine Erythroleukemia (MEL) cell lines, mESCs in the same study 
were shown to methylate the ERV regardless of the starting levels of 5mC (Lorincz et al., 
2002).  
 
1.6 Dnmt2  
Before discussing Dnmt1 in detail, it is worth bringing to attention Dnmt2. This is present in 
almost all eukaryotes, including humans and mice. Structurally it lacks a large N-terminal 
regulatory region but contains all the characteristic sequences of a methyltransferase 
catalytic domain (Jurkowski and Jeltsch, 2011).  However, the substrates for Dnmt2 are tRNAs 
-Asp, - Gly and –Val at the C38 position and methylation stabilises the structures. In 
Drosophila, Dnmt2 is the only Dnmt-like protein and a role in DNA methylation has not been 
completely excluded yet (Lyko, Ramsahoye and Jaenisch, 2000; Kunert et al., 2003; 
Reviewed: Jeltsch et al., 2017). In isolation, the knockout of Dnmt2 in mice is not sufficient 
to generate a strong developmental phenotype with a reduced rate in the synthesis of 
proteins containing poly-Asp peptide runs being one of the few aberrations found so far 
(Jurkowski and Jeltsch, 2011; Jeltsch et al., 2017). However, if the tRNA-Leu 
methyltransferase NSun2 is also targeted, pups are born smaller than WT, with reduced rates 
of protein synthesis, an underdeveloped cerebral cortex and at ratios significantly less than 
expected by Mendelian inheritance (Tuorto et al., 2012; Jeltsch et al., 2017).  
An important role of Dnmt2 in modifying heritable small non-coding RNAs (sncRNAs) derived 
from tRNAs in sperm has also recently come to light. If a donor male is maintained on a high 
fat diet, glucose intolerance is inherited in the offspring. Notably, sperm from Dnmt2-null 
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mice does not produce this result, in which there is likely a disruption in the pool of sncRNAs, 
due to the impact on tRNA stability and a lack of sncRNA methylation (Zhang et al., 2018).   
 
1.7 Dnmt1 
Prior to mitosis, nascent DNA must be methylated in accordance with the pattern on the 
parental DNA strand and maintained as such during subsequent cell divisions. This is 
catalysed by Dnmt1 in conjunction with cofactors of varying necessity that ensure the 
inheritance of the methylation pattern. Although a compartmentalised model was presented 
initially, the de novo methyltransferases as discussed above also contribute during this 
process. This is necessary as the fidelity of Dnmt1 in mESCs is estimated to be approximately 
98% (Jackson et al., 2004). 
Displaying 86% sequence identity, it is unsurprising that crystal structures for mDnmt1 and 
hDNMT1 in conjunction with a DNA substrate suggests the same mode of action. Overlays of 
the bacterial M.Hha-1-DNA complex are also comparable for the majority of the ten 
conserved sequence motifs in the catalytic domain that define a methyltransferase 
(Takeshita et al., 2011; Z.-M. Zhang et al., 2015).  
In vivo, Dnmt1 has to recognise the appropriate substrate while interacting with the 
methylgroup donor AdoMet, before forming and then subsequently breaking a covalent 
bond with the cytidine ring of a nucleotide upon transfer of the methyl group (Takeshita et 
al., 2011). Once engaged with chromatin, the enzyme operates in a processive manner, 
transferring methyl groups to multiple hemimethylated sites without dissociating from the 
substrate after each individual reaction (Fatemi et al., 2001). Fidelity is increased at regions 
dense in CpG dinucleotides and is compensated for at sparser regions by the co-factors 
discussed below (Goyal, Reinhardt and Jeltsch, 2006). Replication foci arising at the earliest 
stage of the S phase of the cycle show an enrichment of Dnmt1, yet it becomes more 
concentrated at decondensed heterochromatin during the latter stages (Schermelleh et al., 
2007).  
In mESCs and other cell types, whilst the majority of methylation patterns are restored within 
1 hour post-replication, it takes a further 3 hours for all the appropriate marks to be 
established to the same extent as the parental cell (Charlton et al., 2018). This suggests a 
replication-uncoupled mechanism of Dnmt1 activity may also be operative, in addition to the 
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contributions of the de novo methyltransferases. Nevertheless, the modification status of 
neighbouring CpG dinucleotides correlate strongly, supporting the notion that Dnmt1 acts in 
a processive manner. This can give rise to a heterogenous population of cells that are present 
within different phases of the cell cycle and with various extents of methylation. Active 
transcription factor binding sites are preserved in a partially methylated state thus, 
demonstrating the influence transcription imposes on the methylome (Liang et al., 2002; 
Charlton et al., 2018).  
Dnmt1 is a large multi-domain enzyme of 1620 amino acids in the mouse and 1616 in humans 
(Jurkowska, Jurkowski and Jeltsch, 2011). The structure will now be discussed in a manner 
starting at the C-terminal catalytic domain through to the N-terminal regulatory domain (see 
Figure 1.5). 
 
Figure 1.5 – Schematic of the functional domains of Dnmt1. The role of each domain is discussed in 
the main text in detail. 
 
 1.7.1 Catalytic domain 
The methyltransferase domain of Dnmt1 is composed of a catalytic core and a target 
recognition domain (TRD) that confers an intrinsic affinity for hemimethylated sites, 
calculated to be over 40-fold relative to unmethylated nucleotides (Hermann, Goyal and 
Jeltsch, 2004). Engaging with double stranded DNA promotes a conformational change of this 
domain (Ye et al., 2018).  
Mutation of a series of evolutionarily conserved residues that comprise a hydrophobic pocket 
in the TRD that envelopes the methyl group on the parental strand, and others that stack 
with the base, can abolish methyltransferase activity or the specific affinity for 
hemimethylated substrates (Takeshita et al., 2011; Kanada et al., 2017). On the opposing 
unmethylated strand, a catalytic cysteine points towards the target cytosine residue that is 
flipped out of the DNA strand upon binding of AdoMet, and this is further stabilised by 
interactions with highly conserved residues that contact the base and the phosphate 
backbone (Song et al., 2012). Crystal structures of human DNMT1 show the catalytic residue 
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is poised for catalysis prior to an interaction with the methyl-donor AdoMet, whereas a 
conformational change is induced in mDnmt1 upon interacting with this co-factor (see Figure 
1.7) (Z.-M. Zhang et al., 2015). 
1.7.2 GK, BAH & CXXC Domains 
A stretch of glycine-lysine (GK) repeats is situated between the catalytic and N-terminal 
regulatory domains, a feature that is conserved amongst all eukaryotic homologues 
(Yarychkivska, Tavana, et al., 2018). This motif is highly flexible, rendering its resolution in 
crystal structures difficult. Nevertheless, substitution of the lysine residues with arginine, 
which prevents their acetylation, imparts de novo methyltransferase activity at paternally 
imprinted regions when the construct is used in Dnmt1 -/- mESC rescue experiments.  This 
raises the possibility that selective deacetylation of Dnmt1 in spermatogonia imbues it with 
an ability to establish imprints (Yarychkivska, Shahabuddin, et al., 2018). This also prompts 
the question as to whether specific insects and fungi that seemingly only have a maintenance 
enzyme also have integral mechanisms that promote a switch to a de novo methylation 
capacity (Bewick et al., 2016; Catania et al., 2017).  
The highly conserved tandem bromo adjacent homology (BAH) domains 1 and -2 are also 
demonstrably important for Dnmt1 activity. These are linked by an alpha-helix and when 
folded, adopt a dumb-bell configuration with BAH1 orientated closely to the catalytic 
domain. Found in a wide range of proteins with a chromatin remodelling function across 
different species, deletion of the BAH domains significantly impairs Dnmt1 recruitment and 
its capacity to maintain DNA methylation genome wide in mESCs, possibly owing to the 
absence of an essential intermolecular interaction (Yang and Xu, 2013; Yarychkivska, 
Shahabuddin, et al., 2018).   
A preparation of the isolated CXXC Zn finger DNA-binding domain has been described as 
possessing an affinity for both methylated (Fatemi et al., 2001) and unmethylated (Pradhan 
et al., 2008) DNA, indicating that Dnmt1 has multiple potential DNA binding sites. 
Nevertheless, others have shown that this is not essential for the loading of Dnmt1 onto 
chromatin (Schneider et al., 2013). This domain was initially posited to act in an 
autoinhibitory manner from resolved crystal structures of truncated proteins, contacting 
unmethylated cytosine residues to block methylation by the catalytic domain. However, this 
was not confirmed in other studies using full-length Dnmt1 in crystal structures or in vitro 
assays (Song et al., 2011; Takeshita et al., 2011; Bashtrykov et al., 2012).  
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The N-terminal domains that are by far the subject of most intensive focus are the 
proliferating cell nuclear-antigen (Pcna) binding domain (PBD) and replication foci-targeting 
sequence (RFTS) because of their functions in recruiting co-factors necessary for the loading 
of Dnmt1 onto chromatin.  
1.7.3 Pcna Binding Domain and RFTS 
Despite the affinity of the Dnmt1 catalytic domain toward hemi-methylated substrates, this 
property alone is insufficient to maintain methylation patterns in vivo. There is a dependency 
on additional recruitment factors that likely act cooperatively to target Dnmt1 to chromatin 
at the appropriate stage of the cell-cycle. In this regard, Dnmt1 is assisted by Pcna and Uhrf1 
that bind to specific sequences in its N-terminal regulatory domain. The importance of this 
terminus as a whole is also underscored by the detection of domain-domain interactions with 
the C-terminus and the inability of the isolated catalytic domain to methylate substrates in 
vitro. This suggests that a role of the N-terminal domain is to maintain Dnmt1 in an 
appropriate conformation (Fatemi et al., 2001). During proteolysis, fragments of the C-
terminal domain will therefore be unable to aberrantly methylate DNA if they associate with 
chromatin (Jurkowska, Jurkowski and Jeltsch, 2011).  
The RFTS to which Uhrf1 binds also serves an autoinhibitory function, with mutants impaired 
for an interaction between this domain and the catalytic region displaying greater activity in 
vitro (Bashtrykov, Rajavelu, et al., 2014).  When unbound to chromatin, the RFTS is inserted 
deeply into the catalytic pocket. This conformation is sustained by direct electrostatic 
interactions and hydrogen bonding, along with a linker helix between the CXXC and BAH1 
domain contacting both the RFTS and catalytic domain. The trigger for the unfolding of this 
structure is likely promoted by direct interaction with the SET and RING associated (SRA) DNA 
binding domain of Uhrf1 (Bashtrykov, Jankevicius, et al., 2014; Bashtrykov, Rajavelu, et al., 
2014). A range of neurological conditions associated with Dnmt1 mutations have been 
mapped back to this region and it is conceivable that the dysregulated enzymatic activity is 
due to impaired recruitment (Z.-M. Zhang et al., 2015).  
There is also a report that this domain mediates a homotypic dimerization and as it is 
particularly hydrophobic in nature, this property is likely the driving intermolecular force. 
Overall the necessity of this remains relatively unexplored and the temporal association of 
two Dnmt1 proteins requires investigation (Fellinger et al., 2009).  
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It was proposed that the loading of Dnmt1 hinges on Pcna in early to mid S phase, switching 
to Uhrf1 at latter stages wherein densely methylated and repetitive heterochromatin is 
replicated and therefore multiple hemi-methylated sites are presented for renewal. Partial 
deletion of the RFTS domain (459-501), which Uhrf1 binds, results in a weaker association to 
foci (Takebayashi et al., 2007; Schneider et al., 2013) and deletion of Uhrf1 results in global 
hypomethylation, impacting patterns in both euchromatin and heterochromatin (Bostick et 
al., 2007; Sharif et al., 2007). The differentiation potential of Uhrf1-null mESCs is also 
equivalent to Dnmt1-null mESCs (Bostick et al., 2007). This suggests Uhrf1 is the main 
regulator of Dnmt1 activity.   
Alternative splicing can give rise to a functional variant of Dnmt1 that lacks the PBD. This 
displays a ~2-fold lower efficiency in recruitment to replication forks and work in HCT116 
cells suggests that this equates to a 20% reduction in global methylation. The cells remain 
viable and healthy in vitro until further knockdown of the truncated transcript, indicating 
PCNA is not essential for the maintenance of DNA methylation (Schermelleh et al., 2007; 
Spada et al., 2007). This result can also be recapitulated in mESCs where Dnmt1 defective in 
Pcna binding can substantially restore methylation in Dnmt1 -/- lines. This suggests that the 
interaction is not strictly essential across multiple cell types and its involvement is necessary 
but limited to the recruitment during the early to mid-stages of the S phase in the cell cycle 
only (Schermelleh et al., 2007; Spada et al., 2007; Takebayashi et al., 2007). These 
observations also uncouple DNA methylation from replication, a conclusion enforced 
experimentally by immobilising Dnmt1 on chromatin which can still permit DNA replication 
to proceed (Spada et al., 2007).  
 
1.8 Uhrf1 
The multi-domain composure of Uhrf1 would feasibly enable it to assist Dnmt1 in processing 
hemimethylated sites, linking DNA methylation with histones through multivalent 
interactions. Uhrf1 contains the H3K9me2/3 binding tandem tudor domain (TTD) and plant 
homeobox domains (PHD), in addition to a hemimethylated CpG binding SRA domain (see 
Figure 1.6). Homologues found in A. thaliana and insects demonstrably perform similar 
functions but they are not necessarily dependent on the reading of histone marks (Bostick et 
al., 2007; Du  et al., 2015; Bewick et al., 2016). Furthermore, Uhrf1 can also bind directly to 
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unmodified H3, albeit inefficiently, and this interaction is enhanced by hemimethylated DNA 
(Fang et al., 2016).  
mESC lines heterozygous for WT and catalytically dead Dnmt1 alleles display a normal cell-
cycle dependent distribution of Dnmt1, suggesting that the residual methylation maintained 
by the WT protein is sufficient for Uhrf1 to bind the hemimethylated DNA and recruit both 
Dnmt1 variants. This is supported by the diffuse localisation of Dnmt1 in a heterozygous 
null/catalytically dead embryonic somatic cells which are globally hypomethylated. In mESCs 
with this genotype however, Dnmt1 localised to pericentric heterochromatin throughout the 
S phase (Takebayashi et al., 2007). As de novo methyltransferases are expressed in these 
cells, the amount of DNA methylation that is maintained may have been sufficient for Dnmt1 
recruitment by Uhrf1, coupled to an interaction with histone marks.  
Due to the mitotically arrested state of oocytes, evidence of Dnmt1 activity is minimal. It was 
therefore surprising that Uhrf1 knockdown results in a ~20% loss DNA in methylation, 
specifically across moderately methylated regions. This suggests that Uhrf1 in certain 
contexts can also influence de novo methylation (Maenohara et al., 2017). As de novo 
methyltransferases have an intrinsic preference for CpGs flanked by a purine at the 5’ end 
and a pyrimidine at the 3’ end , Uhrf1 may recruit Dnmt1 to methylate the opposing CpG that 
does not have  favourable neighbouring bases (Ravichandran, Jurkowska and Jurkowski, 
2018).  
 
Figure 1.6 – Schematic of the functional domains of Uhrf1. The role of each domain is discussed in the 
main text in detail. 
 
1.8.1 SRA domain 
The SRA domain of Uhrf1 is a concave structure which undergoes rearrangement upon 
binding of 5mC to enclose the opposing DNA strands. The methylated cytosine within the 
symmetrical dyad is flipped out and into a charged patch within the concave, stacking with 
highly conserved residues. Other residues of the SRA domain enter the vacated space and 
interact with neighbouring bases, including the guanine base previously bound to the flipped-
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out methylated cytosine. Loops that emerge from the conformational change may stabilise 
the interaction as they contact both minor and major grooves of the DNA. Despite all of this, 
the DNA retains its overall structure when engaged with Uhrf1. The configuration of the SRA 
regions and subsequent extensive network of interactions between the base and the pocket 
have been presented as the means through which hemimethylated patterns are 
discriminated from fully methylated dyads and other nucleotides, thus conferring specificity 
(Arita et al., 2008; Avvakumov et al., 2008; Hashimoto et al., 2008). Dnmt1 successively flips 
out the corresponding cytosine on the nascent strand which likely occurs, given the potential 
for steric clashes otherwise, upon Uhrf1 disembarking from the methylated cytosine (see 
Figure 1.7) (Hashimoto et al., 2008). Intriguingly, given the inhibitory effect on activity, 5-
hydroxymethylcytosine (5hmC) is also bound by the SRA domain of Uhrf1 with an affinity 
comparable to that of 5mC interactions (Frauer et al., 2011). The consequences of this on the 
maintenance of DNA methylation however remains to be investigated.  
 
Figure 1.7 – An overview of Dnmt1 and Uhrf1 facilitated maintenance DNA methylation. See main 
body of text of references. 
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At the molecular level, binding of hemimethylated DNA induces a conformational change in 
Uhrf1 whereby blockage of the TTD by a spacer region situated between the SRA and RING 
domains is alleviated. This enables a more favourable interaction between PHD-TTD and 
histones and for the spacer region to facilitate SRA mediated DNA binding otherwise as 
shown in vitro, histone modifications do not enhance an interaction between 
hemimethylated DNA and Uhrf1 (Fang et al., 2016).  
1.8.2 TTD and PHD domains 
Introduction of a point mutation (Y188A, human) in the aromatic cage structure of the TTD 
renders Uhrf1 incapable of binding H3K9me2/3. This mutant was unable to rescue DNA 
methylation in Uhrf1-null HeLa cells (Rothbart et al., 2012). Furthermore, mESCs deficient in 
DNA methyltransferases display a diffuse Uhrf1 localisation pattern, which would initially 
suggest that both marks, H3K9me2/3 and 5mC, are required for proper recruitment (Sharif 
et al., 2007; Rothbart et al., 2012). Direct evidence for the requirement of existing DNA 
methylation to recruit Dnmt1 comes from a study in which WT Dnmt1 was transfected into 
TKO cells and yet it remained diffuse and this was partially rescued with the reintroduction 
of a de novo transferase (Sharif et al., 2007; Takebayashi et al., 2007).  
The TTD also robustly interacts with DNA ligase 1 (Lig1) and this is abolished upon mutation 
of residues that accommodate H3K9me2/3 (human Y188A/Y191A). Further inspection of the 
LIG1 domain that mediates the interaction showed it bears a TARK motif that is found in H3 
tails and methylation of the lysine residue within this by G9a/GLP mediates the interaction 
with Uhrf1. Methylated Lig1 dependent co-localisation with Uhrf1 was confirmed in mESCs 
which had concordant effects on Dnmt1 too, demonstrating they form a complex (Ferry et 
al., 2017).   
The study from which this model was developed was fuelled by the disparity between 
convenient observations that Uhrf1 has a 10-fold more affinity to hemi-methylated DNA and 
can bind H3K9me2/3, against the sheer potential number of hemimethylated CpG sites 
during cell division: 25 million methyl cytosines per human cell and 30 million nucleosomes, 
with 50% bearing H3K9me2/3. Whilst this Lig1 model finesses how Dnmt1 is recruited, it is 
complicated by the fact that Lig1 -/- mESCs lines have no detectable loss of methylation, in 
contrast to mutants lacking the residues methylated by G9a/GLP. Furthermore, analyses of 
methylation levels of the mutated Lig1 cells which give striking effects on Uhrf1 recruitment, 
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still have ~30% more methylation than Uhrf1-null cells. This suggests that an alternative DNA 
ligase, such as Lig3, may substitute (Ferry et al., 2017).  
What requires reconciling for all models implicating histone or histone mimic modifications 
in Uhrf1 recruitment is that mice homozygous for a knock-in point mutation that renders 
Uhrf1 deficient for H3K9me2/3 binding are viable and fertile (Zhao et al., 2016). Conversion 
of tyrosine 187 and proline 188 to alanine in mUhrf1, equivalent to those used in the study 
cited above (Rothbart et al., 2012)  was sufficient to abolish H3K9me2/3 binding, however 
this only equated to an average of 10% less methylation across the genome in multiple tissues 
tested. This had no subsequent effect on H3K9me3, H3K27me3 or histone acetylation. Given 
the abundance of H3K9me2/3 over repetitive elements, it was surprising that DNA 
methylation levels were comparable to the global average loss. The reduction was accounted 
for by an inability of the mutated Uhrf1 to bind nucleosomes and utilise H3K9me2/3 to 
facilitate recruitment of Dnmt1 at demethylated sites at the dyads of nucleosomes (Zhao et 
al., 2016). Furthermore, a subset of genes, attention to which was drawn earlier, whose 
expression is regulated expressly by DNA methylation are also depleted of H3K9me2/3 
(Hackett et al., 2012). Collectively, this suggests DNA methylation can be maintained largely 
independently of H3K9me2/3 in differentiated tissue.  
On the other hand, ablating H3K9me3 levels through knockdown of Suv39h1/2 had no 
significant impact on Uhrf1 recruitment in NIH-3T3 cells. The effect on DNA methylation was 
not investigated in this case and recruitment may still have been achieved through binding 
to H3K9me2 marks deposited by alternative histone modifying enzymes, such as G9a/GLP 
(Papait et al., 2008).  
The implications of these studies are that in vivo, the predominant substrate for Uhrf1 
binding is hemimethylated DNA, mediated through the SRA domain. Therefore, why Dnmt1 
is responsive to histone modifications appears difficult to reconcile, particularly under the 
burden of evidence that healthy mice are born if the Uhrf1-H3K9me2/3 interaction is 
disrupted (Zhao et al., 2016). Could it be therefore that mESCs are a poor reflection of what 
truly occurs developmentally regarding epigenetics? The transient moment for which the 
state exists in vivo and the long-term culture of mESCs could be the source of the discrepancy. 
Global DNA methylation analyses and biochemistry would enhance our understanding of 
how strict the dependency on histone modifications or the proteins that conduct these are 
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in setting up or maintaining 5mC patterns in mESCs and somatic cells (Dong et al., 2008; Zhao 
et al., 2016).   
1.8.3 RING and UBL domains 
As the name suggests, Uhrf1 also has ubiquitination activity in the form of a RING domain 
and is therefore both a reader and writer of histone marks. The substrate in mammalian lines 
was identified as H3K18, a prerequisite for the localisation of Dnmt1 to chromatin (Qin et al., 
2015). Further work has revealed additional Uhrf1-dependent mono-ubiquitinated sites to 
which Dnmt1 binds in coordination with similar affinities: H3K14 and H3K18, K14 and K23 
and at K18 and K23 (Ishiyama et al., 2017).  
Although the RING domain is not required for Uhrf1 localisation and interaction with Dnmt1 
per se, when the ubiquitination function is defective, the recruitment of Dnmt1 is impaired 
and consequently methylation patterns are only marginally maintained during S phase 
(Nishiyama et al., 2013; Qin et al., 2015). The identification of a unique and conserved 
ubiquitin interacting motif (UIM) (mouse 380-399) in Dnmt1 provides evidence of a direct 
relationship. Interestingly, when this is deleted or mutated, there is an increased affinity for 
core histones. As this domain maps to the RFTS that also serves an autoinhibitory function, 
binding to H3K18 may be the trigger for the displacement from the catalytic domain. This is 
supported by in vitro studies demonstrating augmented Dnmt1 activity in the presence of 
H3Ub2 (Qin et al., 2015; Ishiyama et al., 2017). Furthermore, the ubiquitin like (UBL) domain 
of Uhrf1, which in isolation can stimulate Dnmt1 in vitro by 2-fold, structurally resembles 
ubiquitin. Deletion of this segment also negatively impacts Dnmt1 recruitment in mESC 
models (T. Li et al., 2018) and is critical for the E3 ligase activity. This is due to its role in 
binding to the E2 ligase UbcH5a and facilitating the transfer of a ubiquitin molecule UbcH5a 
bears to the RING domain of Uhrf1 (Foster et al., 2018).   
Ubiquitination is also dependent on binding of the PHD domain. Reportedly, this is due to 
recognition of H3R2 however, given its proximity to the ubiquitinated residues and a resolved 
crystal structure showing the residue within a lobe formed by RFTS, further work is required 
to understand the role (Qin et al., 2015; Ishiyama et al., 2017). 
The inclusion of the ubiquitination component to the Dnmt1 recruitment model presents an 
intermediate state that accounts for the fact that a stable interaction between Uhrf1 and 
Dnmt1 is not necessarily found unless the components are overexpressed (Nishiyama et al., 
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2013; Lu et al., 2015) (see Table 1.1). The identification of the UIM also raises the possibility 
that Dnmt1 can interact with the polycomb system. Indeed, Dnmt1 was found to bind to 
K119Ubq that is deposited by RING1A/B, components of PRC1. Dnmt1 can also interact 
directly with Ezh2 of PRC2, which may facilitate its recruitment (Qin et al., 2015).  
Taken together, one could posit a model in which Uhrf1 is localised to chromatin, primarily 
dictated by hemimethylation, which then sets up a more permissive state for Dnmt1 activity 
and facilitates its recruitment through H3K119Ubq. Experimental evidence supports a minor 
role of topoisomerase II-α (TopII-α) in regulating Dnmt1 activity at pericentric 
heterochromatin, albeit indirectly through an interaction with Uhrf1. The resolution by TopII-
α of precatenanes produced after DNA replication may present a more favourable substrate 
for Dnmt1 (Lu et al., 2015) (see Figure 1.8). 
 







1.9 Dnmt1 interactors 
The N-terminus of Dnmt1 is a platform for the binding of numerous transcriptional 
repressors. This has led to enquiries into the extent to which the phenotype of Dnmt1-null 
mice is dependent on DNA methylation per se or functions independent of this. Although the 
same outcome, lethality at E10.5, manifests in mouse models with a catalytically dead 
protein, this severe phenotype would still obscure other functions (Takebayashi et al., 2007).  
The N-terminus of Dnmt1 can bind HDAC1, HDAC2 and Dnmt1-associated protein 1 (DMAP1). 
These contribute to transcriptional repression either directly, or in the case of the latter, 
through interaction with other factors such as TSG101 (tumour susceptibility gene 101) 
Bait Cell line Reference 
Biotin-labelled Uhrf1 mESCs (Sharif et al., 2007) 
CBD-DNMT1 HEK-293T (Bostick et al., 2007) 
GFP-UHRF1 /His-DNMT1 Dnmt1-/- mESCs  (Qin et al., 2015) 
HA-FLAG-UHRF1 HeLa (Ferry et al., 2017) 
Endogenous DNMT1 HeLa (Felle et al., 2011) 
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(Rountree, Bachman and Baylin, 2000; Fuks et al., 2000). DMAP1 is critical for pre-
implantation development in its role as a TIP60/p400 complex component, maintaining ESC 
identity and differentiation potential (Fazzio, Huff and Panning, 2008), however this function 
appears to be mediated independently of Dnmt1. Conversely, levels of DMAP1 are important 
in the maintenance of imprints in early development (Rountree, Bachman and Baylin, 2000).  
The endogenous interaction of retinoblastoma (Rb) protein and E2F1 with the N-terminal 
domain of DNMT1 suggests that this portion can serve as a binding platform for multiple 
synergistically acting transcriptional repressors. This was shown to indeed be the case when 
HDAC inhibitors or a catalytically dead DNMT1 were only able to partially relieve inhibition 
of a reporter transgene. Likewise, when DNMT1 was co-transfected with Rb, there was 
repression of an E2F1 responsive ARF reporter. The use of an artificial E2F1 responsive 
reporter however demonstrated that DNMT1 alone was insufficient to modulate 
transcription and that Rb was required to initiate repression, which was potentiated by 
increasing DNMT1 amounts. Taken together, this suggests that DNMT1 could be specifically 
targeted to genes with E2F1 binding sites and that whilst Rb initiates repression in this 
context, silencing is ensured by DNMT1 activity or a dependent recruitment of additional 
repressors such as HDACs 1 and -2 (Robertson et al., 2000). Similar interactions with 
transcription factors have also been reviewed and represent a highly specific mode of gene 




Figure 1.8 - The recruitment of Dnmt1 to hemi-methylated sites and its activity in restoring a fully 
methylated CpG dyad is dependent on Uhrf1 for multiple reasons. The description that follows is not 
necessarily ordered in the sequence of events that occur in vivo as these have yet to be fully 
established. Dnmt1 adopts a conformation wherein the RFTS is inserted deep into its own catalytic 
domain. Upon interacting with the methylation binding SRA domain of Uhrf1, the RFTS is prompted to 
be removed. This presumably facilitates the interaction of the RFTS with ubiquitinated H3K18Ubq 
marks that are deposited by the RING domain of Uhrf1. Uhrf1 itself is localised to chromatin through 
a network of interactions between K9me2/3, mediated by PHD and TTD domains, and by the binding 
of the SRA domain to methylated sites. Other ancillary proteins assist in the loading of Dnmt1 onto 
chromatin. For example, Topoisomerase II-α (Topo II-α) interacts with Uhrf1 and likely deconcatenates 
DNA to present it in a more favourable conformation for DNA methylation. Methylated DNA ligase 1 
meanwhile can direct Uhrf1 to chromatin at H3K9me2/3 depleted regions. Furthermore, this whole 
process occurs under the influence of post-translational modifications which can affect protein 




Staining for heterochromatin protein 1- β (HP-1 β), and its binding site H3K9me2/3 in Dnmt1 
homozygous null and Dnmt1-null/catalytically dead mESCs would suggest that the 
localisation of HP-1 β is dependent on Dnmt1 recruitment to chromatin. Left unanswered 
however was whether it is dependent on Dnmt1 per se or on DNA methylation as catalytically 
dead Dnmt1 is unable to bind efficiently to chromatin (Takebayashi et al., 2007). There is also 
evidence that the chromodomains of all three mammalian isoforms of HP-1 (α, β, γ) co-purify 
with DNMT1 N and C-term domains in HCT116 lysates. In vitro assays suggested that DNMT1 
can increase HP-1 binding to an immobilised DNA substrate independent of its catalytic 
activity. This effect is reciprocated as the incubation of DNMT1 with HP-1 proteins promoted 
a 3-fold increase in the rate of substrate methylation. Furthermore, in more complex 
nucleosome arrays, the necessity of G9a dependent histone methylation was shown in order 
for HP-1 to be recruited to histones and to subsequently promote DNMT1 activity 
(Smallwood et al., 2007).  
Direct relationships between Dnmt1 and G9a have also been explored in cell lines and with 
in vitro assays. Knockdown of Dnmt1 in HeLa cells impaired the loading of G9a onto 
chromatin and reduced total H3K9me2 levels by 50%, compared to a 65% reduction upon 
G9a knockdown. An in vitro DNMT1 activity assay within which full length G9a and DNMT1 
were incubated, indicated that the association increases the rate of DNA methylation. 
Furthermore, in the absence of G9a in a colon cancer cell line, the methylation of a selected 
sequence was reduced by 60%. The reciprocal experiment, to determine whether Dnmt1 
promotes G9a activity, revealed only a relatively modest positive effect in vitro (Esteve et al., 
2006).  
This raises the possibility that G9a may have catalytically independent roles in maintaining 
DNA methylation, as has been shown for Dnmt3a and -b (Dong et al., 2008). The reciprocity 
model however does not translate wholesale to mESCs as Dnmt1-null and TKO cells have 
normal levels of H3K9me2/3 (Tsumura et al., 2006; Takebayashi et al., 2007). This 
relationship also contradicts that discussed earlier demonstrating G9a is dispensable for DNA 
methylation in other somatic cells (S. Sharma et al., 2012).   
Immunoprecipitations have also detected a DNMT1-SUV39H1 interaction, although this 
occurred post replication. The chromodomain of SUV39H1 can bind H3K9me2, which may 
then be modified further to H3K9me3 (Esteve et al., 2006). It would be of interest to 
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determine to what extent this SUV39H1 recruitment can account for post-replicative DNA 
methylation maintenance. 
1.9.1 Transcriptional control of Dnmt1 
Multiple signalling effectors have been implicated in the transcriptional regulation of 
DNMT1. This includes Ras which can be accounted for by the presence of c-Jun dependent 
enhancers and AP-1 binding sites amongst the four identified transcription initiation sites of 
DNMT1.  An interplay with the inhibitory effects of p53 and Sp-1 binding has also been 
described, in addition to inhibitory roles of microRNAs acting at the 3’UTR and protein coding 
regions (Kar et al., 2012). The 3’UTR of DNMT1 mRNA is also a site at which AUF1/hnRNP D 
protein binds, as demonstrated in HeLa, HEK-293 and T24 cells. Overexpression of AUTF1 
reduced DNMT1 mRNA stability however, as this was accompanied by impaired cell-growth, 
this effect could have been non-specific. Conversely, AUF1 knockdown led to increased 
DNMT1 protein. As levels of AUF1 anticorrelate with DNMT1 mRNA, this is an attractive 
candidate that accounts for the cell cycle dependent regulation of DNMT1 levels in particular 
tissues (Torrisani et al., 2007).    
Furthermore, the human DNMT1 protein was shown to be susceptible to inhibition by RNAs, 
namely the long non-coding RNA (lncRNA) asCEBPA-2HPE and micro-RNA (miRNA) miR-155-
5p, amongst others. These likely act as competitive inhibitors against the hemi-methylated 
substrate and are most potent when present in a G-quadruplex form. Whilst the effect was 
greatest in vitro, when miR-155-5p was transfected into HCT116 cells, changes were subtle. 
Nevertheless, as miR-155 is highly expressed in breast cancer, this warrants further 
investigation as it may illustrate a relationship with aberrant methylation observed in 
cancerous tissue (G. Zhang et al., 2015).    
1.9.2 Post-translational modification of Dnmt1 
Interactors may also possess enzymatic activity and chemically modify Dnmt1 by adding or 
removing a post-translational modification (PTM). Although Dnmt1 is reportedly decorated 
with PTMs (www.phospsite.org) few have been fully characterised (Jeltsch and Jurkowska, 
2016). Furthermore, a recent publication from the Bestor group that is discussed below, 
ought to stimulate a discussion as to whether manipulation of Dnmt1 levels through 
overexpression can bring about false candidate PTMs (Yarychkivska, Tavana, et al., 2018). 
What also needs to be considered is the proportion of Dnmt1 that would be modified by 
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endogenous levels of the interacting partner and whether the effect would manifest given 
there is a surplus of Dnmt1 in cells required to maintain DNA methylation (Gaudet et al., 
2003, 2004; Schermelleh et al., 2007). Those PTMs explored so far associate with both a 
stimulatory and inhibitory effect on activity and protein stability. A selection of these are 
discussed below and summarised in Table 1.2 
1.9.2.1 Phosphorylation 
Adenosine monophosphate (AMP)-activated protein kinase (AMPK) mitigates the effects of 
dysregulated mitochondrial function by promoting the activity of PGC-1a (peroxisome 
proliferator-activated receptor gamma coactivator-1a), a transcription factor whose 
downstream targets include nuclear respiratory factor 1 and -2 (NRF1 and NRF2), which 
regulate mitochondrial biogenesis (Marin et al., 2017).  
In a HUVEC (Human Umbilical Vein Endothelial Cell) model, DNMT1 activity was shown to be 
impaired by AMPK-mediated phosphorylation in response to cellular stress.  An interaction 
with phosphorylated RBBP7, a coactivator of histone acetyltransferase 1 (HAT1), then 
reportedly facilitated the transcription of PGC-1a, NRF1 and NRF2, amongst other genes. This 
coincided with increased mitochondrial mass and citrate synthetase and electron transport 
chain activity. Using a line in which DNMT1 is mutated so that it cannot be subject to AMPK 
phosphorylation, these cellular responses did not occur. The implication from this study is 
that reduced Dnmt1 activity leads to a permissive state for genes that regulate mitochondrial 
biogenesis to be expressed (Marin et al., 2017). This requires further deconvoluting as AMPK 
activation leads to cell cycle arrest (Marin et al., 2017) and therefore dilution of the 
methylation patterns from impaired Dnmt1 activity would not be able to account for the 
hypomethylated gene promoters.  
Phosphorylation of mouse Dnmt1 at serine 146 (S146) was identified and initial experiments 
using DNA-cellulose substrates suggested that this modification reduces the affinity of Dnmt1 
for DNA. In an in vitro catalytic assay however, the implications of this were not detected as 
the phosphorylated form performed similarly to a non-phosphorylated Dnmt1 (Sugiyama et 
al., 2010). An additional experiment to uncover an effect, if any, could be to titrate the 
amount of phosphorylated and non-phosphorylated protein in the in vitro assay as the 
minimal amount of Dnmt1 that may have bound in initial experiments could have been 
sufficient to achieve comparable rates of methylation.  
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An example of a phosphorylation that increases human DNMT1 activity is that at S154, and 
potentially the orthologous mouse S152. As this is mediated by cyclin-dependent kinases, 
this raises the possibility that it may occur in a cell-cycle dependent manner however, it is 
constitutively phosphorylated in the mouse (Lavoie and St-Pierre, 2011). Phosphorylation of 
residues within the N-terminal domain, like S154, have proven to induce Dnmt1 activity in 
vitro by stabilising an interaction with the C-terminal catalytic domain (Goyal et al., 2007). 
This explanation alone is insufficient and needs to be examined in the context of the 
conformational changes that occur in vivo when present at replication foci.   
Phosphorylation of the N-terminus of DNMT1 has also been suggested to regulate stability. 
Although western blots in the paper suggest a loose relationship, Sun et al. were prompted 
to follow the serendipitous observation that Phosphatidylinositol 3-kinase/protein kinase B 
(PKB) positively correlates with DNMT1 levels in multiple normal, transformed and cancer 
lines. An antagonistic effect of DNMT1 phosphorylation was found against ubiquitin-
mediated degradation, likely mediated by a downstream effector of PKB, glycogen synthase 
kinase 3β (Gsk3β) (Sun et al., 2007). As Gsk3β inhibition in mESCs does not affect Dnmt1 
levels, the universality of this mechanism is unclear (von Meyenn et al., 2016).   
The influence of phosphorylated S143 (human) and the adjacent methylation of K142 have 
been characterised as an interdependent switch that controls DNMT1 stability. As 
phosphorylation by AKT1 during mid to late S phase leads to an accumulation of DNMT1 in 
HEK-293 cells, this antagonises SET7-mediated methylation through steric hindrance. 
Depletion of AKT1 in HeLa cells reduced total DNMT1 protein levels and conversely, SET7 
overexpression led to reduced S143phospho species. Whilst levels of Lys142 methylation 
were shown to be most abundant between the end of G2 and the start of the next G1 phase, 
total endogenous DNMT1 levels and the modified forms subtly fluctuate when accounting 
for the margins of error depicted from quantified western blots. Nevertheless, DNMT1 
abundance does reach a maximum when the phosphorylated species is more prevalent than 
the methylated form (Esteve et al., 2009; Estève et al., 2011). The overexpression of the 
mediators therefore may over emphasise the actual extent that these modifications affect 






Ubiquitin was referred to earlier in the context of Dnmt1 recruitment to histones. However, 
this stable moiety is also associated with directing protein localisation, interactions and as 
exemplified here, initiating proteasomal degradation (Komander and Rape, 2012).  
Telomeres are specialised regions of heterochromatin that cap the end of chromosomes and 
offer protection from degradation. These stretches shorten with ageing in somatic cells and 
this results in cellular senescence. Multiple pathways are active in ESCs to ensure that 
telomeres are restored, thus enabling self-renewal. One such mechanism utilises zinc finger 
and SCAN domain-containing protein 4 (Zscan4) which is a characteristic marker, along with 
the retrovirus derived transcript Mu-ERV-L, of the 2-cell state that mESCs enter transiently. 
This state imbues mESCs with totipotent characteristics typical of early development 
(Morgani et al., 2013). Expression of Zscan4 and Mu-ERV-L correlates with low protein levels 
of Dnmt1 and Uhrf1 and incidentally cells in this state are globally hypomethylated. In a 
Uhrf1-dependent manner, Zscan4 interacts with both Dnmt1 and Uhrf1 and instructs Uhrf1 
to ubiquitinate itself and Dnmt1, likely precipitating proteasome-mediated degradation (Dan 
et al., 2017). In mESCs lacking Dnmt1 or Dnmt3a/b, telomere lengths are significantly longer 
than WT counterparts. Whilst the mechanism that leads to this increase has not been fully 
explained, the hypomethylated cells undergo more frequent telomeric sister-chromatid 
exchange events, suggesting that DNA methylation is a negative regulator of this process 
(Gonzalo et al., 2006).   
1.9.2.3 SUMOylation 
Small ubiquitin-related modifier (SUMO) is a moiety resembling ubiquitin that similarly acts 
on lysine residues.  Multiple potential targets in human DNMT1 have been found, spanning 
lysine residues between positions 412-1616. In vitro assays indicate that sumoylation has the 
potential to accelerate DNMT1 activity and overexpression of a SUMO ligase enhances 
binding of DNMT1 to chromatin, but that it is not essential (Lee and Muller, 2009). 
1.9.2.4 Acetylation 
Bridging the N and C-terminal domains of Dnmt1 are a series of GK repeats. It has been 
reported that these are subject to acetylation which enables Uhrf1 to ubiquitinate DNMT1 
and mark it for degradation. Deacetylation was shown to promote binding of ubiquitin-
specific protease 7 (USP7) and prevent this event (Du et al., 2010; Felle et al., 2011; Qin, 
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Leonhardt and Spada, 2011). However, in a more recent study, when endogenous USP7 was 
reduced to near undetectable levels in MEFs and human lung carcinoma cell line H1299, 
there was no subsequent effect on DNMT1 levels nor DNA methylation (Yarychkivska, 
Tavana, et al., 2018). The ramifications of this extend to other studies and should prompt a 
re-evaluation of conclusions reported for other PTMs in which overexpressed proteins were 
required to demonstrate an effect. Given the variety of different cell lines used across similar 
studies it would be interesting to investigate whether there are cell specific effects that may 
account for the discrepancies as not all the criticisms stand: knockdown of endogenous USP7 
and HDAC1, that potentially removes acetylated moieties from DNMT1, did have negative 
effects on DNMT1 levels in LS174T and RKO colorectal cancer cells, respectively (Du et al., 
2010; Felle et al., 2011) 
Of the examples discussed so far, the PTMs have been located in the N-terminal domain yet 
acetylation at the catalytic portion has also been found at Lys1349 and Lys1415 (human). 
When these are mutated to arginine residues to act as a lysine mimic in an exogenously 
expressed construct, the recovered lysate exhibits greater methyltransferase activity by 2-
fold in vitro relative to an overexpressed WT protein, suggesting that acetylation here is 
inhibitory. In vivo, deacetylation was shown to be mediated by SIRT1 however the biological 
context in which acetylation may be regulated was not explored (Peng et al., 2011).  
1.9.2.5 Poly-ADP-ribosylation 
Utilising NAD, poly ADP-ribose polymerases (PARP) generate polymers of between 2-200 
units that are either held in the catalytic domain or free and can bind non-covalently to 
proteins bearing a specific motif. One such example is DNMT1 that has two motifs in the N-
terminal regulatory domain. Lysates from L929 fibroblasts subjected to PARP inhibition were 
more active in a methyltransferase activity assay, compared to the control, whilst free and 
PARP1-bound polymers were sufficient to inhibit DNMT1 activity by up to ~90%. L929 
fibroblasts were further used to show an in vivo interaction between PARP1 and DNMT1. 
Whilst the authors speculate this mechanism may be important at CGIs (Reale et al., 2005), 
it would be interesting to investigate a potential role in DNA methylation reprogramming in 





Table 1.2 – Post-translational modifications of Dnmt1 and the respective effects 
Modification Method Effect 
Phospho S143 (human) by 
AKT1 
In vitro, Cos-7 cells, 
overexpressed with 
AKT1 
Phosphorylation by AKT1 
inhibits methylation of adjacent 
K142 by SET7, promoting 
stability (Estève et al., 2011) 
Phospho S146 (mouse) by 
CK1δ/ε 
Brain lysates using GST-
mDnmt1 as bait, in vitro 
Reduces DNA binding affinity 
(Sugiyama et al., 2010) 
Phospho S152 




endogenous and in vitro 
Increased Dnmt activity relative 
to non-phosphorylated form (in 
vitro with lysates from 
transfected HEK-293 cells) 
(Lavoie and St-Pierre, 2011) 
Phospho S154 (mouse) Murine Erythroleukemia 
cells, insect cells  
Increased Dnmt1 activity in 
vitro compared to non-
phosphorylated form 
(Glickman, Pavlovich and Reich, 





Facilitates interaction with 
RBBP7; reduced activity in 
nuclear extracts from HUVECs 
and MEFs; hypomethylation of 
promoters in MEFs, HUVECs 
and in vivo (aorta) (Marin et al., 
2017) 
Methylation K142 
(human) by SET7 
In vitro and HeLa cells, 
endogenous 
Knockdown of SET7 in HeLa 
cells led to a corresponding 
increase in Dnmt1; 
overexpression in HeLa were 
10% globally hypomethylated 









Enhances Dnmt1 activity (in 
vitro) and binding (HCT116) (Lee 
and Muller, 2009) 
Ubiquitination  mESCs, endogenous and 
overexpressed  
Expression of Zscan4 correlates 
with reduced Dnmt1 protein 
levels, likely driven by Uhrf1 
mediated ubiquitination (Dan et 
al., 2017) 
Acetylation K1111, K1113, 
K1115, K1117 (mouse) 
HEK-293T cells, 
overexpressed, HDACis 
Potentially involved in 
mediating proteasomal 
degradation or conferring de 
novo methylation function (Du 
et al., 2010; Felle et al., 2011; 
Peng et al., 2011; Qin, 
Leonhardt and Spada, 2011; 
Yarychkivska, Shahabuddin, et 
al., 2018) 




Reduces DNMT1 activity in a 




1.9.3 Post-translational modification of Uhrf1 
The interactome of Uhrf1 is discussed in Chapters 4 and 6. Below I have outlined the influence 
a number of Uhrf1 PTMs confer on its activity. Of note, Uhrf1 has been annotated with fewer 
PTMs compared to Dnmt1 (www.phospsite.org).  
Apparent from the studies summarised below is that Uhrf1 may have multiple DNA 
methylation independent functions. One such example discussed later entails its role in 
mediating the DNA damage response. Despite this, a study found that Uhrf1 protein declines 
with time upon irradiating cancer cells with UV light. Uhrf1 downregulation was initiated by 
the phosphorylation of a serine residue (human S108) situated within a degron (pSXXDpSG) 
by the kinase CK1δ. Consequently, this phosphorylated degron acts as a substrate for the 
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SCFβ-TrCP E3 ligase complex which is involved in the sequential ubiquitination of proteins for 
proteasomal mediated degradation (Chen et al., 2013) . These findings raise further 
questions with respect to how cells ensure there is sufficient Uhrf1 to regulate aspects of the 
DNA damage response, as discussed later, and what the biological relevance of 
downregulating Uhrf1 upon UV-induced DNA damage is. Furthermore, this also outlines a 
mechanism through which Uhrf1 protein stability may be regulated, a process that becomes 
clear is important in Chapter 3.  
Uhrf1 protein levels are also subjected to Pim1 dependent regulation (Yang et al., 2017). This 
kinase is constitutively active and can facilitate tumorigenesis by synergising with other 
oncogenes. However, its overexpression can also induce cellular senescence, an irreversible 
state of cell-cycle arrest. In this context, Uhrf1 was phosphorylated at S311 by Pim1 when 
the kinase was overexpressed in a fibroblast line, promoting Uhrf1 degradation. Conversely, 
when Uhrf1 was knocked down, markers of cellular senescence increased. These 
complementary observations led to the authors concluding that Uhrf1 degradation by Pim1 
results in the expression of senescence associated genes, such as p16, as the genes 
promoters are hypomethylated (Yang et al., 2017). Whether hypomethylation of the p16 
promoter through Uhrf1 downregulation alone is sufficient to drive expression or unrelated 
cell signalling events from Pim1 overexpression are accountable for the p16 levels require 
further dissecting. Nevertheless, other models of senescence, namely late passage primary 
fibroblasts, also display aberrant DNA methylation patterns (Cruickshanks et al., 2013), as 
discussed later.  Furthermore, knockdown of Uhrf1 was sufficient to induce senescence in 
primary cell lines in a separate study, suggesting Uhrf1 may have a central role (Jung et al., 
2017).  
Another phosphorylation event implicated in UHRF1 protein stability is S652 (human), 
mediated by CDK1-cyclin B. This UHRF1 phosphorylated variant peaked at the M-phase of 
the cell cycle in HCT116 cells, whilst total UHRF1 levels were lower, compared to other stages. 
The inverse relationship between phosphorylation and protein levels were attributed to an 
impaired interaction with USP7, a deubiquitinase that would otherwise protect UHRF1 from 
being degraded via the proteasome (Ma et al., 2012). As a decline in Uhrf1 levels results in 
senescence in primary cells lines, as shown above, and levels may fluctuate in cancer lines 
during the cell cycle, there unsurprisingly appears to be an uncoupling of the influence UHRF1 
may exert on the cell cycle in cancer models.  
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Of note, as this study manipulated levels of the endogenous USP7 and a correlation with 
UHRF1 stability was noted (Ma et al., 2012), these findings are spared some of the criticisms 
levelled at similar studies into the relationship between USP7 and DNMT1, as discussed 
above.  
The region of USP7 that mediates the interaction with Uhrf1 is a UBL domain (Ma et al., 
2012). Whilst Uhrf1 also bears this domain, as discussed above, it would be of interest to 
determine whether this directly activates Dnmt1. In vitro assays suggest that the UBL domain 
of Uhrf1 can increase the Dnmt1 activity by 2-fold (T. Li et al., 2018) as addressed earlier. 
However, this is complicated by the evidence showing Usp7 deubiquitinates histones in 
Xenopus extracts (Yamaguchi et al., 2017), which is an essential marker for Dnmt1 
recruitment in mESCs (Qin et al., 2015). It is therefore important to consider how these 
various interactions are integrated in a cell-specific manner.   
The importance of modifying Uhrf1 in a developmental context has been illustrated in 
zebrafish. Phosphorylation at S648 (human 661) is conducted by the cyclin-dependent kinase 
CCNA2/CDK2. When a WT or a nonphosphorylatable uhrf1 mRNA was coinjected with a uhrf1 
morpholino, only the WT form improved survival. Using immunofluorescence, it was shown 
that mutant uhrf1 is present in the nucleus of all cells whilst the WT protein resides in the 
nucleus and cytoplasm of some tissues (Chu et al., 2012). Whilst this goes against the usual 
perception of the function of Uhrf1, this is particularly interesting as it has been shown to 
shuttle out of the nucleus in models of murine pre-implantation development, raising the 
possibility Uhrf1 may have a role in the cytoplasm (Mulholland et al., 2018). Otherwise, the 
result from the zebrafish may demonstrate it is important to have temporal regulation of 
Uhrf1, which is abrogated with the mutant uhrf1 as it cannot shuttle into the cytoplasm.  
 
1.10 Tets 
Despite the stability of 5mC, it can be erased through a passive means wherein Dnmt1 activity 
is impaired and therefore the epigenetic marks are not maintained on newly synthesised 
daughter strands (Arand et al., 2015). Alternatively, active measures, mediated by the ten-
eleven-translocation (TET) enzymes, can iteratively oxidise 5mC to 5hmC, 5-formyluracil 
(5fC)- and 5-carboxylcytosine (5caC). The latter two products are then susceptible to excision 
from DNA as there is a destabilised interaction between the pyrimidine base and sugar-
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phosphate group. Removal is precipitated by Thymine DNA glycosylase (TDG), a Uracil DNA 
glycosylase (UDG), which leaves an abasic site. This is subsequently cleaved by AP 
endonuclease 1(APE1), to create a single stranded break, before DNA polymerase-β, XRCC1 
and DNA Lig3 coordinate ligation of the strand and restore an unmodified cytosine base (Wu 
and Zhang, 2017).  
Isoforms of two of the TETs, TET1 and TET3, are expressed in somatic tissue but also during 
junctions of epigenetic reprogramming, including in the early embryo. The products of TET 
activity are distributed heterogeneously across the genome and they are highly influenced 
by chromatin state. As such, TETs are enriched at enhancer and DNAse-hypersensitive sites 
with low CpG density and moderate methylation. On the other hand, whilst TET1 is enriched 
at CGIs marked with H3K4me3 in mESCs of highly expressed genes, 5hmC levels are low, 
which is keeping with observations that 5mC, the initial substrate of TETs, is also usually 
absent. Across gene bodies, 5hmC levels increase from the transcriptional start site, at which 
they are depleted, to the termination site. The relationship with these regions suggests that 
direct recruitment by regulatory factors can direct TET activity. These distribution patterns 
however appear to be cell specific (Tahiliani et al., 2009; Kohli and Zhang, 2013; Wu and 
Zhang, 2017).  
Owing to its abundance in various tissues however, 5hmC should not only be regarded simply 
as a 5mC derivative on its way to excision, but potentially as having a function. For example, 
levels are 40% of all 5mC in cerebellar Purkinje neurones whilst half this amount is present 
in heart tissue. This abundance of 5hmC in this cell type is likely related to their postmitotic 
state as replication-dependent dilution does not occur. Conversely, products of 5hmC are 
scarce across all tissues (Kriaucionis and Heintz, 2009; Kohli and Zhang, 2013). In addition, 
5hmC and indeed 5f-and 5-caC are binding site for proteins that show little affinity for 5mC, 
and these readers can form complexes with other chromatin modellers. Inversely, these 
marks can also repel 5mC readers. Whilst the number of 5hmC readers is modest in mESCs, 
levels are greatest in adult brain tissue for example in which 5hmC is high. This could be 
explained by a change in the absolute protein level of the reader in the different cell types in 
some cases (Spruijt et al., 2013). As roles independent of catalytic activity are also evident, 
as well as the capacity to physically prevent Dnmt recruitment to loci, further work is required 
to dissect the specific function of 5hmC from the TETs (Wu and Zhang, 2017). 
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During PGC specification, which will not be discussed at length, and post fertilisation of the 
oocyte, a wave of demethylation that erodes marks on the paternal and maternal genome 
occurs. Evidence supports that this process entails synergistic passive and TET-mediated 
active pathways (von Meyenn et al., 2016).   
 
1.11 Methylation life cycle 
The genome undergoes extensive epigenetic remodelling in pre-implantation development 
(Smallwood and Kelsey, 2012). Genome scale analyses have been employed to map the 
progressive loss of methylation that occurs upon fertilisation and up to the formation of the 
inner-cell mass (ICM) and implantation at E4.5. This epigenetic reprogramming occurs 
asymmetrically with the paternal complement of the genome losing marks at a relatively 
faster rate than the maternal component (Smith et al., 2012; Peat et al., 2014) (see Figure 
1.9). The mechanisms that execute this epigenetic reprogramming can be broadly classified 
as passive or active. A passive measure to promote hypomethylation involves the impairment 
of methylation maintenance, meaning that DNA methylation patterns will not be restored 
with progressive rounds of cell division. With time, 5mC will therefore be diluted. In active 
demethylation for example, Tet3 can be employed to propagate the direct removal of 5mC 




Figure 1.9 – DNA methylation is reprogrammed after fertilisation. The paternal complement of the 
genome (blue line) is subject to both passive and pervasive active mechanisms of demethylation. 
Meanwhile, the maternal genome (red line) is also reprogramed but is protected from extensive active 
mechanisms. Methylation of repeat sequences derived from both genomes are typically preserved 
throughout this window, as are marks at imprints due to the action of Stella and Zfp57. After 
implantation of the blastocyst around E4.5, new methylation patterns are established in a tissue 
specific manner under the influence of histone marks and transcription during differentiation. The 
time at which the de novo transferases, Dnmt3a and –b, are first expressed is shown. Dnmt1 and 
Uhrf1, an important co-factor for Dnmt1 activity, are expressed throughout albeit at relatively lower 
levels than differentiated cells. Adapted from Smallwood and Kelsey, 2012.  
 
In this section, I outline the evidence supporting the notion that impairment of DNA 
methylation maintenance is the predominant mechanism through which demethylation 
occurs in pre-implantation development.  
Generally, in seeking to understand the biological importance of demethylation in pre-
implantation development, maintaining the view that transcription is negatively affected by 
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DNA methylation would be narrow and to ignore the evidence discussed above that some 
transcription factors have a preference for methylated motifs (Yin et al., 2017). Imposing a 
model in which DNA methylation regulates transcription in one direction therefore needs to 
be replaced with a nuanced view at individual motifs and transcription factors. Subsequently 
the impact of inhibiting DNA demethylation on gene expression should be viewed through 
the prism of this specific approach.    
1.11.1 Demethylation  
Generally, intergenic regions and gene bodies incur the greatest loss of methylation after 
fertilisation, with LINEs also enriched as examples reprogrammed (Peat et al., 2014; Shen et 
al., 2014). Gene regulatory elements such as enhancers, miRNAs and long intergenic non-
coding RNAs (lincRNAs) also follow the trend toward hypomethylation, typically from a 
higher starting methylation state in spermatocytes relative to oocytes (C. Li et al., 2018). At 
the blastocyst stage, methylation levels of the ICM are approximately 20% of the starting 
combined methylation state, with trophoectodermal cells that develop into the placenta 
having a slightly lower amount (Maenohara et al., 2017). Data collected from human 
equivalents at similar stages show that comparable dynamic changes also occur. Exceptions 
include sequence-specific repetitive elements and satellites however, this reflects the 
differing starting methylation level across species (Smith et al., 2014; C. Li et al., 2018).  
Comparatively, oocytes are roughly two-fold more hypomethylated globally relative to 
sperm but are hypermethylated in the context of CGIs that reside in intragenic 
transcriptionally active regions (Smallwood et al., 2011; Santos et al., 2013). In this regard, 
oocytes have been described as having a distribution more similar to early embryonic stages 
wherein there is a weak correlation with local CpG density and methylation. On the other 
hand, post-implantation embryos, somatic tissue and sperm are highly methylated at lower 
CpG densities and marks tend to be excluded from CpG dense regions (Smallwood et al., 
2011; Smith et al., 2012). 
Throughout the window of epigenetic reprogramming in pre-implantation development, 
Dnmt1o is expressed. This is a truncated Dnmt1 isoform from an oocyte-specific transcript 
that lacks the first 118 N-terminal residues. Despite an estimate that it is 2000-fold more 
abundant than full-length somatic Dnmt1 (Dnmt1s), this isoform resides in the cytoplasm for 
all but the 8-cell stage when it is trafficked into the nucleus and contributes to the 
maintenance of imprints (Ratnam et al., 2002) and X-chromosome inactivation in 
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extraembryonic tissues (McGraw et al., 2013). Contrary to this, Dnmt1s is detected in nuclei 
throughout the majority of the pre-implantation sequence; a weaker association is initially 
observed with the paternal pronucleus but on the onset of cell division, levels are comparable 
to the maternal pronucleus. The two-cell stage sees Dnmt1s transit out the nucleus in G2, 
possibly through exportin-mediated export, otherwise it remains nuclear and chromatin 
associated in subsequent S phases (Kurihara et al., 2008). Dnmt1s levels notably increase 
after the 2-cell stage, coinciding with zygotic gene activation (ZGA), and peak at the blastocyst 
stage (Cirio et al., 2008). In parallel, faint IF signals of Uhrf1 are also detectable throughout 
pre-implantation development where, as in other tissues, it is important for maintaining DNA 
methylation. Knock-out of the maternal gene decreases methylation levels at both maternal 
and paternal imprints, in addition to regions that are resistant to reprogramming in control 
cells (Maenohara et al., 2017). 
The Dnmt3a de novo transferase meanwhile is oocyte derived yet levels beyond the 8-cell 
stage and up to implantation are undetectable. Conversely, Dnmt3b is distinguished as it is 
produced in the embryo on the onset of division to a 4-cell state and accumulates thereafter 
(Hirasawa et al., 2008). 
Low levels of the Dnmts and Uhrf1 are likely contributing factors to the progressive loss in 
methylation however, the extent to which requires experimental validation as mouse models 
have an excess pool of Dnmt1 (Gaudet et al., 2003, 2004; Schermelleh et al., 2007).  
1.11.1.1 Active demethylation in pre-implantation development 
Immunofluorescence staining illustrated that the paternal genome is subjected to 
replication-independent 5mC oxidation by Tet3 throughout pronuclear stages. Additional 
evidence from Tet3-null models demonstrated that this process contributes mainly at single-
copy loci, such as Oct4 and Nanog although others were not able to assign any genomic 
features that could distinguish these cases from other methylated sequences (Hashimoto et 
al., 2012; Guo et al., 2014). Whilst Tet3 becomes more diffuse in the cytoplasm at later 
stages, the high 5hmC signal persists up to the 8-cell stage and therefore Dnmt1 will continue 
to be disposed to its effects as it has an inability to restore 5mC at an opposing 5hmC mark 
(Hashimoto et al., 2012; Arand et al., 2015). At most genomic loci however, particularly those 
densely methylated in sperm, Tet3-null zygotes displayed only a minor defect in 
demethylation. Furthermore, clustering of methylation sequencing data of pronuclei placed 
Tet3-null models and WT closer together than patterns from null and WT pronuclei treated 
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with a cell-replication inhibitor. This suggested that Tet3-independent passive demethylation 
is the major mechanism that promotes epigenetic reprogramming in pre-implantation 
development (Peat et al., 2014; Shen et al., 2014).   
The biological significance of Tet3 activity has nevertheless been investigated with 
conditional deletion in oocytes; when females with this mutation were mated with WT males, 
there was a significant reduction in viable offspring. This may be associated with the 
compromised demethylation and subsequent expression of Oct4 from the 4-cell stage 
onward as, determined using an EGFP-Oct4 transgene as a proxy. At the blastocyst stage 
however, the levels of EGFP-Oct4 were comparable to WT mice, so this may be unable to 
wholly account for the lethal effect, despite it being suggested as such. Whilst pre-
implantation development progresses normally in this circumstance, and transplanted 
embryos implant, prenatal development occurs at a reduced rate. Conversely, Tet3 deletion 
from male germ cells could be compensated by WT females in heterozygous offspring (Gu et 
al., 2011).  
One study suggested that broadly, demethylation of genes is coincident with transcriptional 
activation, an intriguing prospect given the enrichment of ZGA examples at the two-cell stage 
and the effects of Tet3 deletion on viability (Gu et al., 2011; Peat et al., 2014). Others have 
shown that the absence of Tet3 in the mouse has no significant impact on gene expression 
profiles, including ZGA and the small number that are downregulated are not enriched for 
examples of genes directly dependent on Tet3 for 5mC removal (Shen et al., 2014). In 
equivalent human stages of development, the global trend also suggests an uncoupling of 
methylation and gene expression (Smith et al., 2014). 
As referred to earlier, Tets can act at the beginning of a process to actively remove DNA 
methylation. The products that Tets generate then serve as substrates for other enzymes 
that can lead to the restoration of a cytosine base (Wu and Zhang, 2017). The biological 
importance of these enzymes have been investigated across multiple studies, as discussed 
below. Collectively however, the conclusions minimise the role that active mechanisms likely 
play in pre-implantation demethylation.  
Tdg can cooperate with Ape1 and Xrcc1 to excise 5caC derived from the iterative oxidation 
of 5mC by Tets and 5-hydroxymethyluracil (5hmU) from the deamination of 5hmC by 
activation-induced deaminase (AID) activity. Conceivably Tdg may contribute to 
demethylation in pre-implantation development yet mRNA levels are negligible and 
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knockout models are embryonic lethal at E11.5. This corresponds to findings in vitro whereby 
the impact on gene regulation is minimal in ESCs and the effect is strongest in differentiated 
lineage committed cells (Morgan et al., 2004; Cortázar et al., 2011; Cortellino et al., 2011; He 
et al., 2011; Pfaffeneder et al., 2014; Wu and Zhang, 2017).  Tdg is also highly unlikely to act 
directly on 5mC substrates as in vitro analyses suggest it has a 30-40-fold greater activity 
against base-pair mismatches (Gehring, Reik and Henikoff, 2009). Levels of 5mC are also 
comparable between zygotes lacking maternal Tdg and WTs (Guo et al., 2014).  
An alternative mode of demethylation similarly involving AID proposes that unmodified 
cytosine bases are first subject to deamination, forming a uracil base, before repair is 
initiated by uracil glycosylase (UNG2). Long-patch base excision repair (BER) would then 
precipitate a loss of adjacent 5mC marks. Whilst cytosine has been shown as the preferred 
substrate of AID above modified forms, owing to steric hindrance imposed by methyl groups, 
(Hashimoto et al., 2012; Santos et al., 2013; Schiesser et al., 2013) such a mechanism raises 
questions regarding the specificity and the purpose of invoking the initial cytosine 
deamination event. Other work has cast doubt on the extent to which the mechanisms 
involving AID and the related enzymes APOBEC could contribute to epigenetic 
reprogramming. Overexpression of these components in HEK-293T cells had no measurable 
effect on 5mC or 5hmC levels (Nabel et al., 2012). 
Nevertheless, Xrcc1, Ape1 and Parp1, another BER factor, are present in the male pronuclei 
of zygotes and were seen to localise to chromatin on the onset of epigenetic reprogramming. 
The separate chemical inhibition of Parp1 and Ape1 was sufficient to significantly reduce the 
demethylation of 5mC in zygotes as measured by immunostaining of paternal pronuclei. A 
significant effect upon LINE-1 elements only emerged with Parp1 inhibition, suggesting 
specificity of the mechanisms (Hajkova et al., 2010). It is important to note that Parp1 can 
directly inhibit Dnmt1 activity, which is currently unexplored in the context of pre-
implantation development (Reale et al., 2005). Perversely, Parp1 can modify the SRA domain 
of Uhrf1 to increase its binding to Dnmt1, as revealed in co-immunoprecipitations (Co-IP) 
from NIH 3T3 cells. Furthermore, Parp1 reduced the apparent Uhrf1 directed ubiquitin-
mediated degradation of Dnmt1, although additional controls in a repeat experiment would 
be necessary to definitively conclude this. Nevertheless, a Parp1-null cell line had equally 
efficient loading of Dnmt1 onto heterochromatin as a WT line and the DNA methylation 
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profile at these regions was also comparable (De Vos et al., 2014). This suggests the effects 
on Dnmt1 may dominate in pre-implantation development. 
A common mechanism invoked by active demethylation processes entails the recruitment of 
DNA damage repair enzymes. In a study into the regulation of DNA damage in the zygote, it 
was observed that Xrcc1 deletion in the oocyte led to increased DNA damage markers in 
zygotes prior to the first round of cell division however, these lesions resolved in interphase. 
Furthermore, knockout of a cohesion subunit, Scc1, similarly led to the accumulation of DNA 
damage markers in the paternal pronuclei in G2 phase of the cell-cycle. Consequently, there 
was an extended interphase arrest or Chk1-dependent delay into mitosis in these lines. In 
this background, chemical inhibition of Tet3 significantly reduced the abundance of DNA 
damage markers and partially abrogated the block with an improvement in the number of 
zygotes that entered mitosis recorded. Live-cell imaging demonstrated that if left unrepaired, 
DNA lesions generated by Tet3 activity lead to anaphase bridges and embryo fragmentation 
(Ladstätter and Tachibana-Konwalski, 2016).    
1.11.1.2 Passive demethylation in pre-implantation development 
Notably, despite the potential contribution of Tet3, inhibiting DNA replication at the zygotic 
to 2-cell stage transition prevents reconfigurations of DNA methylation at most loci, 
illustrating a dependency on passive modes of demethylation. This is supported by the 
persistence of hemi-methylated CpG dyads throughout pre-implantation development, 
reflecting impaired methylation maintenance (Guo et al., 2014; Shen et al., 2014; Arand et 
al., 2015). 
As a representative genomic class, LINEs exhibit the most pronounced demethylation during 
the sperm to zygotic stage in humans and mice (Smith et al., 2014). In the mouse, ~50% of 
LINE-1 CpG dyads are on average present in a hemimethylated state, albeit distinct families 
are more resistant. In contrast, demethylation at ERV and SINEs progresses relatively 
uniformly (Shen et al., 2014; Arand et al., 2015). Such a loss may be causative for their 
transcriptional activity, shown to be important for pre-implantation development due to 
effects on chromatin conformation and gene transcription (Kigami et al., 2003; Beraldi et al., 
2006; Thompson, Macfarlan and Lorincz, 2016; Jachowicz et al., 2017). It has been suggested 
however that their demethylation may be counteracted by de novo methylation after the 2-
cell stage, despite the rapid downregulation of the machinery at equivalent stages, before a 
sharp drop is again promoted prior to the blastocyst stage (Arand et al., 2015). Of note, the 
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absence of Tet3 has no significant impact on the expression of these elements either (Inoue, 
Matoba and Zhang, 2012; Shen et al., 2014).  
In contrast to the male complement, the maternal genome undergoes some 
hydroxymethylation at a broad range of genomic elements but is largely protected from 
pervasive Tet3 activity; the extent of which however is disputed (Guo et al., 2014; Peat et al., 
2014). Nevertheless, a small overlap in regions actively demethylated in both male and 
female pronuclei during early pre-implantation development have been identified (Guo et 
al., 2014). The differential rate of demethylation has been attributed to the action of the 
maternal effect gene Dppa3/Stella and its binding partner RanBP5. The absence of Stella, or 
a perturbation in its nuclear localisation, promotes extensive demethylation of the maternal 
genome in pronuclear stages, impacting some imprinted genes and repeats (Nakamura et al., 
2007). Its mode of action is dependent on the G9a deposited H3K9me2 mark, to which it 
binds with high affinity. As this mark is particularly enriched across the maternal pronuclei 
the rate of demethylation proceeds more slowly, possibly through an inhibitory effect on 
Tet3 and BER components (Hajkova et al., 2010; Nakamura et al., 2012).  
1.11.2 Inheriting DNA methylation patterns 
Heritable methylation patterns, defined as such as they deviate from the global trends and 
are resistant to loss throughout cleavage divisions, have been identified by comparing 
regions hypermethylated in either gamete and hypomethylated in the other. The quantity of 
regions contributed by sperm are greatest and reside in intergenic regions, in contrast to 
oocytes which are CGI-associated. These loci are highly methylated in the respective gamete 
and are distinct from imprinted genes, which retain the sex-specific pattern against the global 
loss of methylation (Smallwood et al., 2011). With respect to reconfigurations in the human, 
methylation dynamics are represented by 10 varying patterns. Notably, there is local 
maintenance of patterns across gene bodies; nearly two thirds were shown in one study to 
retain at least some methylation at the blastocyst stage compared to sperm.  Divergent 
regulation is evident at methylated regions derived from oocytes, but this contrasts with ICRs 
which are conserved. Diversity between mouse and human extends to the demethylation 
and transcription of repeat elements, owing to species specificity (Smith et al., 2014).  
Zebrafish inherit parental methylation patterns and are not subject to global erasure in 
embryogenesis. Paternal patterns are identical to those of pluripotent embryos whilst 
maternal marks are gradually erased concurrently with cleavage divisions against 
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a background of histone pattern remodelling (Murphy et al., 2018). Throughout the growth 
of the pre-implanted embryo and two phases of ZGA, an increasing number of 
promoters become more accessible, as determined by ATAC-seq, and therefore the 
corresponding genes are more likely to be transcribed. Whilst there is some correlation 
between the time at which a specific site is more accessible and CpG density, the strongest 
predictor is the extent of DNA methylation; more densely methylated regions are associated 
with delayed accessibility. This is likely to be driven by CXXC domain-containing factors that 
bind preferentially to unmethylated CpG sequences. This relationship however doesn’t hold 
true when applied to distal regulatory regions that similarly emerge during ZGA. These have 
relatively high levels of DNA methylation and are enriched for binding sites for the zebrafish 
Oct4 homolog and Nanog, which induce a local hypomethylation when engaged. Cell 
signalling changes will therefore likely dictate the binding of these factors and not simply the 
removal of DNA methylation (Liu et al., 2018). If there is evidence of the association with 
residual methylation and accessibility in the mouse, this may enable a function to be assigned 
to these marks that are not associated with imprinted regions.  
Mosaic hypomethylation patterns associated with ZFP57 mutations provided evidence that 
this Kruppel-associated box-containing zinc-finger protein (KRAB-ZFP) protects the 
methylation status of ICRs genes post-zygotically, and the establishment of a subset in 
oocytes (Li et al., 2008; Mackay et al., 2008). This function occurs through the binding to a 
methylated hexanucletoide sequence situated within an ICR, prior to recruitment of KRAB-
associated protein 1 (KAP1), a scaffold for a number of histone modifying proteins. 
Immunoprecipitations in ESCs have also demonstrated a direct interaction with Dnmts -1, -
3a, -3b and Uhrf1, thus potentially creating an environment that can withstand the global 
loss of methylation in pre-implantation development (Quenneville et al., 2011). Indeed, sites 
targeted by ZFP57 are methylated in oocytes and these marks are retained as such in ESCs 
and pre-implanted blastocysts (Strogantsev et al., 2015).  
Inactivation of Zfp57 is embryonic lethal by E14.5–E16.5 whilst the use of mESCs models 
shows an effect on the expression of only 9 imprinted genes. The aberrant 
expression is generally associated with the acquisition of H3K4me3 at the Zfp57 binding site, 
which would further impede the reestablishment of methylation patterns. Interestingly, 
there is an enrichment of H3K4me1/3 at these sites in differentiated tissues; this mark may 
be present on the unmethylated allele otherwise this would suggest that the effects of 
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Zfp57 supersede the inhibitory effect of H3K4 methylation in dictating the activity of de novo 
transferases (Riso et al., 2016). Zfp57 binding sites are interesting loci to study for how 
histone methylation marks influence the deposition of DNA methylation patterns. In TKO 
cells for example, there is a loss of H3K9me3 at Zfp57 binding sites, supporting a model in 
which Zfp57 binding is dependent on DNA methylation, enabling recruitment of histone 
modifying complexes (Quenneville et al., 2011). However, in Zfp57-null mESCs, there is a loss 
of both H3K9me3 and DNA methylation (Riso et al., 2016), suggesting that Zfp57-driven 
histone methylation operates within a feedback loop.  
1.11.3 Implantation and remethylation 
The establishment of new methylation patterns at low and intermediate density CpG 
promoters is coincident with uterine implantation, predominantly through the action of 
Dnmt3b. On average, methylation is a poor predictor of gene expression but correlates 
strongly with silencing when present within a CGI. This is exemplified by germ-line specific 
and X-linked genes and some tissue-specific transcription factors (Weber et al., 2007; Borgel 
et al., 2010; Isagawa et al., 2011). In most cases, the underlying methylation pattern is 
dictated by neighbouring histone marks, which are also subject to renewal during early 
development (Mikkelsen et al., 2007; Meissner  et al., 2008; Isagawa et al., 2011).  
The majority of DNA methylation is deposited in the E6.5 epiblast with promoters of 
pluripotency related factors such as Tcl1 being subject to modification. Lineage specific 
differences between early germ layers are limited but methylation accumulates as 
development progresses. A further set of pluripotency genes, represented by Rex1 and Stella, 
become modified at E9.5, and tissue specific methylation patterns are adopted (Borgel et al., 
2010; Isagawa et al., 2011). The differentiation of multipotent stem cells is accompanied by 
small changes in promoter methylation and the majority are relayed to daughter cells (Weber 
et al., 2007; Sørensen et al., 2010). Marks deposited across clusters of intermediate CpG 
density promoters are also potentially erased in a tissue specific manner during terminal 
differentiation, exemplified by brain, eye and haematopoietic specific genes in the respective 
tissues (Borgel et al., 2010).  
ESCs are counterparts to the ICM of E3.5 blastocysts from which the embryo derives. As this 
population retains their developmental potential when explanted, as evidenced by their 
ability to contribute to the three germ layers in chimeras, their enforced differentiation in 
vitro has proven a useful tool in tracking the dynamics of methylation as specific cell fates 
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are adopted (Marks and Stunnenberg, 2014).  Despite the development of alternative culture 
methods that will improve the veracity of the pluripotent state (discussed later), they have 
provided further evidence for the accumulation of DNA methylation and the influencing 
factor of histone marks; high density CpG regions in neural progenitor cells that lose 
H3K4me3 partially acquire 5mC and this is accentuated when there is a complete loss of 
H3K27 and H3K4 methylation at previously bivalent promoters (Meissner et al., 2008). 
Separately, it was shown that promoting the differentiation of mESCs through application of 
retinoic acid stimulates G9a to target DNA methylation to the Oct3/4 locus, whereby the 
modification and heterochromatin formation occurs after the silencing of the gene and it 
demonstrably ‘locks’ in a transcriptionally repressive state (Feldman et al., 2006; Tachibana 
et al., 2008). 
This relationship has also been corroborated in hESCs stimulated to differentiate randomly. 
Gene ontology analysis inferred that gains in methylation occur predominantly at genes 
related to developmental processes, such as organogenesis and anatomical structure 
development. In this study however, the CGIs that behaved in this way were notable for their 
enrichment at the 3’ end of genes. Furthermore, the tissue specific differential methylation 
correlated positively with expression. An overlap of this stretch of nucleotides with a CTCF 
binding motif suggests a mechanism analogous to that which is operative at the H19/Igf2 
imprint control region. Here, methylation would abolish CTCF binding and prevent the 
insulating effect it would have on the ability of an enhancer to act on an upstream promoter 
(Yu et al., 2013).  
The tracking of hESCs induced to differentiate into motor neurones illustrated differential 
dynamics of the de novo DNMTs during lineage fate commitment: DNMT3A levels were 
sustained highly throughout whereas DNMT3B was rapidly downregulated upon initiation. 
As expected, genes and regulatory elements associated with alternative lineages acquire 
methylation in differentiating WT cells but more prominent is the demethylation at genes 
associated with spinal cord and neural tube development. In the absence of DNMT3A, global 
methylation levels in progenitor and differentiated cells are comparable to those from a WT 
line however, differentiation is significantly impaired, as is the viability and fitness of 
differentiated cells. Within the window of differentiation, intermediate progenitor cells from 
the DNMT3A-null line were shown to express markers associated with the gliogenic lineage 
more highly than a neuronal lineage. Cross referencing the genes with aberrant methylation 
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and expression returned a list of 148 DMRs and these tended to overlap with gene enhancer 
elements. An absence of methylation at a regulatory element of PAX6, a master neurogenic 
factor, failed to promote its expression as this likely permitted the binding of a repressor. 
Conversely, DNMT3B knockout has no significant effect during this specific differentiation 
pathway on efficiency, despite the number of DMRs that arise compared to WT cells being 
much greater than in the case of DNMT3A-null hESC differentiation (Smith et al., 2014; Ziller 
et al., 2018). This further presses the need to unpick relationships between methylation and 
transcriptional changes, which ultimately drive the fates of differentiating cells. 
In addition to promoters, methylation patterns are established at the enhancers of 
pluripotency genes following differentiation cues, primarily due to Dnmt3a recruitment in 
response to H3K4me1 and H3K27ac erasure by the Lsd1-Mi2/NuRD complex. This activity 
correlates with reduced expression of the associated gene (Petell et al., 2016). These distal 
regulatory elements are regions at which most of the changes in DNA methylation actually 
occur during differentiation (Meissner, 2010). This transition is also in part influenced by the 
binding of pioneer factors that can protect remodelling at tissue specific loci. For example, 
FoxD3 binds to the Alb1 enhancer during endoderm differentiation, which proceeds 
diversification to a hepatocyte lineage, and Ptcra enhancers are protected by Sp1 and E 
protein in thymocyte specification (Xu et al., 2009). This aforementioned study however was 
concerned only with the correlation between DNA methylation and transcription factor 
binding, leaving the biological relevance of the relationship to be explored. It nevertheless 
puts into context the influence transcription factors exert over DNA methylation machinery.  
The relationship between gene expression, specifically that of variant native transcripts, and 
the methylation of CpG patches distal to promoters is displayed too at the Zdbf2 locus. This 
gene is expressed in multiple regions in the mouse brain. Following fertilisation however, it 
remains methylated on the maternal allele and is regarded as being transiently imprinted 
throughout pre-implantation development. During this developmental window, a longer 
isoform is expressed briefly from a transcription site residing within a paternal germline DMR. 
Upon implantation and acquisition of methylation across the locus on both alleles, 
H3K27me3 is evicted and this induces the derepression of a shorter form expressed from a 
somatic DMR upstream of the promoter (Greenberg et al., 2017). This mechanistic study 
elegantly encapsulates the interplay between epigenetics, both methylation and histone 
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modifications, and transcription, whilst also exploring the functional role of partially 
demethylated loci.  
 
1.12 Methylation in disease and altered cell states 
Methylation patterns are not necessarily maintained indefinitely in somatic tissues, with 
changes observed in ageing, cellular senescence and more dramatically in cancer and ICF.  
1.12.1 Senescence and ageing 
Senescence describes the process of cell proliferation arrest, which can prevent tumour 
formation. A panel of morphological and gene expression changes are associated with this 
cell state, in addition to modifications to chromatin and an altered DNA methylation profile. 
In this case, there is global hypomethylation, predominantly at late replicating and laminin 
associated domains that are partially methylated in the equivalent primary cell line and at 
lowly expressed genes. Modest hypermethylation is also evident at early replicating domains 
and is significant at the periphery of genes repressed in senescence, such as cell cycle 
regulators. The mechanism that imposes the differential effects would be interesting to 
uncover, with suggestions including a redistribution of Dnmt1. This becomes more pertinent 
as the methylation patterns in senescent cells, with respect domains and genes predictive of 
clinical outcome, resemble those in cancer (Cruickshanks et al., 2013).  
The functional significance of the DNA methylation changes in senescence are currently 
unknown. This is similar to the examples seen with ageing, in the so-called epigenetic clock. 
Variable levels of DNA methylation can arise at CGIs, bivalent domains and Polycomb targets 
with age. Interestingly, these changes can be used to develop models that predict biological 
age from the methylome of a wide variety of tissues. Changes have been shown to occur 
more rapidly during earlier years however, this is unlikely to reflect mitotic age as non-
proliferative tissues also exhibit differences. Furthermore, cancerous tissue tends to deviate 
from this model and in the case of breast cancers, different stratified tumour classes display 
variable rates of ageing (Horvath, 2013). This particular observation supports the need to 
consider transcriptional changes, and the inputs that influence these, when deciphering the 





A comprehensive review of the role of DNA methylation in cancer is beyond the scope of this 
thesis however, comments on some important findings are found below.   
The observation that aberrant DNA methylation is present in nearly all human neoplasms 
makes it an attractive source of investigation in the pursuit of therapeutic agents, particularly 
in cases of hypermethylated tumour suppressor genes (Jones and Baylin, 2002). Indeed, 
epigenetic medicines, such as DNMT inhibitors (DNMTi), have FDA approval for the 
treatment of acute myeloid leukaemia (AML) and their use in combinatorial therapies with 
other drugs targeting epigenetic modifiers has been explored (Jones, Issa and Baylin, 2016).  
A role in gene silencing and the potential for spontaneous deamination, resulting in a C to T 
transition, are possible mechanisms through which DNA hypermethylation could promote 
cancer development. Studies in colon cancer cell lines suggest that signalling pathways which 
regulate Dnmt activity are also perturbed: impairing DNMT1 had little effect on global 
methylation levels and it required combinatorial knockouts of DNMT1 and DNMT3B to confer 
a notable change. Furthermore in the same study, silenced p16 was re-expressed and the 
growth rate of the line was significantly reduced upon application of a demethylating agent 
(Jones and Baylin, 2002).  
This case is an illustration of the 50 % of genes shown to be mutated in familial cancer that 
also undergo hypermethylation. Other silenced genes of predicted importance for cancer 
development have no consistent mutation and therefore the main driver of their suppression 
is potentially epigenetic (Jones and Baylin, 2002). 
Experimental models have also shown a causal link between DNA hypomethylation and 
neoplasia.  Compound heterozygous mice carrying null and hypomorphic Dnmt1 alleles were 
generated and the expression of the protein was 10% of WT levels. The majority of mice 
developed thymic tumours, with nearly all tumours exhibiting a gain of multiple 
chromosomes and c-myc overexpression. A follow up study determined that 
hypomethylation can promote loss of heterozygosity (Eden et al., 2003; Gaudet et al., 2003). 
Although these models are extreme cases of hypomethylation, they serve as a proof of 
principle that perturbation of DNA methylation levels can be causative. Nevertheless, large 
numbers of malignant tumours and metastases with low methylated cytosine content have 
been screened. An increase in LINE-1 and ERV mobility, and subsequent mutational 
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insertions, expression of proliferation associated genes and chromosomal rearrangements 
from demethylated satellite sequences were noted (Ehrlich, 2002).  
Although the examples above provide compelling evidence for a role of dysregulated DNA 
methylation in cancer, to establish that hypermethylation is neoplastic, it is important to 
evaluate the expression of aberrantly methylated genes in both cancerous and preneoplastic 
tissue. For this, the specific cell type from which the cancer arose within a tissue, the 
presence of alternative promoters and whether the methylation is a secondary event 
following an upstream silencing event are important considerations (Bestor, 2003; Sproul 
and Meehan, 2013), as are evaluations of copy-number alterations (Martin-Trujillo et al., 
2017). There is also evidence that promoters of CGIs associated with genes found frequently 
hypermethylated in a large variety of cancers are typically silent in the tissue of origin prior 
to neoplasia. The majority of hypermethylated genes may therefore be regarded as 
passenger genes, distinct from the driver genes whose methylation can promote neoplasia 
(Sproul et al., 2011, 2012). The importance of assessing transcriptional profiles is further 
underscored by observations that in vitro culture of primary cell lines can impose changes to 
the methylation profile (Varley et al., 2013; Nestor et al., 2015).    
Furthermore, the therapeutic benefits of DNA demethylating agents may not necessarily 
depend on the expression of silenced tumour suppressor genes but rather the promotion of 
an immune response driven by the presence of dsRNAs from endogenous repeats that 
become expressed. This causes a cascade of antiproliferative and pro-apoptotic interferon 
response genes that can engage the immune system (Chiappinelli et al., 2015; Roulois et al., 
2015) 
1.12.3 ICF 
A disease that brings to light secondary structural roles of DNA methylation is ICF 
(immunodeficiency, centromere instability and facial anomalies). This is characterised in 
humans by hypomethylated satellite 2 and 3 of constitutive pericentromeric 
heterochromatin of chromosomes 1, 9 and 16 in all cell types. Thread-like chromosomes 
prone to breakage are also found in lymphocytes (Xu et al., 1999; Jin et al., 2008). Patients 
can be stratified depending on the additional demethylation of alpha satellites and females 
can also present a hypomethylated inactive X-chromosome however, perturbations in 
expression of X-linked genes are minimal. Sequencing has shown that the majority of cases 
can be explained by point mutations within the catalytic domain of Dnmt3B, resulting in 
64 
 
substitutions or splicing defects that impair the protein function. In compound heterozygous 
patients, nonsense mutations within the N-terminus of the gene can also be causative (Jiang 
et al., 2005).  
Furthermore, mutations that cause substitutions, splice defects and interestingly, given the 
absolute requirement in mouse models, null alleles of the interacting partner Lsh/HELLS are 
associated with the emergence of the disease (Thijssen et al., 2015). Deleterious mutations 
in the zinc finger domains of cell division cycle associated 7 (CDCA7) and ZBTB24, which 
encodes a transcription factor important for regulating CDCA7, and more generally B- and T-
cell differentiation, account for other cases (de Greef et al., 2011; Thijssen et al., 2015). The 
mechanism in which these mutations cause ICF has recently come to light with use of a 
Xenopus model. Under these circumstances, there is reduction in Lsh loading at chromatin 
due to a disrupted interaction with CDCA7. Together, these act in a bipartite complex to 
remodel chromatin, which is demonstrably a prerequisite for DNA methylation at satellite 
sequences (Jenness et al., 2018).  
The phenotype of ICF provides evidence for the role of DNA methylation in maintaining 
chromatin integrity and for the specificity of the methyltransferases as evidently, DNMT3A 
or DNMT1 could not compensate for reduced DNMT3B function. It would be of interest to 
determine whether the recruitment of DNMT3B to the hypomethylated sequences still 
occurs in the disease and if this occludes DNMT3A from compensating. Further work is also 
required to dissect heterogeneous transcriptional changes in patients. Evidence suggests 
that altered promoter methylation is not a sufficient explanation for all genes and may be an 
effect of redistributed H3K27me3 (de Greef et al., 2011).   
1.12.4 Rett Syndrome 
A rare disease related to the function of DNA methylation is Rett syndrome. Mechanistically, 
the Rett syndrome phenotype is attributed to the reduced binding of mutated MeCP2 to 
methylated DNA and with other complexes that influence transcription, potentially through 
histone modification. Downstream, many cell specific effects have been observed, 
encompassing a variety of biological processes (Leonard, Cobb and Downs, 2017).  
Patients have reduced brain volume and poor synaptic connectivity between neurones. 
Conditional knockout mouse models yield a phenotype only in the region from which it was 
deleted, and additional consequences emerge with whole knockouts. This includes fatty liver 
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and aberrant bone structure, suggesting a role of MeCP2 in non-neuronal tissue (Leonard, 
Cobb and Downs, 2017). The importance of this factor extends beyond early development as 
post-natal deletion in adult mice results in Rett syndrome-like symptoms (McGraw, Samaco 
and Zoghbi, 2011). Conversely, rescue reverses many of the defects (Guy et al., 2007).  
The overwhelming majority of patients are female and because the gene is X-linked, it is 
typically fatal in males. However, mutations in MeCP2 that do not manifest as Rett syndrome 
in females can lead to mental retardation in males (Chahil, Yelam and Bollu, 2018).  
The molecular mechanism of this disease illustrates the complex relationship between DNA 
methylation and the histone code and the cascade of events that develop under particular 
circumstances in different cell types.  
 
1.13 Modelling pluripotency 
The culture of mESCs in conventional medium, supplemented with either FCS or BMP4 and 
the cytokine LIF, is appropriate to maintain a heterogeneous population of differentiated and 
pluripotent cells (Ying et al., 2003). A contributing factor to this heterogeneity is the capacity 
of LIF to engage the gp130 receptor, which simultaneously leads to activation of the 
pluripotency promoting STAT3 transcription factor and the pro-differentiation Ras-Erk 
signalling cascade. Whilst cells integrate the insulating effects of serum or BMP4 that regulate 
levels of Inhibitor of Differentiation (Id) proteins via R-Smad protein phosphorylation (Ying et 
al., 2003; Marks and Stunnenberg, 2014), the networks are insufficient to wholly prevent 
differential expression of markers associated with ESCs and PGCs. This is best represented by 
variable levels of Stella, Nanog and Oct4 across the population of cells cultured in this 
medium. In addition, cells representative of an intermediate state between ESCs and late 
epiblast stem cells (EpiSCs), which markedly express Fgf5, can also co-exist. Separating the 
populations by these markers and testing the respective developmental potential 
demonstrates that the high Nanog and Oct4 expressing cells are more efficient at generating 





Figure 1.10 - Serum-based culture is insufficient to shield the pro-differentiation effects of Fgf4 which 
is secreted from mESCs in an autocrine manner. Additionally, LIF promotes the maintenance of 
pluripotency however, as it also influences Mek activity, it has antagonistic effects. Media 
supplemented with serum or one particular component of this, Bmp4, activates Smad signalling and 
this positively regulates Id proteins that stabilise the undifferentiated state. In 2i+LIF media, Mek 
activity is abrogated with the addition of PD0325901. Furthermore, the degradation of β-catenin is 
prevented through the inhibition of Gsk3β with CHIR99021. This enables β-catenin to disrupt Tcf3, 
which would otherwise negatively affect the expression of pluripotency genes. Adapted from Marks 
and Stunnenberg, 2014 
 
The development of an alternative medium referred to as 2i + LIF has enabled mESCs to be 
harvested from pre-implanted blastocysts and propagated in vitro to an extent that ground 
state pluripotency is more closely recapitulated (Ying et al., 2008; Marks et al., 2012). This 
term refers to the developmental period before inductive fibroblast growth factor 4 (Fgf4) 
signalling promotes specification of the ICM into the hypoblast, the source of extraembryonic 
tissue such as the yolk sac, and the priming of the naive epiblast to respond to developmental 
cues and differentiate into germ layers that constitute the embryo (Silva and Smith, 2008; 
Nichols and Smith, 2009).  
Prohibiting the differentiation of mESCs in culture driven by mitogen-activation protein 
kinase (Mek) and the canonical Wnt pathway component Gsk3β, is achieved with the 
inhibitors PD0325901 and CHIRON99021 (CHIR99021), respectively. Collectively, when used 
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in a chemically defined base medium with LIF, this is termed 2i+LIF (Ying et al., 2008). From 
hereafter, it will be referred to as 2i.   
The rationale for developing a model system in which Mek is inhibited was explained by the 
evidence that Fgf4 exerts an effect through this signalling axis. Furthermore, exposure of pre-
implanted blastocysts to 2i prevents the emergence of the hypoblast and the ICM becomes 
entirely pluripotent epiblast (Nichols et al., 2009; Wray, Kalkan and Smith, 2010). As Fgf4 is 
produced in an autocrine manner by undifferentiated ESCs, this could prompt a commitment 
to differentiate into various lineages whereas in the presence of PD0325901, this influence 
is abrogated. This is a direct result of reduced Erk1/2 phosphorylation, an intermediate in 
Mek signalling that leads to neuronal or mesodermal differentiation (Kunath et al., 2007).  
At the molecular level, Gsk3β inhibition results in the stabilisation of β-catenin and this 
interacts directly with Tcf3 and alleviates its binding to chromatin. This Tcf/Lef transcription 
factor would otherwise negatively influence the expression of core pluripotency transcription 
factor targets (see Figure 1.10) (Silva and Smith, 2008; Wray, Kalkan and Smith, 2010; Wray 
et al., 2011). 
The majority of transcriptional changes occur within 48 hours upon transitioning mESCs from 
serum-based cultured to 2i media (Hackett et al., 2013; Galonska et al., 2015). Whilst ~75% 
of genes are expressed at similar levels, that cells are maintained more robustly in a 
pluripotent state in 2i is reflected in reduced expression of ectoderm and mesoderm 
specification genes relative to serum media. There is also higher expression of Prdm14 which 
can act to supress extraembryonic endoderm transcription, but markers of this lineage are 
generally expressed to a similar extent (Marks et al., 2012; Marks and Stunnenberg, 2014).  
On the other hand, a greater number of transcripts associated with stem cell maintenance 
are present at higher levels within serum culture. Nevertheless, in 2i there is a uniform 
expression of the pluripotency regulators Rex1 and Nanog, which may further antagonise 
signalling mediated through Mek (Ying et al., 2008). Furthermore, Nanog is biallelically 
expressed in 2i, thus recapitulating the transient state in vivo when this occurs in early 
development. The expression of other important auxiliary genes expressed in serum culture 
are absent in 2i, such as c/N-Myc, which underscores the dramatic transcriptional rewiring 
that occurs (Marks and Stunnenberg, 2014).  
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Proteomic analysis suggests that many of the transcriptional changes have a corresponding 
effect on protein abundance. In accordance with gene expression data, Gene Ontology and 
KEGG analyses stipulate that proteins involved in metabolic processes, linked to the 
reduction in c/N-Myc levels and the influence of Mek and Gsk3β on glucose processing, are 
more enriched in 2i. Meanwhile, mesoderm and ectoderm development classes are 
represented strongly in serum culture (Ying et al., 2008; Taleahmad et al., 2016). 
Various iterations of the base media to which 2i is added impose differential outcomes in 
mESCs on the expression of genes and retrotransposons, particularly those of the ERV class, 
that are associated with either primed or naïve pluripotent states. Distinct clusters are 
evident in principal component analyses between conditions with 2i additives and those 
without, which reflect more naïve and primed states of pluripotency respectively. Application 
of either inhibitor individually promotes the expression of master primary germ layer genes 
but these are nearly extinguished in combination, demonstrating the interdependency to 
dampen the effects of differentiation promoting networks. Another distinction is the 
expression of genes associated with the two-cell stage of pre-implantation development, 
such as Zscan4. These are more highly expressed in a 2i base media containing KnockOut™ 
Serum Replacement (KOSR) compared to N2B27 (Hackett et al., 2017). Further details about 
these two different base media are discussed in chapter 3.   
Interestingly, culture of E2.5 embryos in N2B27+2i for a period of 3 days was insufficient to 
supress the emergence of a subpopulation of cells coexpressing both pluripotent markers 
and the trophoblast marker Hex, amongst other examples. The trophoblast is the outer 
epithelial layer of cells of the blastocyst that develop into the placenta. This property 
reflected a pre-implantation stage during which early cells are totipotent. Indeed, when Hex 
positive cells were sorted and used to form chimeras, there was evidence that they 
contributed to embryonic and extraembryonic lineages (Morgani et al., 2013). Whether 2i 
therefore can sustain the propagation of a cell that has the potency of both ground state 
epiblast and EpiSCs would be an interesting path to follow (Brons et al., 2007). Nevertheless, 
this observation provides further support for the use of 2i as a means to recapitulate early 
development and suggests that further manipulations of the media may improve the 
developmental potency of the cultured cells and the veracity with which individual 
developmental stages can be modelled.  
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The 2i formulation has enabled the derivation of embryonic germ cells and ESCs from 
multiple different mouse strains (Hanna et al., 2009; Kiyonari et al., 2010; Leitch et al., 2010) 
and from the rat, which were previously intractable (Buehr et al., 2008; Leitch et al., 2010). 
The use of 2i therefore facilitates research into the fundamental mechanisms that govern the 
pluripotent state across cell types and species. 
1.13.1 DNA methylation and 2i 
Changes in the histone modification landscape occur upon switching from serum to 2i media. 
The most striking is the reduction in H3K27me3 levels at the promoters of lowly expressed 
genes and within a 5kb region up- and downstream and redistribution across satellite DNA. 
As the effect on H3K4me3 is slight, approximately two thirds of the 3000 bivalently marked 
gene promoters in ESCs resolve to being modified by H3K4me3 alone, which has little effect 
on the already low expression levels of the associated genes (Marks and Stunnenberg, 2014; 
Guo et al., 2016). With respect to H3K9me2, multiple studies have noted reduced levels 
through ChIP and western blot methods however, there are conflicting reports as to whether 
H3K9me3 is similarly affected (Leitch et al., 2013; Marks and Stunnenberg, 2014; Sim et al., 
2017).  
Furthermore, global DNA methylation levels are reduced between 2-3-fold within 14 days of 
culture in 2i, from ~4% to ~1% of all cytosines bearing the mark. This establishes a population 
of cells that in this regard closely resembles the E3.5 stage of pre-implanted epiblasts. In 
contrast, cells maintained in serum have global levels comparable to that of EpiSCs. 
Methylation patterns at ~69% of gene promoters are equivalent between serum cultured 
mESCs and EpiSCs, compared to only 38% in pre-implanted blastocysts (Borgel et al., 2010; 
Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013). Of the various genomic regions 
associated with gene regulation, CpG and non-CpGI promoters, enhancers and bivalent 
promoters are impacted, although the rate at which methylation is lost varies. Meanwhile 
GO term analysis suggests a lack of correlation between specific processes and methylation 
retention (Hackett et al., 2013; Walter et al., 2016).  Whilst minor satellites and LINEs and 
SINEs are subject to methylation loss, levels at ERVs, particularly those belonging to the IAP 
class, major satellites and ICRs are largely maintained, and this correlates with H3K9me3 
enrichment. Expectedly, as 5mC is the precursor to 5hmC, the dynamics are closely mirrored. 
The alterations in epigenetic patterns are also fully reversible upon switching between 
serum-based media or 2i. Ultimately, the resulting methylation patterns in 2i resemble that 
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of the early pre-implantation blastocysts (Ficz et al., 2013; Habibi et al., 2013; Hackett et al., 
2013; Leitch et al., 2013).  
The high 5hmC levels observed at the enhancers and promoters of some pluripotency genes 
in serum-based culture have been suggested to assist in maintaining a more permissive state 
for their expression (Hackett et al., 2013). However, as an equivalent highly methylated yet 
pluripotent state is not present in vivo, the observations are likely to be an artefact of tissue 
culture and not the result of a coordinated mechanism.    
Long-term culture of male derived mESCs in 2i can compromise their developmental 
potential. Methylation deposited at ICRs is eroded and this results in the aberrant expression 
of imprinted genes. At other DMRs that distinguish male and female ESCs and in the 
distribution of the histone variant H2A.X, which is situated proximal to genes that regulate 
early development, male derived cells can resemble less developmentally potent female ESCs 
with long-term 2i culture (Choi et al., 2017). This is supported by findings that Gsk3α and -β 
double knockout lines exhibit reduced methylation at imprints and aberrant expression 
(Meredith et al., 2015).   
Demethylation in 2i media coincides with reduced Dnmt3a, Dnmt3b and Dnmt3l mRNA and 
protein levels. This is at least partially regulated by Prdm14, an important effector of PGC 
specification that also assists in maintaining ESCs in a pluripotent state. Levels of Prdm14 
increase in 2i and it likely exerts an effect through a dual mechanism, acting as a 
transcriptional repressor upstream of the respective gene promoters and initiating 
ubiquitination of the proteins in a complex with G9a (Grabole et al., 2013; Sim et al., 2017). 
Although downregulation of the de novo pathway components is a contributing factor, as 
they assist Dnmt1 in maintenance methylation, the rate at which hypomethylation is 
achieved in Dnmt3a and –b-null lines is significantly delayed compared to 2i culture (Lei et 
al., 1996; Liang et al., 2002; Chen et al., 2003; Jackson et al., 2004). Similarly, the increase in 
Tet activity in 2i was shown in knockout lines to partially contribute but not be wholly 
responsible for driving hypomethylation. An exception to when Tets contribute robustly is 
with vitamin C supplementation, a co-factor of α-ketoglutarate-dependent dioxygenases, 
such as Tets, that can induce their activity (Blaschke et al., 2013; Hackett et al., 2013; 
von Meyenn et al., 2016; Sim et al., 2017).  
Evidence therefore points towards the impairment of the DNA methylation maintenance 
machinery as the means by which mESCs become hypomethylated in 2i. Indeed, it was shown 
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that Uhrf1 protein levels decline upon switching cells from serum to 2i media. A correlation 
was also noted between the levels of H3K9me2 at genomic loci and the extent of DNA 
demethylation incurred. This relationship therefore contributes to the locus specific 
maintenance of DNA methylation at certain genomic regions despite a global loss of the mark 
(von Meyenn et al., 2016).  
In light of these dramatic changes, one question which arises is to what extent does 
differential transcription between the different media depend on the epigenetic changes, 
such as DNA hypomethylation?  Furthermore, can these conclusions be extrapolated to 
understand the biological relevance of DNA demethylation in pre-implantation 
development?  
1.13.2 DNA methylation and pluripotency 
The rate of demethylation varies for individual genes in 2i culture (Walter et al., 2016) and 
expression changes are uncoupled from promoter demethylation (Ficz et al., 2013). Nearly 
half the genes repressed and around a quarter of those induced in 2i already display a 
significant change within 24 hours. The three components, Oct4, Sox2 and Nanog (OSN), that 
constitute the core pluripotency network are subject to binding rearrangements within this 
same period, yet the sites at which this occurs are distinct from the regions at which 
H3K27me3 and H3K4me3 marks change and that exhibit DNA demethylation (Galonska et 
al., 2015).  
The differential binding of OSN nevertheless appears to influence distal regulatory elements 
and therefore potentially transcription. These sites are however depleted of the 
aforementioned histone marks and are only subjected to a gradual loss in methylation 
beyond 7 days in 2i culture (Galonska et al., 2015). Taken together, this suggests that the 
outcomes relating to OSN binding at this stage are influenced directly by alterations in 
transcription and independent of epigenetic changes.  
Whilst DNA demethylation is globally uncoupled from transcription, this does not exclude 
locus specific effects and it may require the use of single cell sequencing technologies to 
assay DNA methylation and transcription to uncover a possible relationship. One single-cell 
DNA methylation method is in its infancy however, it has indicated the heterogeneity of 
serum culture, with respect to DNA methylation, is not eliminated in 2i. This will cofound the 
72 
 
ability to ascertain a relationship between changes in DNA methylation and cell signalling 
(Smallwood et al., 2014).  
Distilling the approach to uncover how DNA methylation regulates transcription and 
pluripotency can be achieved by comparing WT and TKO cells. However, TKOs are rather a 
blunt tool and there is a caveat that long-term culture of this line may have permitted 
compensatory mechanisms to be acquired that silence aberrantly expressed genes (Fouse et 
al., 2008). Nevertheless, 337 genes are over 2-fold upregulated in TKO cells, representing X-
linked and tissue-specific genes and transcription factors, which is in line with other studies 
(Fouse et al., 2008; Karimi et al., 2011; Hackett et al., 2012). Of the genes bound by Oct4 and 
Nanog in WT cells, which are themselves expressed at normal levels in TKO cells and are 
typically unmethylated in WT mESCs (Imamura et al., 2006; Fouse et al., 2008), ~75% of 
methylated genes were expressed compared to ~90% of unmethylated genes, suggesting 
DNA methylation has little influence in directing the activity of these factors (Fouse et al., 
2008). This is further supported by the observations in 2i discussed earlier (Galonska et al., 
2015) and by the fact that less than 2% of genes upregulated in TKO cells are bound by 
Oct4/Nanog. (Fouse et al., 2008). As introduced above, some transcription factors have an 
affinity for methylation and this was shown to be the case for Oct4 (Yin et al., 2017). 
Therefore, assessing the direct effects of DNA methylation on Oct4 binding would likely be 
unnecessary.  
An alternative technique, RNA-FISH, was employed to track Nanog expression itself. This 
showed that DNA methylation has a subtle effect on its heterogeneous expression in serum 
cultured cells and signalling changes imposed by 2i were a greater influence in attaining 
homogeneity (Singer et al., 2014).  
Collectively, these studies suggest that DNA methylation has little influence in dictating the 
binding of the core pluripotency network. Therefore, the transcriptional profile of 2i cultured 
cells and the fact that it more closely recapitulates the ICM is independent of DNA 
methylation changes and can be accounted for largely by alternate cell signalling effects 
imposed by 2i. However, to what extent is the presence of any amount of DNA methylation 
important for pre-implantation development?  
This question has been addressed by generating embryos by nuclear transfer using TKO ESCs 
as the donor. In this case, they developed grossly normally throughout the pre-implantation 
stage. Chimeric embryos showed evidence that the TKO cells contribute to the ICM at E4.5, 
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before residing specifically in the placenta and yolk sac at E17.5 and E18.5. Notably, embryoid 
bodies constituted from TKO ESCs upregulated primitive ectoderm and early mesoderm 
markers to a relatively higher extent than WT embryoid bodies, whilst 
also downregulating Nanog (Sakaue et al., 2010). Development of the trophoblast is also 
initiated prior to changes in methylation patterns that define this specific layer and the 
pluripotent ICM (Nakanishi et al., 2012).   
Furthermore, mouse knockout models for the Dnmt genes are lethal after the event of 
implantation (Li, Bestor and Jaenisch, 1992; Okano et al., 1999). Collectively, the above 
evidence argues against a role of DNA methylation in pre-implantation development.  
The alternative question is whether DNA demethylation is important for the development of 
the pluripotent ICM. Notwithstanding the Tet3 knockout models referred to earlier, this 
would be difficult to test directly as it would require maintaining high DNA methylation levels 
in vivo. Studying the dynamics throughout reprogramming of somatic cells to induced-
pluripotent cells (iPSCs) may offer some indications however, the main distinction to consider 
is that the generation of iPSCs is an artificial system.  
Upon overexpression of the well-described OSKM (Oct4, Sox2, Klf4 and c-Myc) transcription 
factors in MEFs, a delayed redistribution of DNA methylation was noted to occur after 
transcriptional changes and histone modification occupancy. Acquisition of DNA methylation 
accounted for the silencing of a subset of bivalent or monovalent genes that loose either the 
repressive H3K27me3 or active H3K4me3 marks. Conversely, of the few protein coding genes 
and lncRNAs that acquire H3K4me3 and are expressed in the latter stages of reprogramming, 
the density of H3K4me3 correlated inversely with DNA methylation (Hussein et al., 2014). 
However, DNA methylation dynamics were not unidirectional with domains shown to either 
acquire methylation gradually or during the latter stages of reprogramming, acquire or lose 
marks before reverting to the state prior to the transduction of OSKM or alternatively, to lose 
methylation late in reprogramming and remain demethylated in the pluripotent state. 
Examples of the latter include binding sites for OSK and Nanog. The extent to which this 
reflects reprogramming of the zygote would be an interesting comparison to establish (Lee 
et al., 2014).  
The use of Dnmt inhibitors, Dnmt1 knockdown (Mikkelsen et al., 2008) and transduction of 
Tet1 (Gao et al., 2013) have been used to improve reprogramming efficiency. Knockdown of 
Tet1, which is consistently upregulated throughout reprogramming of MEFs, reduces colony 
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formation whereas overexpression has a positive effect. Against an initial background of 
increasing de novo methyltransferase expression and DNA methylation, Oct4 demethylation 
and expression is promoted by Tet1 in conjunction with SKM in a secondary reprogramming 
system. This cocktail had comparable efficiency to the transduction of OSKM in generating 
pluripotent colonies. Overall, genes derepressed in the pluripotent state had reduced 5mC 
at promoters, which includes Oct4, Nanog and Rex1. At the end point of reprogramming, 
most silenced genes were not associated with acquisition of 5mC, although such a correlation 
was observed in intermediate stages (Gao et al., 2013). As TetKO models die perinatally and 
Oct4 expression is delayed upon Tet3 deletion, this would suggest Tets in the reprogramming 
system have a greater influence compared to an in vivo context (Gu et al., 2011; Wu and 
Zhang, 2017).   
Transposing the conclusions from reprogramming systems to in vivo development should 
therefore be done with caution. Analyses into the 2i system would also argue for a locus and 
time-specific approach to assess the interplay between transcription and DNA methylation. 
An important point to consider however, is that a pluripotent cell is only regarded as such if 
it has the potential for multilineage differentiation, under the appropriate culture conditions 
(Martello and Smith, 2014). Therefore, by definition, DNA methylation is important for 
pluripotency as Dnmt-null models are lethal, as discussed above (Li, Bestor and Jaenisch, 
1992; Okano et al., 1999). The use of TKO cells have already shown it is dispensable for self-
renewal, another important characteristic of pluripotency (Tsumura et al., 2006). Where the 
window of opportunity lies to further dissect the role of DNA methylation is in considering 
whether it is important for it to be erased in pre-implantation development.  
It is therefore clear that further investigations are necessary to identify mechanisms that 
contribute to DNA methylation in pre-implantation development. Once these have been 
characterised in functional studies, attention can then turn to perturbing them in vivo in 







1.14 Project Aims 
The maintenance of mESCs in naïve and primed pluripotent states can be modelled using 2i 
and serum-based culture media and this is accompanied by profound changes in the global 
methylation profile of the cells, as discussed earlier. When this project began, there was a 
deficit of reports on the molecular mechanisms responsible for promoting hypomethylation 
in 2i media.  Furthermore, whilst N2B27+2i media had been shown to effectively demethylate 
mESCs, an alternative system referred to as KOSR+2i lacked any similar report.  
Considering the gaps in the knowledge, one of the aims of this thesis was to: 
1) Identify the interacting partners of DNMT1 and Uhrf1 in primed and naïve mESCs. 
Proteins that differentially interact with the DNA methylation maintenance 
machinery between serum and 2i media would be considered as candidate 
regulators of DNA methylation.   
The effects of PTMs that may modulate DNA methylation in the context of 2i media were 
also considered however, the focus was on a specific example termed protein citrullination. 
This aim was developed from preliminary data generated by Maria Christophorou that 
suggested both Dnmt1 and Uhrf1 were subjected to this modification. This was interesting in 
the context of 2i media as previous studies, discussed later in the relevant chapter, suggested 
citrullination is promoted in mESCs with its application. Therefore, a second aim was to: 
2) Understand the implications of citrullination on DNA methylation in both serum and 
2i media and address the underlying molecular mechanisms.  
Collectively, these aims could be summarised as attempts to define the molecular 
mechanisms that regulate the differential levels of DNA methylation in mESCs in response to 
a change in the signalling environment. In the context of serum and 2i media, which model a 
more primed and naïve state of pluripotency in vitro respectively, this will begin to link 
specific cell signalling cascades to an underlying change in the chromatin state, which itself 
may have subsequent effects on cell biology. However, this information also has the potential 
to inform future studies investigating the biological significance of DNA methylation 








2. 1 Cell culture 
All cell lines used throughout this project were mESCs maintained on tissue culture grade 
flasks and plates (Corning) with 0.1% (w/v) porcine gelatin (Sigma) at 37oC with 5% CO2. Cells 
were detached using AccutaseTM (BioLegend®) and passaged every other day or when 
confluency reached 70-80%. Cells from an E14 background were cultured in Glasgow's MEM 
(GMEM; GibcoTM) base media supplemented with 10% (v/v) FCS (GE Healthcare Hyclone), 1X 
Non Essential Amino Acids (NEAAs; GibcoTM), 1mM Sodium Pyruvate (GibcoTM), 2mM L-
Glutamine (in house technical services preparation), 0.1mM 2-Mercaptoethanol (GibcoTM ) 
and 1.0 x 103 U mL-1 of LIF (Millipore). For J1 background mESC lines, including TKO-121 lines 
(Tsumura et al., 2006), the same recipe was followed as above except Dulbecco's Modified 
Eagle Medium (DMEM; GibcoTM) base media, in place of GMEM, and a 15% (v/v) FCS 
supplement were used. 
Two different 2i base media compositions were used during the project. The most 
predominantly used and referred to as KOSR elsewhere consisted of: GMEM supplemented 
with 10% (v/v) KOSR (GibcoTM), 1% (v/v) FCS, 1X NEAAs, 1mM Sodium Pyruvate, 2mM L-
Glutamine, 0.1mM 2-Mercaptoethanol and 1.0 x 103 U mL-1 of LIF. Media referred to widely 
as N2B27 was used on one occasion during the characterisation of the 2i systems, as shown 
in Chapter 3. This was composed of a 1:1 ratio of NeurobasalTM Medium (GibcoTM) and 
DMEM/F-12 (GibcoTM) to which: 0.5X N-2 supplement (GibcoTM), 0.5X B-27™ Supplement 
(GibcoTM), 2mM of L-Glutamine, 7.5% (v/v) bovine serum albumin (BSA; GibcoTM), 11.9M 
monothioglycerol (Sigma) and 1.0 x 103 U mL-1 of LIF were added.  
From both 2i base medias, aliquots were taken and 1µM of PD0325901 (Selleckchem) and 
3µM of CHIR99021 (Sigma) prepared in DMSO were added and kept for no longer than 48 
hours.   
Where the pan-PADI inhibitor Cl-amidine (Millipore) was utilised, it was dissolved in water 
and used at 200µM.  
 
2.2 Microbiology methods  





To propagate plasmids, an appropriate strain of bacteria was transformed. Owing to the 
presence of the ccdB lethality gene, the pB Destination vector used in the Gateway® cloning 
introduced below was propagated with XL1 Blue Competent E.coli Cells (Agilent). These 
contain the F’ episome to negate the effects of the aforementioned lethality gene. For the 
sequential steps throughout the Gateway® cloning of the pB BirA* construct, Library 
Efficiency™ DH5α™ Competent E.Coli Cells (Invitrogen™) were utilised. For the In-Fusion 
mediated cloning of constructs into the pB BirA* vector, Stellar Competent E.coli Cells (Takara 
Bio) were used. In all instances, an appropriate amount of plasmid or reaction mixture, as 
dictated by the manufacturer’s instructions, was initially incubated with 50µL of cells on ice 
for 30 mins. These were subsequently heat-shocked for 45 secs at 42oC, recovered on ice for 
2 mins and then added to 450µL of room-temperature SOC media. After a 1 hour recovery 
period at 37oC, various dilutions were plated separately onto LB-Agar plates and incubated 
overnight at 37oC.     
2.2.2 Minipreps 
In order to screen for ‘positive’ bacterial clones containing the desired plasmid, individual 
clones were picked and grown overnight in 5mL L-Broth at 37oC with shaking and appropriate 
antibiotics for selection. Plasmids were subsequently extracted using QIAprep Spin Miniprep 
Kit (Qiagen) without deviations from the protocol supplied. Diagnostic tests were carried out 
with appropriate restriction enzymes (New England Biolabs) in accordance with the 
manufacturer’s instructions. The digested plasmid was then resolved on TBE-agarose gels 
and compared against a predicted digestion pattern generated by the program SnapGene®. 
Sequencing of plasmids was performed on a 3730 Series Genetic Analyzer (Applied 
Biosystems®) by technical services staff.  
2.2.3 Maxipreps 
Once the sequence of a plasmid was confirmed, larger quantities were generated for further 
manipulation or transfection into mammalian cell lines. To this end, the Qiagen Plasmid Maxi 





2.3 Generation of BirA* stable cell lines 
2.3.1 Gateway cloning of BirA* into a piggyBac vector 
Vectors encoding BirA*, pcDNA3.1 mycBioID, was a gift from Kyle Roux (Addgene plasmid # 
36047 ; http://n2t.net/addgene:36047 ; RRID:Addgene_36047) (Roux et al., 2012). This was 
initially unsuitable for expression in mESCs as the vector was optimised for viral delivery and 
would be susceptible to silencing. Therefore Gateway® cloning (Thermo-Fisher) was 
employed to transpose BirA* into a pDestination piggyBac vector with a CMV early 
enhancer/chicken β actin (CAG) promoter. pPB-PGK-destination was a gift from Austin Smith 
(Addgene plasmid # 60436 ; http://n2t.net/addgene:60436 ; RRID:Addgene_60436) 
(Takashima et al., 2014) . In order to subsequently clone a gene of interest and ensure it 
would be fused with BirA* at the N- or C-terminus, primers were designed so that a unique 
restriction site not present in the piggyBac backbone was inserted also. The protocol to 
establish these was provided by Thermo-Fisher and the primers were designed utilising tools 
on Snapgene® software.  
2.3.1.1 Gateway cloning - BP recombination  
In Gateway cloning, the BP reaction is dependent on the use of an Insert with flanking attB 
sites that are complementary to attP sites in a pDONR vector. Following recombination of 
these sites, an Entry clone is established in which the gene of interest is flanked by attL sites, 
a substrate for the subsequent LR reaction. 
To generate a BirA* insert with attB sites, 1ng of the original BirA* vector was added to a mix 
of 12.5µL CloneAmp™ HiFi PCR Premix (Takara Bio), 0.3µM each of forward and reverse 
primers (Sigma-Aldrich; see Table 2.1) and a PCR reaction was performed consisting of 30 
cycles of: 98oC for 10 secs, 55oC for 15 secs and 72oC for 1 min. The product was resolved on 
a TBE-agarose gel and the appropriate band excised and recovered using NucleoSpin Gel and 
PCR Clean-Up kit (Takara Bio). 
Using an online service provided by New England Biosciences 
(http://nebiocalculator.neb.com/#!/dsdnaamt), 50 fmol of the BirA* insert and pDONR 221 
vector were calculated and the appropriate amounts incubated together with 2µL of BP 
Clonase II enzyme at 25oC for 1 hour, in a total reaction volume of 10µL. This reaction was 
stopped by adding 1µL of Proteinase K at 37oC for 10 mins after which 1µL was taken and 
transformed as described above. Colonies were screened using diagnostic restriction enzyme 
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digestion (New England BioLabs) and candidates were sequenced accordingly to identify the 
desired Entry clone. 
2.3.1.2 Gateway cloning - LR recombination 
Following the reaction to generate an Entry clone, the plasmid for which the sequencing data 
was most complete when aligned to the expected sequence was used in the LR reaction. 
Here, attL sites that flank the gene of interest in the Entry clone are recombined with attR 
sites in a pDestination vector. Accordingly, 50ng of the Entry clone was incubated with 150ng 
of the pDestination vector in a total volume of 8µL, to which 2µL of LR Clonase II was added. 
This was incubated for 3 hours at 25oC and then stopped with 1µL Proteinase K and 
incubation for a further 10 mins at 37oC. Transformation of 1µL of this mixture then followed 
as described above and colonies were picked, screened and sequenced. 
2.3.2 In-Fusion cloning of hDNMT1 and mUhrf1 into pB BirA* 
In-Fusion cloning reagents (Takara Bio) were used to separately clone in human DNMT1 
(hDNMT1) and mouse Uhrf1 (mUhrf1) into the assembled pB BirA* vectors, exploiting a 
unique restriction site so as to generate fusion proteins that are tagged both at the N- and C-
terminus with BirA*. Owing to the high molecular weight of both DNMT1 and Uhrf1 and the 
various domains present in each protein, this approach offered an opportunity to detect a 
greater range of interactors. pcDNA3/Myc-DNMT1 was a gift from Arthur Riggs (Addgene 
plasmid # 36939 ; http://n2t.net/addgene:36939 ; RRID:Addgene_36939) (Li et al., 2006) and 
mUhrf1 in a vector was kindly supplied by Tomek Jurkowski.    
Using the In-Fusion cloning tool on SnapGene®, primers were designed in accordance with 
the N-terminal vector being cut with Pac1 and the C-terminal vector with SmaI. As PacI cuts 
with an overhang, to ensure that genes were in frame after ligation, the sequence ‘AA’ was 
added to the forward primer between the sequence that would anneal to mUhrf1 and 
hDNMT1 in the template vectors, and the backbone of the pB BirA* vector. 
To generate inserts, CloneAmp™ HiFi PCR Premix and primers (see Table 2.1) were incubated 
with 1ng of a template vector containing either hDNMT1 or mUhrf1 as detailed above. The 
program was adjusted appropriately depending on the length of the gene being amplified, in 
accordance with the protocol. The reaction was resolved on TBE-agarose gels and the 
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appropriate band excised and recovered using the NucleoSpin® Gel and PCR Clean-up kit. A 
no-template control was also prepared and resolved. 
 The pB BirA* vectors were linearised by incubating with either PacI or SmaI restriction 
enzymes overnight. Using the phenol-chloroform extraction method outlined below, the 
vector was recovered and 50ng was incubated with an amount of insert that fulfils the ratio 
of 2:1, insert to vector. This was calculated 
on http://nebiocalculator.neb.com/#!/ligation which utilises the formula: Insert mass = 
desired insert/vector molar ratio x mass of vector x ratio of insert to vector lengths. The total 
volume of this reaction was made up to 8μL and 2μL of In-Fusion HD Enzyme Premix (Takara-
Bio) was added. This reaction was incubated for 15 mins at 50oC, from which 2.5μL was taken 
and transformed into Stellar competent E.coli cells (Takara-Bio) as outlined earlier and 
colonies were picked, screened and sequenced. Transformation of the linearised vectors 
alone served as negative controls and gave an indication of the reaction efficiency. 
2.3.3 Purifying vectors – Phenol/chloroform extraction 
Following the overnight linearisation of the vectors as outlined above, 1X volume of phenol 
solution (Sigma) was added to each reaction mixture before vortexing briefly and centrifuging 
at 17,000 x g for 2 mins. The top aqueous layer was recovered and treated with 1X volume 
of chloroform (Fisher Chemical), vortexed and centrifuged at 17,000 x g for 2 mins. The top 
layer was then recovered and one-tenth volume of 3M NaOAc and 3.5X volumes of 100% 
(v/v) EtOH were added to precipitate the plasmid. Following centrifugation at 17,000 x g for 
10 mins, the supernatant was removed and the pellet was washed in 1X volume of 70% (v/v) 
EtOH with centrifugation at 17,000 x g for 2 mins. The supernatant was removed and the 
plasmid air-dried before being suspended in nuclease-free water. The concentration was 
measured on the Nanondrop Nucleic Acid channel.  
2.3.4 Transfections 
Stably expressing cell lines were generated using transfection with Lipofectamine 2000 
(Thermo-Fisher), following the protocol supplied. The quantity of DNA in each transfection 
was 2µg of the pBase transposase vector and 1µg of the piggyBac vector containing the gene 
of interest. Cells were maintained in 50mg/mL hygromycin B for up to 10 days for the 
selection of transfected colonies. 
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Other stably expressing cells generated by others, namely the PADI4 and control cells, were 
also established using this method.  
Table 2.1 – Primers for cloning BirA* constructs 
Primer Forward Reverse 
Gateway cloning 















































2.4 BioID experimental procedure 
Culture media used throughout is as detailed above. All solutions for lysis and preparation of 
the beads contained protease inhibitors (Roche). For each cell line and treatment, 2.0 x 106 
cells were seeded in triplicate on gelatin coated 10cm dishes. After ~24 hours, fresh media 
was applied with a supplement of 50µM biotin (Sigma-Aldrich) prepared in DMSO. Following 
a further ~24 hours of culture, the media was drained and the cells were washed 3 X in 10mL 
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ice-cold PBS on ice, whereby the PBS was left on the dish for 30 secs during each wash to 
ensure diffusion of free biotin out of the cells. Cells were next lysed in 1mL RIPA buffer and 
scraped into a pre-chilled 1.5mL tube and pulse-vortexed for 5 secs every 10 mins over a 
period of 30 mins; 100 U of the nuclease reagent Benzonase (Millipore) and 1mM MgCl2 was 
added 15 mins into this period. This time point was selected as the reagent protocol suggests 
the concentration of SDS in the RIPA buffer would ablate Benzonase enzymatic activity after 
15 mins. Lysates were centrifuged at 17,000 x g for 5 mins at 4oC and 22.5µL of the 
supernatant was taken as input and frozen immediately on dry ice. The remainder was added 
to 10µL of streptavidin-conjugated agarose beads (GE-Healthcare) in a new 1.5mL tube that 
had been prepared by thorough washing 3 X with RIPA buffer. The remaining cell pellet 
collected after centrifugation was frozen on dry ice. The pull-down proceeded with end-to-
end rotation at 4oC for 1 hour. Beads were pelleted by centrifugation at 6,200 x g for 40 secs 
and 22.5µL of supernatant was taken as flow-through and frozen immediately on dry-ice; the 
remainder was discarded. The beads were then washed in accordance with the protocol for 
similar proximity ligation methods as follows (Branon et al., 2018), using 1mL of the reagents 
at each step that were prepared in dH2O unless stated otherwise: 1 X RIPA; 1 X 1M KCl; 1 X 
0.1M Na2CO3; 1 X 2M Urea (in 10mM Tris-HCl, pH 8.0) and 2 X in RIPA. A further 3 X washes 
in TBS were conducted prior to submission of the samples for mass spectrometry analysis, 
ensuring transfer to a new tube with each wash to eliminate detergent carry-over. For the 
purposes of western blotting, the beads were boiled for 5 mins in 2X Laemmli-SDS buffer 
(Sigma) and the supernatant was taken. The input and flow-through were similarly prepared 
with 4X Laemmli-SDS buffer (Sigma) and boiled for 5 mins.  
Prior to optimising the aforementioned method, cells were lysed in RIPA and by a 60 mins 
pulse of sonication (10 secs on/10 secs off) in a Bioruptor® (Diagenode). Whilst chromatin 
was completely solubilised, mass spectrometry analysis suggested this method caused 
proteins to precipitate during the pull-down as few proteins were enriched over the control. 
Therefore, the compromise method outlined above was developed in which a small 
chromatin pellet remains after clarifying the lysate however, the majority of the BirA* fusion 
proteins are solubilised (Figures 3.11 and 12) and no precipitate forms. An example of the 
data obtained from the earlier lysis method is shown below in Table 2.2. Note the small 
number of proteins that are enriched over the background.  
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Table 2.2 – A portion of BioID data obtained from cell lines prepared using an older method. This 
displays all interacting candidates from an experiment using the DNMT1-BirA* N-terminally tagged 
line that are enriched over a control (Ratio N-Dnmt1/Empty vector).   
Gene names Average Empty (LFQ) 




TEX2 1 40818001 40818001 
TUBAL3 1 27558001 27558001 
GFPT1 1 19291667.67 19291667.67 
SKA2 1 8150334.333 8150334.333 
DYNC1LI1 1 7645301 7645301 
DAP3 1 4960634.333 4960634.333 
NAA40 1 1152501 1152501 
DNMT1 550343334.3 1.69E+11 266.0593137 
NUP98 947693334.3 700576667.7 0.748426038 
TXN 141863334.3 90293001 0.615410308 
DNAJC2 1073343334 626646667.7 0.594407961 
 
2.5 Myc pull-down experimental procedure 
The details of the culture media used are described above. Buffers for lysis and washes 
contained protease inhibitors (Roche). Each cell line for both serum and KOSR + 2i treatments 
were plated at a density of 2.0 x 106 cells in triplicate on gelatin coated 10cm dishes. After ~ 
24 hours, media was replaced with fresh media. The following day, cells were washed on ice 
with 10mL ice-cold PBS and lysed with 200µL lysis buffer containing: 10mM Tris-HCl; 150mM 
NaCl; 0.5mM EDTA; 0.5% NP-40 and 5 U of Benzonase were added with 1mM MgCl2. The 
tube was left on ice for 30 mins and pulse-vortexed at 10 min intervals before centrifugation 
at 17,000 x g for 10 mins at 4oC. The supernatant was transferred to a pre-chilled tube 
containing 300µL of the dilution/wash buffer: 10mM Tris-HCl; 150mM NaCl and 0.5mM 
EDTA, from which 22.5µL was taken as input. The remainder was transferred to a pre-chilled 
tube containing magnetic beads conjugated to a MYC-trap (Chromotek) that had been 
washed 3 X in the dilution/wash buffer. This was end-to-end rotated for 1 hour at 4oC. The 
beads were then magnetically separated from the lysate, of which 22.5µL was taken as flow-
through and the remainder discarded. For 3 X, the beads were washed in ice-cold wash buffer 
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and prepared appropriately as above for mass spectrometry analysis or western blot, along 
with the remaining cell pellet, input and flow-through.  
 
2.6 BioID and Myc pull-down data analysis 
Data for the BioID screen was initially processed by calculating the mean LFQ intensity for 
each individual protein identified from triplicate samples. The average LFQ value for 
experimental samples were then divided over the corresponding value in the Empty vector 
control and separately, the free BirA* control. A two-tailed unpaired t-test was also applied 
to filter out proteins that had significantly (p>0.05) variable LFQ intensities between 
replicates in an experimental condition, compared to a control condition. Proteins that were 
at least two-fold and significantly (p≤0.05) enriched in an experimental line over the Empty 
or free BirA* control were taken forward for consideration. 
The Myc pull-down data was similarly analysed by dividing the average LFQ intensity of a 
protein in an experimental line over the average intensity in the pull-down control in the 
same culture conditions. Proteins enriched at least 2-fold were then filtered further using a 
t-test to identify those significantly enriched.  
The approach taken to identify proteins from the BioID and Myc pull-down screens that 
differentially interact with DNMT1 or Uhrf1 in either serum or KOSR+2i is discussed in 
Chapter 4. Volcano plots with imputed values were generated by Jimi Wills (IGMM, University 
of Edinburgh) in R using a script available at the following address: 
https://github.com/wasimaftab/LIMMA-pipeline-proteomics/blob/master/limma_main.R.  
 
2.7 Co-immunoprecipitation experimental procedure 
The culture and lysis of cells is as described in the above procedure: ‘Myc pull-down 
experimental procedure’. Following the centrifugation step to clarify the lysate, the 
supernatant was recovered and diluted with 300µL of the dilution/wash buffer: 150mM NaCl 
and 0.5mM EDTA. From this, 22.5µL was taken as input and the remainder was incubated 
overnight at 4oC with rotation in a new microfuge tube with 10µL of Protein G Magnetic 
Beads (Thermo-Fisher); these had been prepared earlier by washing 3 X in the dilution/wash 
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buffer. The following day, 2µg of antibody (see Table 2.3) was added and left rotating at 4oC 
for a further 2 hours. Next the beads were magnetically separated from the 
lysate and 22.5µL was taken as flow-through and the remainder discarded. The beads were 
then subjected to 3 X washes in ice-cold wash buffer with agitation.  
 
2.8 Western blotting 
2.8.1 Protein lysate preparation for western blotting 
Lysates were prepared from cells washed 1 X in ice-cold PBS with modified Laemmli buffer 
(120mM Tris-HCl pH 8.0; 4% (w/v) SDS; 20% (v/v) glycerol). After boiling for 5 mins, chromatin 
was sheared with a 15G needle and syringe until the consistency was no longer viscous. 
Protein was quantified on the Nanodrop using the Protein A280 channel and aliquots taken 
and normalised with Laemmli and a 10X loading buffer (β-mercaptoethanol, 1% (v/v) 
bromophenol blue), before boiling for a further 5 mins. Samples were either loaded 
immediately into gels or stored at -80oC until required. 
2.8.2 Experimental procedure 
Samples were resolved on precast 4-20% Tris-Glycine gradient polyacrylamide gels (Bio-Rad) 
at 200V with a Tris-Glycine SDS Running buffer (25mM Tris-HCl, 190mM glycine, 0.1% (w/v) 
SDS). Proteins were subsequently transferred onto 0.2µm pore-sized nitrocellulose 
membranes (Bio-Rad) at 800mA for 1 hour using a Tris-Glycine Transfer buffer (25mM Tris-
Cl, 190mM glycine, 20% (v/v) methanol). Membranes were next blocked in 5% (w/v) BSA in 
TBS-T (Tris-buffered saline, 0.1% (v/v) TWEEN-20) at room temperature for 1 hour with 
gentle agitation. Primary antibodies were then applied in blocking buffer at appropriate 
dilutions (see Table 2.3), typically overnight at 4oC with agitation. The following day, 
membranes were washed with TBS-T over 45 mins, wherein the buffer was changed every 
15 mins, before the blots were incubated in appropriate horseradish peroxidase (HRP) 
conjugated secondary antibodies (see Table 2.3) in blocking buffer for 1 hour at room 
temperature with agitation. After washing membranes over another 45 min period, bands 






Table 2.3 – Antibodies for western blotting and immunofluorescence  
Reactivity Clone Dilution Host 
Western blotting – Primary antibodies 
Apobec3 B-2 1:200 Mouse 
Aust2 (ab96326) 1:500 Rabbit 
Dazl 3/11A 1:500 Mouse 
Dnmt1  K18 1:200 Goat 
Dnmt3a 64B1446 1:200 Mouse 
Dnmt3b 52A1018 1:200 Mouse 
Dppa3/Stella B-2 1:200 Mouse 
Gapdh GA1R 1:5000 Mouse 
Histone H3 mAbcam 10799 1:2000 Mouse 
Histone H3 (citrulline R2) EPR17703 1:2000 Rabbit 
Myc 9B11 1:5000 Mouse 
Padi2 (ab50257) 1:1000 Rabbit 
Padi4 EPR20706 1:1000 Rabbit 
Pdk1 4A11F5 1:200 Mouse 
Streptavidin (HRP conjugated) - 1:2000 - 
Uhrf1 M-132 1:2000 Rabbit 
Utf1 (ab24273) 1:1000 Rabbit 
Western blotting – Secondary antibodies (HRP conjugated) 
α-Goat - 1:5000 Rabbit 
α-Mouse - 1:5000 Rabbit 
α-Rabbit - 1:5000 Goat 
Immunofluorescence – Primary antibodies 
Dnmt1  K18 1:1000 Goat 
Uhrf1 D6G8E 1:250 Rabbit 
Myc 71D10 1:200 Rabbit 
Immunofluorescence – Secondary antibodies 
α -Goat- Alexa Fluor® 488 - 1:200 Donkey 
α -Rabbit- Alexa Fluor® 555 - 1:200 Donkey 
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2.9 Quantitative polymerase chain reaction  
2.9.1 Isolation of RNA  
RNA was harvested from cells in accordance with the Qiagen RNeasy Plus Mini handbook. 
RNA was eluted with RNAse-free water and stored at -80oC until required.  
2.9.2 RNA quantification and cDNA synthesis  
Eluted RNA was quantified on the Nanodrop channel A260. Equal concentrations of each 
sample in an experiment were taken for further processing into cDNA; this was typically 
between 200ng-1µg. To this, 250ng of random primers (Promega) and 10mM dNTPs (Life 
Technologies) were added and the volume was made up to 13µL with RNase free water. After 
incubating at 65oC for 5 mins, 1µL of SuperScript™ III Reverse Transcriptase was added, along 
with the requisite 1µL DTT, 4µL First Strand Synthesis Buffer (Promega) and 20U of RNasin® 
(Promega). The reaction then proceeded at 25oC for 5 mins, 50oC for 60 mins and 70oC for 15 
mins. A negative-reverse transcriptase control (-RT) was also made using a selected sample, 
in which the reverse transcriptase was omitted. This was used in reverse transcriptase 
quantitative polymerase chain reactions (RT-qPCRs) to determine potential DNA 
contamination.   
2.9.3 RT-qPCR procedure 
The majority of primer sequences used in RT-qPCRs (see Table 2.4) were from published 
sources. For occasions when primers were designed, the 'Primer3' program 
(http://frodo.wi.mit.edu/primer3/) was used to produce primers with an annealing 
temperature of 60oC and an amplicon size of ≤200bp.  
Samples and reagents were loaded into 96- or 384-well qPCR plates (Axygen) with automatic 
pipettes to minimise error. The cDNA was diluted 1:50 in RNAse-free water, from which 2.5µL 
was included in a reaction with 5µL SYBR™ Select Master Mix (Thermo-Fisher) 
and 1.25µM of each primer (Sigma-Aldrich; see Table 2.4). RNAse-free water was added up 
to a final reaction volume of 10µL. Quantitative gene expression analyses were conducted 
with the LightCycler® 480 System (Roche) using the following program:  95°C for 2 mins, 50 
amplification cycles at 95°C for 15 secs followed by 60°C at 50 secs then a further 10 secs, 
before a melting curve at 95°C for 5 secs and 65°C for 1 min. Each replicate was loaded twice 
and only samples for which the duplicates were within 1 ‘Ct’ value were included in 
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subsequent analyses. A standard curve of each primer pair was calculated, using a serially 
diluted sample in which the gene was known to be expressed. A primer efficiency from this 
standard curve of between 1.8-2.2, determined using LightCycler® 480 
System Software 1.5 (Roche), was required for consideration. The expression of Ubiquitin C 
(UbqC), a ubiquitous house-keeping gene, was determined in all samples and used to 
normalise the expression of a gene of interest. The mean and the standard deviation were 
then calculated from normalised triplicate samples. Statistical significance was determined 
using an unpaired and two-tailed t-test. Two controls for contamination, the –RT from cDNA 
synthesis and a non-template control, wherein cDNA was omitted from the well in the qPCR 
plate, were also included. If these returned equivalent ‘Ct’ values as experimental samples 





Table 2.4 – Sequences of primers used for RT-qPCR 
 








































60oC (Ficz et 
al., 2013) 
Dnmt3b TGGTGATTGGTGGAAGCC AATGGACGGTTGTCGCC 60oC (Ficz et 












































2.10 Quantification of 5-methylcytosine 
Liquid chromatography-mass spectrometry (LC-MS) was employed for the quantification of 
global DNA methylation levels. This is an unbiased method to assess DNA methylation 
however, it is unable to detect the genomic redistribution of the mark. Determining the 
possible biological impact on small albeit statistically significant changes in levels also 
requires an alternative approach that provides data at the resolution of individual loci. 
2.10.1 DNA extraction 
The Qiagen DNeasy Blood & Tissue Kit was used in accordance with the manufacturer’s 
instructions to collect DNA for global DNA methylation analysis. All recommended steps were 
followed, including incubation with RNaseA (Qiagen).  
2.10.2 DNA digestion 
An aliquot of 2.5µg of DNA was denatured by heating to 95oC for 10 mins in a total volume 
of 44µL with nuclease free H2O. Next, 10 U of T7 DNA polymerase (Thermo-Fisher) and 1X 
reaction buffer was added and incubated overnight at 37oC. The activity of the polymerase 
promotes the hydrolysis of the DNA strands into single nucleotides. The following day, 
samples were centrifuged for 45 mins at 12,000 x g and 20µL of the supernatant was 
recovered and added to a new tube, into which 50µL MeOH and 20µL acetonitrile was added. 
After 10 mins of centrifugation at 17,000 x g, the supernatant was recovered, transferred to 
a new tube and the DNA precipitated in a DNA SpeedVac™. The pellet was then suspended 
in 20µL of mass spectrometry grade H2O. Samples were loaded and mass spectra acquired 
by Jimi Wills (IGMM, University of Edinburgh).  
2.10.3 Data analysis  
Data was analysed using Xcalibur™ software (Thermo-Fisher) with a processing method 
designed by Andy Finch (IGMM, University of Edinburgh). The intensity of 5mC as a 
proportion of the total intensities of cytosine, 5mC and 5hmC from three technical replicates 
was calculated using this processing method. Error bars were calculated as the standard 
deviation from the mean. Statistical significance was determined using unpaired two-tailed 
t-tests. A summary of the molecular masses of the nucleotides searched for in the spectra, 
as designated on the metabolite database Metlin (https://metlin.scripps.edu/), are 
presented in Table 2.5. Each individual experiment was performed with internal controls: J1 
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and TKO-212 (Tsumura et al., 2006) mESCs. Retention times of the nucleotides could then be 
adjusted accordingly and applied to all samples in the same experiment.  
Table 2.5 – Masses inputted to quantify nucleotide abundance  
 
 
2.10.4 Optimisation of method  
In initial attempts to quantify global 5mC levels, DNA was prepared using DNA degradase 
(Zymo Research) and a 150 x 2.1mm SeQuant® ZIC®-pHILIC column (Millipore) for 
chromatography. However, the chromatograph peaks of the nucleotides were less defined 
as they had tails. This introduced subjectivity into the analysis when selecting the area of the 
chromatograph peak to quantify. Use of the T7 polymerase and a 30 x 1mm HyperCarb 
column (VWR) column reduced this as demonstrated in Figure 2.1, which shows a 












Figure 2.1 - Figure legend on next page 








Figure on previous page Figure 2.1 – Representative chromatographs of 5mC using different digestion 
methods and chromatography columns. A. DNA prepared using DNA degradase and chromatography 
with 150 x 2.1mm SeQuant® ZIC®-pHILIC column. B. DNA prepared with T7 polymerase and 
chromatography with HyperCarb column. Note the less defined peak in A compared to B.  
 
2.11 Immunofluorescence procedure 
Cells were seeded at densities of between 3.0 x 105 - 6.0 x 105 cells in 12 - or 6-well plates on 
EtOH sterilised coverslips coated with 0.1% (w/v) gelatin.  When appropriate, media was 
removed and cells were washed 3 X with PBS containing calcium and magnesium (Life 
Technologies) then fixed for 10 mins at room temperature with 4% (w/v) PFA 
(paraformaldehyde; Sigma). Blocking was conducted overnight at 4oC in 10% (v/v) donkey 
serum (Sigma) with 0.1% (v/v) Triton X-100 (Sigma) in PBS. Primary antibodies were diluted 
appropriately (see Table 2.3) in 1% donkey serum with 0.1% Triton X-100 in PBS and added 
overnight at 4oC to the coverslips. After 3 X washes with PBS, incubating for 10 mins each 
time, secondary antibodies (see Table 2.3) in 1% donkey serum with 0.1% Triton X-100 in PBS 
were applied for 1 hour at room temperature. Coverslips were washed 3 X with PBS and 
mounted onto glass slides with VECTASHIELD® Antifade Mounting Medium with DAPI (4′,6-
diamidino-2-phenylindole; Vector Laboratories). Images were acquired on an upright 
epifluorescence microscope (Zeiss), ensuring exposure times were constant for each channel 




Chapter 3 – Design of a screen to investigate mechanisms of DNA 




DNA hypomethylation is promoted in 2i media however, the mechanism through which this 
occurs was previously unknown. In this chapter, I have characterised alternative 2i systems 
and described the set-up of a proteomic screen that aimed to identify candidate regulators 
of the DNA methylation maintenance machinery. 
 The emergence of 2i media was the result of attempts to improve traditional serum-based 
culture media to an extent that mESCs could be maintained in vitro with a transcriptional 
state that more closely recapitulates their in vivo counterparts. Further studies noted that 2i 
promotes DNA methylation reprogramming in mESCs and the distribution resembles 
patterns in cells of the ICM of early embryos. As a consequence, 2i provides an opportunity 
to understand the role of DNA methylation within early development and decipher the 
molecular mechanisms that regulate this epigenetic process. The effects of 2i are also 
influenced by serum withdrawal or depletion which has led to various iterations of the base 
medium being conceived (Ying et al., 2008; Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 
2013; Hackett et al., 2017).  
The vast majority of publications utilise N2B27 media, a system used previously to sustain 
neural populations in culture (Ying et al., 2008).There have also been reports that KOSR can 
directly substitute for the FCS that supplements GMEM in standard mESC culture and is a 
sufficient base media for 2i to exert an effect. In these studies, this composition, referred to 
hereafter as KOSR+2i, can drive the establishment of iPSCs from a partially reprogrammed 
starting state. This is characterised, amongst other markers, by the expression of endogenous 
Oct4 at the end of the reprogramming process, rather than a dependency on exogenous Oct4 
initially transduced with a viral vector (Silva et al., 2008; Christophorou et al., 2014). The 
KOSR reagent has also been reported to sustain human ESCs (Garcia-Gonzalo and Izpisúa 
Belmonte, 2008) in addition to primordial and embryonic germ cells (Horii et al., 2003). 
Transcriptomic analyses conducted on mESCs treated with 2i in either a KOSR or N2B27 base 
medium unsurprisingly highlight differences between the systems. Importantly however, the 
profiles of cells in the serum depleted medias have more similar gene expression profiles 
than a population cultured in traditional media. Globally, transcripts are more reflective of 
an earlier naïve state in development, contrasting with the serum culture which is 
heterogenous and markers associated with differentiation are also expressed (Hackett et al., 
96 
 
2017). This demonstrates that the 2 molecular inhibitors are largely able to overcome the 
effects of other ingredients in the base medias.  
In this results chapter, I detail the set-up of a screen to identify mechanisms which may 
contribute to the reprogramming of DNA methylation. By transitioning mESCs from serum-
based culture to both of the aforementioned 2i systems in parallel, I characterised the 
kinetics of DNA demethylation. The 2i system with the greatest dynamic range, with respect 
to DNA methylation levels relative to serum-based culture, will then be taken forward and 
used to screen for interacting candidates of DNMT1 and Uhrf1. Using the media that imposes 
the greatest change will facilitate the quantification of any effects on DNA methylation in 





3.2 Results  
3.2.1 Characterising DNA methylation in KOSR and N2B27 2i media systems 
To establish the effects of the two different culture conditions on DNA methylation, I 
performed a time course experiment in which global methylation levels were assessed, in 
addition to the gene and protein expression of DNA methylation regulators. To this end, I 
conducted LC-MS for the quantification of global 5mC, RT-PCR for gene expression analyses 
and western blotting to assess protein levels. Samples were taken daily for five days and 
another at day 14 in culture. This time point has previously been reported as the time when 
cells reach a steady state with respect to methylation levels (von Meyenn et al., 2016).   
For each LC-MS experiment, two control cell lines were also included: TKO mESCs, in which 
all three Dnmts have been knocked out, and the parental J1 line (Tsumura et al., 2006). These 
provided an internal control when quantifying unknown levels of DNA methylation. The 
values for each of the daily time points are presented relative to that obtained from WT E14 
cells cultured in serum, which is taken as 1. As the experiment commenced with cells from 
the same line, the starting methylation state for both KOSR+2i and N2B27+2i conditions is 
equivalent.   
Within 1 day of transitioning cells from serum culture, both of the 2i medias begin to promote 
hypomethylation. The effect however is more pronounced in KOSR+2i throughout the time 
course. The lowest level of methylation attained in N2B27+2i culture, a 30% loss after 14 days 
relative to serum at day 0, is reached within 2 days of KOSR+2i application. By contrast, after 
14 days in KOSR+2i, cells exhibited a loss of methylation of over 80%. This demonstrates that 
more efficient demethylation is occurring in the latter system (Figure 3.1A). In order to 
quantity this, the relative values from days 0-5 in culture were transformed into their natural 
logs and plotted against time to enable the rate of demethylation to be calculated. Assuming 
first order kinetics, the slopes of the respective trendlines show that KOSR+2i promotes the 
loss of DNA methylation at an approximately 4-fold faster rate, compared to N2B27+2i, a 





Figure 3.1 – A. DNA methylation levels of WT E14 mESCs cultured in different media, KOSR and N2B27, 
with 2i for the days indicated. Values presented as relative levels to serum cultured cells at 0 days. B. 
The relative values from days 0-5 of culture presented as natural logs. The slope of the line indicates 
the rate of demethylation, assuming first order rate kinetics. Error bars represent the standard 
deviation of the mean from three technical replicates.  Representative experiment from two repeats.   
A 
B 
y = -0.0486x - 0.0111































































3.2.2 Protein and mRNA dynamics of DNA methylation mediators in KOSR and N2B27 2i 
systems 
To assess the impact of the different 2i media compositions on the protein levels and 
expression of the DNA methylation machinery, I performed western blots and RT-qPCRs as 
described above. In contrast to the serum and N2B27 + 2i culture systems, Dnmt1 protein 
was subject to a partial downregulation in KOSR + 2i after 3 days. Contrary to previous 
publications (von Meyenn et al., 2016), Uhrf1 protein levels were shown to not be affected 
in N2B27 + 2i, similarly to serum, whereas a decline was precipitated after 2 days in KOSR + 
2i. It is important to note that a relative drop of methylation by 30% was recorded in KOSR+2i 
medium prior to the loss of Uhrf1. In both 2i systems, Dnmt3a was regulated similarly as 
levels dropped sharply by 3 days. Meanwhile Dnmt3b protein was present in KOSR+2i, albeit 
to a lower extent than serum. Its regulation in N2B27+2i mirrored Dnmt3a whereby a steep 
decline was seen (Figure 3.2). 
 
Figure 3.2 – Western blot of whole cell lysates from cells cultured in traditional media supplemented 
with FCS (serum) or two types of 2i (KOSR + 2i, N2B27 + 2i). Time since switching to 2i culture 
represented as days. Gapdh was used as a loading control and TKO and parental J1 lysates are shown 





Comparison of Dnmt1 gene expression between the different 2i media shows it is subject to 
fluctuation throughout culture however, it reaches a state comparable to that of serum-
maintained cells in the latter stages of the transition. Despite the mRNA of Uhrf1 being 2-fold 
higher in KOSR+2i by day 14, the protein was still evidently subject to posttranslational 
regulation. At the end of this time course, the N2B27+2i media also displayed higher levels 
of Uhrf1 mRNA compared to serum cultured cells yet protein was sustained to a comparable 
level (Figures 3.2 and 3.3). 
The downregulation of Dnmt3b protein in N2B27+2i can be accounted for by the rapid drop 
in transcript levels. While a decline was initiated in KOSR+2i, the mRNA began to rebound 
after 5 days and remained comparable to the serum culture thereafter, despite protein levels 
being lower. This direct relationship to mRNA and protein also holds for Dnmt3a which in 
both treatments declined rapidly. Statistically significant (p≤0.05) differences are evident at 
some time points, particularly in the earlier stages of the transition. In all occasions however, 
levels remain lower than in serum (Figures 3.2 and 3.3). 
Interestingly, whilst Dnmt3l is almost undetectable in N2B27+2i culture after 2 days, 
expression increases after 3 days in KOSR+2i despite an initial drop, which mirrors the 
regulation of Dnmt3b in the same system (Figure 3.3).  
Of note, despite the intention of only including it as control to validate the Dnmt antibodies, 
the TKO line is shown to also have a lower amount of Uhrf1 protein, suggesting an association 
between Dnmts and Uhrf1 stability (Figure 3.2).    
Based on the results above, and as discussed later, KOSR+2i represented the most 
informative system to use for investigating mechanisms that lead to hypomethylation. This 
is due to the more pronounced demethylation following 14 days of culture and the early 








Figure 3.3 – RT-qPCR analysis of DNA methylation mediators in two different 2i media compositions, 
KOSR + 2i and N2B27 + 2i, at the indicated time in days. Values are presented relative to UbqC 
expression. Error bars represent the standard deviation from three technical replicates. (* = p≤0.05; 
**= 0.001<p<0.05). Representative of two independent experiments.  
 
3.2.3 Generation of cell lines expressing DNMT1 and Uhrf1 -BirA* fusion proteins 
To elucidate routes by which hypomethylation is promoted, I sought to characterise the 
interactome of the fundamental components of DNA methylation maintenance, DNMT1 and 
Uhrf1. Capturing the interacting partners of these proteins in mESCs maintained in serum-
based media and KOSR+2i, where DNA methylation levels are markedly different, could lead 
to the identification of novel regulators. For example, if an enzyme interacts more prevalently 
with Uhrf1 in KOSR+2i compared to serum, it could be inferred that Uhrf1 is impaired by a 
PTM. Likewise, if a complex forms with Dnmt1 in serum media, this could be hypothesised to 
promote Dnmt1 activity. This dataset would ultimately facilitate the design of functional 
studies to determine whether the interacting partners influence DNA methylation 
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maintenance. The method of choice for identifying the interacting partners of DNMT1 and 
Uhrf1 was BioID, owing to the advantages over Co-IPs as discussed below.  
The BioID method utilises a promiscuous biotin ligase, BirA*, that modifies lysine residues of 
vicinal proteins that are within a 10 nm radius. If BirA* is tagged to a protein of interest, 
biotinylated proteins can therefore be inferred as interacting partners or within a 
macromolecular complex with the protein of interest. It is necessary for cell culture media to 
be supplemented with biotin for a period of up to 24 hours. As biotinylation is a rare 
biological process, there is a high degree of confidence that biotinylated proteins are within 
close proximity or indeed interactors of the tagged protein in cells. To recover the 
biotinylated proteins, harsh lysis conditions can be used as there is no requirement to 
preserve the interaction. This is particularly useful for DNMT1 and Uhrf1 which are chromatin 
associated factors. Furthermore, as the pull-down is mediated by streptavidin, stringent 
conditions can be used to remove background proteins as the interaction between biotin and 
streptavidin is one of the strongest known in nature. Proteins that are pulled-down in a BioID 
experiment can then be identified by mass-spectrometry. Those that are enriched by a 
particular factor over control conditions as outlined below are then taken forward for 
consideration (Figure 3.4) (Roux et al., 2012; Varnaitė and MacNeill, 2016).  
 
Figure 3.4 – Figure legend on next page 
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Figure on previous page Figure 3.4 – Overview of the BioID method. A promiscuous biotin ligase (BirA*) 
is fused to proteins of interest, such as DNMT1 and Uhrf1. If vicinal proteins are within 10nm then they 
are susceptible to biotinylation (blue teardrops) at lysine residues (K) when biotin is provided 
exogenously. Cells are then lysed and the biotin moiety is maintained, enabling streptavidin mediated 
pull-down. Following this, the recovered proteins can be identified by mass-spectrometry. Adapted 
from (Roux et al., 2012). 
 
Importantly, equivalent cell lysis and washing steps would require extensive optimisation in 
order to capture the interactome with a conventional co-IP. Lysis conditions to solubilise 
chromatin associated factors and the subsequent washing steps of an appropriate stringency 
need to be balanced against the potential disruption of interactions between the target of 
interest and other proteins. In this regard, the use of BioID is advantageous (Roux et al., 2012; 
Varnaitė and MacNeill, 2016). 
To establish the requisite experimental cell lines for BioID, I cloned human DNMT1 and 
mouse Uhrf1 into BirA* expressing vectors and stably transfected these into an E14 cell line 
(Figure 3.5). A more complete overview of this process is described earlier in Chapter 2 which 
covers both the initial cloning of BirA* into a piggyBac vector and the subsequent In-Fusion® 
mediated cloning of the genes of interest. I will reiterate here however that as both DNMT1 
and Uhrf1 are large multidomain proteins, lines were generated so that the proteins were 
tagged at the N- and C-terminus in order to capture a broader number of partners that may 
specifically interact with one portion of the protein.  
To validate the cell lines, several assays were performed. Firstly, I confirmed that the tagged 
protein is expressed by western blotting. As expected, both an endogenous band was present 
and another ~30kDa higher, corresponding to the protein fused with BirA*, for both the 
DNMT1 and Uhrf1 lines. Whilst Uhrf1-BirA* is expressed at a level lower than the 
endogenous protein, the DNMT1 fusion protein is more abundant than endogenous Dnmt1. 
Two control lines were also generated: an empty vector control, which expresses the 
piggyBac vector, and a free BirA* control that is not fused or tethered to any protein (Figure 
3.6). The BirA* line represents the most stringent control as this accounts for proteins that 
may interact with the fusion proteins by virtue of the additional tag. The Empty vector control 
accounts for proteins that bind to the streptavidin-conjugated beads irrespective of whether 




Figure 3.5 – Linear maps of DNMT1- and Uhrf1-BirA* vectors. Expression is regulated by a CAG 
promoter. Ampicillin and Hygromycin resistance genes permit selection of positive bacterial clones 
and successfully transfected cells respectively 
 
Figure 3.6 – Western blot of whole cell lysates expressing A Empty control (E), Free BirA* control (B), 
BirA* N-terminally tagged DNMT1 (N), BirA* C-terminally tagged DNMT1 (C) vectors and B BirA* N-
terminally tagged Uhrf1 (N) and BirA* C-terminally tagged Uhrf1 (C) vectors. Upper bands in A Dnmt1 
and B Uhrf1 blots represent BirA* fusion proteins and the lower band the endogenous proteins. Actin 





As depicted in the vector maps (Figure 3.5), the BirA* protein possesses a Myc-tag which 
enables the expression levels of the tagged proteins and the free BirA* to be evaluated. A 
western blot was performed following a time-course wherein biotin was applied to the lines 
for 0, 2, 4, 6 and 24 hours. As shown in Figure 3.7, the expression of the free BirA* is 
comparable to that of the DNMT1-BirA* fusions. The N-terminally tagged protein however 
appears to be subject to cleavage. Figure 3.8 demonstrates that free BirA*  is more abundant 
than both Uhrf1-BirA* proteins. Ideally, the levels would be similiar as this would prevent 
candidates that are true interacting partners from being discarded ; free BirA* may interact 
more frequently with other proteins if there is more of it. Therefore with respect to the 
Uhrf1-BirA* lines, candidates that are indeed enriched over the free BirA* control can be 
considered interacting proteins with a high degree of confidence. Similarly, due to the 
deficiencies of the the N-termially tagged DNMT1 line, candidates enriched over the free 
BirA* control would also be strong contenders. There initially appears to be a decrease in 
DNMT1- and Uhrf1-BirA* proteins at 24 hours however, it should be noted that the Myc-tag 
has a lysine residue and this could be subject to biotinylation. As a consequence the epitope 













Figure 3.7 – Western blot of whole cell lysates to assess the expression levels of N and C-terminally 
tagged DNMT1-BirA* proteins (upper arrow) and free BirA* (lower arrow). The presence of free BirA* 
in the DNMT1-BirA* lanes is indicative of sample degradation or cleavage of the BirA* tag. Coomassie 
staining of a gel was used as a loading control. Empty vector control (E), free BirA* control (B), BirA* 
N-terminally tagged DNMT1 (N) , BirA* C-terminally tagged DNMT1 (C)  
 






 Figure 3.8 – Western blot of whole cell lysates to assess the expression levels of N and C-terminally 
Uhrf1-BirA* proteins (upper arrow) and free BirA* (lower arrow). Coomassie staining of a gel was used 
as a loading control. Empty vector control (E), free BirA* control (B), BirA* N-terminally tagged Uhrf1  
(N)  and BirA* C-terminally tagged Uhrf1  (C). 
 
3.2.4 Testing catalytic activity of BirA* fusion proteins 
Although the fusion proteins are expressed, it was also important to determine that the BirA* 
is functional. To this end, the lines were treated with biotin for 0, 2, 4, 6 or 24 hours and 
whole cell extracts prepared and analysed by a western blot. An antibody conjugated to 
streptavidin was then applied to detect all biotinylated proteins. As shown in Figure 3.9, the 
DNMT1 lines were indeed shown to be functional, with the extent of biotinylation increasing 
with time. Also evident is the relatively greater acitivty displayed by the free BirA*. As 
DNMT1-BirA* and free BirA* are expressed at similar levels (see Figure 3.7), this would 
suggest that the localisation of the proteins, enabling it to find more substrates, can account 





intrinsicly more active. Figure 3.10 initially appears to suggest that the Uhrf1-BirA* line has 
either weak biotinylation activity  or is non-functional. 
Extensive autobiotinylation of the exogenously introduced Uhrf1 and DNMT1 is also 
expected. Blots for the Myc tagged protein after biotin treatment and streptatividin pull-
down can therefore also serve as indicators that the BirA* is functional.  As shown in Figures 
3.11 and 3.12, both proteins are in the lanes corresponding to the pull-down suggesting 
autobiotinylation and that the BirA* fusion proteins have biotinylating activity. The low level 
expression of Uhrf1-BirA* (see Figure 3.8) may therefore account for the inability to detect 
biotinylated proteins in Figure 3.10. Also shown in Figures 3.11 and 3.12 is an enrichment of 
biotinylated proteins in the lanes corresponding to the pull-down. In order to validate the 
suitability of the lysis conditions, the cell debris that remains after clarifying the lysate prior 
to performing the pull-down has also been included in these blots (Pellet). For both DNMT1- 
and Uhrf1-BirA*, very little protein is detected in the Pellet. Therefore, it is evident that the 




Figure 3.9 – Western blot of whole cell lysates to determine the biotinylation function of N and C-
terminally tagged  DNMT1-BirA* proteins following application of biotin for the time indicated. Wild-
type E14 (WT), Empty vector control (E), free BirA* control (B), BirA* N-terminally tagged DNMT1 (N) 








Figure 3.10 – Western blot of whole cell lysates to determine the biotinylation function of N and C-
terminally tagged  Uhrf1-BirA* proteins following application of biotin for the time indicated. Empty 
vector control (E), free BirA* control (B), BirA* N-terminally tagged Uhrf1 (N) , BirA* C-terminally 
tagged Uhrf1 (C) 
 
Figure 3.11 – Western blot of whole cell lysates from BirA* fusion protein and control lines following 
treatment with biotin for 24 hours and streptavidin mediated pull-down. Please note the loading 
order. The pellet heading refers to the cell debris that remains following the clarification of the cell 
lysate prior to the pull-down. Empty vector control (E), free BirA* control (B), BirA* N-terminally 














Figure 3.12 – Western blot of whole cell lysates from BirA* fusion protein and control lines following 
treatment with biotin for 24 hours and streptavidin mediated pull-down. Please note the loading 
order. The pellet heading refers to the cell debris that remains following the clarification of the cell 
lysate prior to the pull-down. Empty vector control (E), free BirA* control (B), BirA* N-terminally 
tagged Uhrf1 (N) , BirA* C-terminally tagged Uhrf1 (C) 
 
3.2.5 Determining the localisation of BirA* fusion proteins 
Another important consideration before embarking on the screen was whether DNMT1- and 
Uhrf1-BirA* fusion proteins localise to the nucleus, as would be expected of the endogenous 
proteins. This would increase the confidence that novel interactors found in the screen are 
not the result of an artefact in the system from mislocalised protein. This was tested by 
immunofluorescence,  exploiting the Myc-tag and by DAPI counterstaining (Figure 3.13). For 
each line, six separate representative images were taken. Merged channels of DNMT1- and 
Uhrf1-BirA* with DAPI suggest that the fusion proteins are exclusively localised to the 
nucleus. Foci of colocalisation (white arrows) are visbile between DAPI dense 
heterochromatic regions and the Uhrf1-BirA* fusion. However as the DNMT1-BirA* is 
ubiquitous in the nucleus, similar incidences are not evident in the respective lines. A high 
density of Uhrf1-BirA* is also detected in at least two cells of a colony in the images taken, 
as depicted in the N-terminus line and other represenitive examples not shown. This may be 
associated with cell cycle regulation and will require further investigation using relevant 








and the cytoplasm, which may account for the extensive biotinylation, compared to the 




Figure 3.13 – Immunofluorescent staining of BirA* fusion proteins and control lines. Arrows indicate 
regions of colocalisation with DAPI dense heterochromatic regions. Images representative of six 
individual colonies. Images acquired with X100 objective. Scale bar = 10 µm.  
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3.2.6 Developing an independent method to validate the BioID screen 
To increase the confidence that a protein identified in the BioID screen is an interacting 
partner, pull-downs were performed in parallel. Figure 3.14 shows that the Myc-tag can be 
used to achieve efficient pull-down of the fusion proteins without biotin, in addition to the 
free BirA* which would serve as the non-specific binding control. This also provides further 
evidence that the N-terminally tagged DNMT1 protein is cleaved. As a protein interaction is 
independent of biotin and its supplementation is only required in BioID, it is appropriate to 
use the N-terminally tagged DNMT1 and Uhrf1 lines only. Although this route may be 
insufficient to detect transient interactors, proteins identified in both the Myc pull-down and 
BioID are likely to be robust interactors and would be the strongest candidates to pursue in 
future functional studies.  
 
Figure 3.14 – Western blot to show Myc-mediated pull-down of BirA* proteins from the respective 
stable cell lines. Upper arrow to DNMT1-BirA*, middle to Uhrf1-BirA* and lower to BirA*. The presence 
of free BirA* in the DNMT1-BirA* lane is indicative of sample degradation or cleavage of the BirA*.  
Pellet refers to the cell debris remaining after clarifying the cell lysate prior to the pull-down. Free 








Prior to the onset of this study, the major mechanism through which 2i promotes 
hypomethylation, particularly in the N2B27 based medium, was unknown. However, in 2016, 
it was reported that downregulation of Uhrf1 precipitates the decline in global methylation, 
with some additional effects accounted for by the reduction in Dnmt3a and -b levels. This 
results in impaired maintenance methylation as Dnmt1 is not as pervasively recruited to 
chromatin and over time with cell division, DNA methylation is diluted. However, marks are 
maintained at certain regions including major satellites and imprinted genes (von Meyenn et 
al., 2016). To my knowledge, I have presented the first characterisation of the dynamics of 
DNA methylation and the mediators in an equivalent system known as KOSR+2i.  
3.3.1 KOSR+2i is an appropriate system to investigate mechanisms that regulate DNA 
methylation 
Despite using previously published protocols, I did not observe the extensive 
hypomethylation that has been reported upon culture of mESCs in N2B27+2i media 
(von Meyenn et al., 2016). Therefore, the influence of environmental factors, such as the CO2 
pressure, and the use of different cell clones will need to be taken into consideration. I raise 
the former point as it has been noted that for the duration of my studies, the CO2 was 
maintained at lower than 1 bar (this has since been rectified). As the epigenetic 
reprogramming in 2i based media is mediated by the application of cell signalling modulators, 
conflicting pathways that are influenced by variable culturing conditions may antagonise the 
effects that are otherwise observed in a different environment. Nevertheless, rapid 
hypomethylation was promoted with culture of mESCs in KOSR+2i.  
As Uhrf1 was not downregulated in N2B27+2i in the experiments presented above and the 
effects on DNA methylation were less dramatic, this provides further evidence that the 
mechanism that accounts for the majority of the hypomethylation in N2B27+2i is indeed 
mediated through Uhrf1. Although an experiment would need to be conducted in parallel 
before decisively concluding as such, I hypothesise that the demethylation observed in the 
N2B27+2i condition above (see Figure 3.1) may largely be accounted for by the 
downregulation of Dnmt3a and -b. Reviewing published studies indicates that the rate of 
demethylation in de novo Dnmt null cells is comparable to the rate observed here with 
N2B27+2i application. Throughout this experiment, the cell lines underwent 6 passages in 
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both media and it has been reported that Dnmt3a -/-; Dnmt3b -/- null cells can lose up to 
20% of their methylation within 5 passages (Jackson et al., 2004). As the proliferation rate is 
comparable between serum and N2B27+2i cultured cells (ter Huurne et al., 2017), there may 
still be a contribution from additional mechanisms acting on the maintenance pathway. As 
Dnmt1 and Uhrf1 protein levels were consistent, PTMs or a disruption in protein complexes 
may also be accountable for the 30% drop recorded in N2B27+2i, in addition to Dmt3a and -
b downregulation.  
Notwithstanding the effect on Uhrf1, other differences were apparent in the regulation of 
the de novo transferases between the 2i culture systems. Whilst Dnmt3a declined rapidly in 
both systems, albeit relatively faster at the transcript level in N2B27, Dnmt3b remained 
expressed to a higher degree at both the mRNA and protein level. One factor previously 
reported to dictate the expression of the de novo transferases in 2i is Prdm14. Prdm14 is an 
important specification factor of germ cells and its upregulation anticorrelates with Dnmt3a 
and -b levels (Grabole et al., 2013). Differential regulation of Prdm14 by KOSR and N2B27 
based systems may account for this disparity.  
With two different base media available, a question that arises is whether an N2B27 or KOSR 
base is the most appropriate system to investigate the mechanisms of DNA demethylation.  
Although it is described as chemically defined, the exact composition of KOSR has not been 
fully disclosed however, a group has identified numerous components by mass spectrometry 
(Garcia-Gonzalo and Izpisúa Belmonte, 2008). Like standard FCS, it is also reportedly subject 
to lot-to-lot variability which may decrease the veracity with which it can model naïve 
pluripotency (Chaudhry et al., 2008; Tamm, Pijuan Galitó and Annerén, 2013). Of note, is the 
maintained expression of Dnmt3b in KOSR+2i (Figure 3.2), which has been reported to occur 
in vivo in most stages of pre-implantation development (Hirasawa et al., 2008).  
In my current attempts, I have been unable to recapitulate the results published using the 
N2B27+2i media (von Meyenn et al., 2016). Notwithstanding this, the transcriptomic profiles 
of N2B27 and KOSR cultured mESCs with 2i are reportedly broadly similar. A distinct class of 
genes found to be relatively more enriched in KOSR than N2B27 based media are associated 
with the 2-cell state, which includes Zscan4 for example. Therefore, KOSR+2i may model a 
broader spectrum of pluripotency (Hackett et al., 2017). As outlined in the introduction, 
Zscan4 can negatively affect Dnmt1 and Uhrf1 levels and the regulation of DNA methylation 
by this route may be more prominent in KOSR+2i (Dan et al., 2017). Other genes are also 
116 
 
differentially expressed between KOSR and N2B27 media and so future experiments may be 
best served by utilising both 2i compositions (Hackett et al., 2017). Protein interactions that 
are common between both systems will be attractive for further characterisation. On the 
other hand, interactions that are found to be unique ought not to be disregarded for this 
reason. As genes are variably expressed throughout pre-implantation development, 
sequential mechanisms may contribute at different stages to promote or maintain the 
reprogramming of DNA methylation (Hackett et al., 2017).  
However, for both N2B27 and KOSR based systems with 2i, or indeed either of the Mek or 
Gsk3β inhibitors in isolation, global transcripts do not faithfully model earlier stages of 
development, such as E2.5 when DNA demethylation is also occurring (Hackett et al., 2017). 
If a differential interacting partner found in the BioID screen is expressed in multiple stages 
of pre-implantation development, this would bolster the credibility that it may regulate Dnmt 
activity in vivo and warrant further investigation in the 2i systems. Confirming the expression 
profile of any candidates that may regulate DNA methylation and a successful functional 
study illustrating this role may render any questions regarding the importance of differences 
between KOSR and N2B27 2i media irrelevant.      
In this present study, application of KOSR+2i was sufficient to drive DNA hypomethylation in 
mESCs. The rapid loss of the 5mC mark suggested an impairment in the maintenance 
machinery was largely responsible for this epigenetic reprogramming. In KOSR+2i, 
demethylation progressed at a similar rate to that reported in studies using N2B27+2i, 
wherein Dnmt1 activity was shown to be impaired through Uhrf1 downregulation. 
Furthermore, demethylation also occurred faster than in mESCs made deficient for the de 
novo Dnmts (Jackson et al., 2004; von Meyenn et al., 2016). Whilst Uhrf1 protein levels 
declined in KOSR+2i, this occurred after 2 days, by which time a 30% drop in 5mC was already 
recorded (see Figure 3.1). This suggested that alternative mechanisms are operative at earlier 
time points in the 2i transition that can account for the effects on DNA methylation. Using a 
proximity ligation method, BioID (Roux et al., 2012), I sought to characterise these changes. 
By tagging both Uhrf1 and DNMT1 the differential regulation of the main components of the 
maintenance machinery can be investigated. A change in the composition of the complexes 
that either DNMT1 and Uhrf1 participates in within serum relative to the KOSR+2i condition, 
or vice versa, would present candidate regulators of these two proteins and consequently, 
the maintenance of DNA methylation.  
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A variety of proximity ligation techniques are now available in the biochemical toolbox to 
query novel interacting partners of a protein under investigation. BioID is highly relevant for 
the focus of this study as it is permissible to use harsh lysis conditions to liberate insoluble 
cellular fractions that are associated with chromatin (Varnaitė and MacNeill, 2016). 
3.3.2 Optimisation of a BioID experiment to investigate the interactome of methylation 
maintenance machinery 
To study the interactome of DNMT1 and Uhrf1 in mESCs, and the potential differential 
makeup of complexes under conditions promoting hyper- and hypomethylation, I have 
demonstrated that a number of suitable cell lines have been established and validated for 
use in BioID and pull-down experiments.    
One potential drawback of the system I generated is the relatively low expression of Uhrf1-
BirA*. Although this may be beneficial as it is also expressed at levels lower than endogenous 
Uhrf1, and therefore the potential for artefacts is minimised, this may exacerbate the issues 
related to the extensive biotinylation performed by the free BirA* control. As free BirA* 
displays a high degree of activity, there is the possibility that known and novel interactors of 
Uhrf1 are discarded as they are not enriched over this control.  
The DNMT1-BirA* proteins are expressed to a similar extent and yet also have lower 
biotinylating activity than free BirA*. This effect may be expected based on the results in 
Figure 3.13 that show that there is a greater distribution of the free BirA* in cells and 
therefore the additional proteins biotinylated in Figures 3.9-3.12 may reside in the 
cytoplasm. This activity may also be an intrinsic property of conducting the experiment in 
mESCs however, a study into Autoimmune Regulator in the same line reported equivalent 
levels of activity were exhibited by a BirA* control tagged with mCherry and the fusion 
protein (Gu et al., 2017). Others have also shown the utility in using a combination of BirA* 
fused with a nuclear localisation signal and a fluorescent tag as they yield different results 
(Lambert et al., 2015). 
At the expense of robustness, candidates enriched over the Empty vector control will 
therefore need to be included in the analysis. A more appropriate control to consider for 
similar experiments in the future is a line in which the protein of interest is overexpressed, 
such as DNMT1 and Uhrf1. This would recapitulate the potential changes in the proteome or 
the cell biology that may be induced by the overexpression of these epigenetic regulators as 
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BirA* fusions. Similarly, the BirA* fusion lines untreated with biotin, as published previously 
(Mulholland et al., 2015), would also serve this purpose. 
The limitations of BioID include those universal to all mass spectrometry methods, the most 
important factors being the efficiency with which lowly abundant proteins are detected and 
coverage. In order for proteins to be detected, they are required to be digested into peptides 
of a suitable length. However, this unavoidably increases the complexity of the mixture 
analysed and can give false positives (Han et al., 2008). Other factors to consider that are 
unique to BioID include accessibility of the BirA* ligase to neighbouring proteins. If this is 
impaired by steric hindrance due to the position of BirA*, biotin ligation will occur less 
extensively and potential interactors or proximal proteins will not be identified. Furthermore, 
free biotin that has not be utilised by BirA* may compete with biotinylated proteins during 
the streptavidin pull-down. To minimise this, the wash buffer applied following the removal 
of media can be maintained on cells for an extended time to promote the diffusion of free 
biotin out of the cells, before commencing with the lysis procedure (Conlan et al., 2018; Roux 
et al., 2018).   
In this study, the BioID screens will be complemented by conventional pull-down 
experiments. Whilst transient interactions will be difficult to maintain, relatively more stable 
interactions may be accounted for using this method. In contrast to BioID, which samples 
proteins in the vicinity, a pull-down may account for direct interactors or if it is preserved, 
components of an interacting complex. The candidates that fulfil the criteria of enrichment 
over the BirA* control and are detected in the pull-down will likely be the lead candidates. 
Initial validation steps will include performing endogenous IPs of Dnmt1 and Uhrf1 from 
serum and KOSR+2i maintained mESCs, followed by blotting for the candidates. Functional 
studies will follow in which the candidate is knocked down or overexpressed before the effect 
on DNA methylation is determined.   
The BirA* of N-terminally tagged DNMT1 protein appears subject to cleavage. Figures 3.7 and 
3.14. show free BirA* and intermediate sized proteins are present in the line. In the BioID 
screen, the free BirA* generated may therefore biotinylate proteins that are not proximal to 
DNMT1. When compared to the free BirA* control line however, these proteins may not be 
enriched and can therefore be accounted for, assuming the cleaved BirA* has a similar 
distribution. The efficiency of the Myc pull-down may also be compromised and it will 
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therefore be important to assess the enrichment of DNMT1 from the N-terminally tagged 
line relative to the control free BirA* line.   
 The use of BioID to assess the interactome of Dnmts has been published before (Mulholland 
et al., 2015). In that particular study, Dnmt3b was selected and the differential interactions 
that occurred during epiblast differentiation were charted. The main focus however was to 
discuss the development of a system in which Dnmts, Uhrf1 and the Tet enzymes can be 
efficiently tagged with various cassettes using Bxb1-mediated recombination at a so-called 
multifunctional integrase (MIN) site introduced by CRISPR. The benefit of having an 
endogenously tagged Dnmt1 and Uhrf1 for example would be the absence of competition 
from an exogenously introduced fusion protein. This potential to compete for complexes may 
reduce the frequency of interactions with other proteins and therefore the detection over a 
background control is compromised. There is no guarantee however that the fusion protein 
will be expressed at a level comparable to the protein in a WT line. Another option available 
to negate the effects of competition would be to stably transfect into a null cell line. Various 
promoters could then be tested to attain a relevant level of protein expression. In both of 
these systems, the capability of the fusion protein to restore or maintain DNA methylation 
could then be assayed. If successful, this would provide further reassurance that localisation 
is equivalent to the endogenous protein and that interactions detected in the screen are 
reflective of events that truly occur in vivo.  
However rather than optimising a system with BioID, there is a more efficient method now 
available that should be considered as the starting point in future experiments. This is known 
as TurboID and it represents the next generation in proximity labelling methods (Branon et 
al., 2018). Developed from BirA* by directed evolution through serial rounds of error prone 
PCR and selection, the TurboID ligase is capable of attaining an equivalent level of 
biotinylation within 10 minutes than can be reached by BirA* in 18 hours. This has the 
potential to increase the depth of proteins captured that interact transiently, which may 
include more signalling mediators. A longer period of biotin incubation was shown to capture 
yet more proteins but this also correlated with an increased frequency of non-specific 
interactions. A free Turbo control may also reduce the background signal compared to free 
BirA* as vicinal proteins may not be saturated due to the requisite incubation time with biotin 
being considerably shorter (Branon et al., 2018). BirA* has proven amenable to protein-
fragment complementation (Trinkle-Mulcahy, 2019) and a similar development with TurboID 
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will be an exciting achievement. This could be exploited in a study like mine in which Dnmt1 
and Uhrf1 fusions are expressed in the same line. As they are known interacting partners 
during the maintenance of DNA methylation, proteins would only be biotinylated when this 
complex is formed and as such the function of novel interactors could be inferred to assist in 
this role. Under conditions such as 2i, the expectation would be that a complex between 
Dnmt1 and Uhrf1 would be disrupted and therefore comparisons could be drawn regarding 
interactors in serum conditions. 
Nevertheless, satisfied that the systems I generated had been optimised and appropriate 
conditions were available in which DNA methylation was modulated, I undertook a screen to 
identify novel interacting partners of DNMT1 and Uhrf1 in conditions that model naïve and 





Chapter 4 – Proteomic screens to identify regulators of Uhrf1 and 






Prior to the onset of this study, downregulation of Uhrf1 had not been identified as a 
mechanism contributing to the DNA hypomethylation observed in mESCs when transitioning 
from serum-based media to N2B27+2i (von Meyenn et al., 2016). Nevertheless, results 
presented in Chapter 3 from an investigation into an alternative and understudied system, 
KOSR + 2i, suggests that mechanisms additional to Uhrf1 downregulation may also contribute 
at early stages to instigate DNA demethylation. In mESCs cultured in KOSR+2i medium, there 
is a 30% decline in methylation within 48 hours and this occurs prior to appreciable 
downregulation of Uhrf1 or Dnmt1 protein. Within this time window, I employed BioID to 
identify differential interacting partners of Uhrf1- and DNMT1-BirA* fusion proteins stably 
expressed in mESCs and cultured in KOSR+2i or serum-based media. This data will be 
complemented by a conventional Myc-tag mediated pull-down. These datasets combined 
will then influence the selection of candidate regulators of DNA methylation maintenance. 
Figure 4.1 represents an overview of the experimental scheme followed to obtain the data 
in this chapter.  
 
Figure 4.1 - Scheme of a BioID and pull-down screen to uncover the interacting partners of DNMT1 
and Uhrf1 stably expressed in mESCs cultured in serum-based media or with KOSR + 2i. The definition 
of a candidate is led by the criteria of enrichment over at least one control cell line. In the BioID screen, 
a cell line expressing an empty vector (Empty) and another overexpressing BirA* (free BirA*) serve as 
controls. The BirA* constructs also contain a Myc-tag which can be exploited for pull-down. This 
dataset will strengthen the validity of the BioID data however, as this method is less suitable to detect 
transient interactions, it is not essential. For this set of experiments, non-specific interactions will be 





Cell lysates for both BioID and Myc pull-down experiments were collected in triplicate for 
each cell line. The streptavidin-conjugated and Myc-trap beads used for BioID and the Myc-
pull down respectively were then prepared following an appropriate washing procedure for 
mass spectrometry analyses. Further downstream processing and spectra analyses were 
performed by Jimi Wills (IGMM, University of Edinburgh) using MaxQuant software (Cox and 
Mann, 2008). Protein abundance was then calculated by myself from the relevant output file. 
As both screens were conducted without the use of isotopic labelling methods, protein 
quantification was measured in accordance with LFQ intensity values. This employs a number 
of algorithms for the purposes of normalising protein intensities and has been used for 
similar protein-protein interaction experiments with satisfactory results (Cox et al., 2014). 
4.2.1 Data processing 
Statistical tests referred to throughout this chapter were two-tailed unpaired t-tests. These 
were applied to filter proteins that are significantly (p≤0.05) enriched over the Empty vector 
or free BirA* controls in serum-based media and KOSR+2i. For example, to isolate proteins 
enriched over the Empty vector control, the first array of data was the triplicate LFQ values 
for the Empty vector control and the second array the LFQ values of the N-terminally BirA* 
tagged Uhrf1 line for a particular protein. Therefore by comparing the mean LFQ values, 
those two-fold enriched in the experimental line relative to a control are not simply enriched 
because one replicate has a disproportionately high LFQ intensity value, but because all 
replicates have similar intensity values and are each enriched by two-fold over the control. 
The same process was applied to all of the samples and relevant controls, meaning the 
average LFQ intensity of a protein in the serum and KOSR+2i cultured experimental lines were 
compared relative to the serum and KOSR+2i cultured Empty, and separately, free BirA* line.  
With respect to the data from the Myc pull-down screen, LFQ intensities from the 
experimental sample were compared to values from the Myc pull-down control that was 
performed in the same experiment (see Figure 4.2).  
 
Figure 4.2 – Schematic of data analysis workflow. See main body of text for details.  
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The initial step of the data analysis was to assess the levels of Dnmt1 and Uhrf1 in the lines 
and experiments. As these are the ‘baits’ or fusion proteins that will biotinylate proteins, the 
intensity of these should be amongst the highest of the proteins detected if the pull-down 
had occurred as intended. 
As shown in Figure 4.3, the levels of Uhrf1 in the BioID experiments are relatively consistent 
across the triplicates in the same culture condition. When applying a t-test as outlined above 
and calculating the fold-enrichment, N- and C- terminally tagged Uhrf1 are 198.73- and 
123.54-fold more enriched over the average LFQ value calculated in the Empty vector 
control. Relative to BirA*, Uhrf1 is 2395.84- and 1489.33-fold more abundant, respectively. 
In KOSR+2i culture, these values are 2754.94 and 3644.88-fold for N-terminally tagged Uhrf1 
over the Empty vector and BirA* controls and 2719.39 and 3597.85-fold for C-terminally 
tagged Uhrf1, respectively.  
Instantly apparent in Figure 4.3 is the greater intensity of Uhrf1 in KOSR+2i compared to 
serum-based culture. This equates to a 2.66- and 4.22-fold difference between the media in 
the N and C-terminal tagged lines, respectively. In order to identify differential interactors, 
the LFQ values for proteins in the experimental lines maintained in serum-based media will 
require normalising through multiplication by this fold-difference. To account for the 
intensity that may be attributed to the binding of the non-biotinylated protein in the serum 
sample, an LFQ intensity that is 2-fold greater than the multiplication factor is regarded as 
differentially enriched. Therefore, proteins that are 5.32- and 8.44-fold more abundant in 
serum-based media by normalised LFQ value in the N- and C-terminally tagged lines are 
considered as differential interactors. On the other hand, an average LFQ intensity that is 2-
fold greater for KOSR+2i compared to serum will be considered as the threshold above which 
a protein is differentially interacting.  
The differential level of Uhrf1 is also observed in the results from the Myc pull-down screen. 
The KOSR+2i culture line exhibits 2.53-fold higher abundance of Uhrf1 on average when 
compared to the serum lines.  As a consequence, serum LFQ intensities have also been 
normalised through multiplication by this factor and a 5.07-fold cut-off taken as the threshold 
above which a protein is considered to differentially interact in serum-based media. An 
enrichment in KOSR+2i that is 2-fold above the average serum value, as in the BioID 
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Figure on previous page  Figure 4.3 – LFQ Intensity of Uhrf1 calculated by mass spectrometry from A. 
BioID and B. Myc pull-down experiments in the cell lines and media conditions indicated. Numbers 1-
3 under each bar represent the replicates of each group. Empty vector control (Empty), Myc control, 



























Figure 4.4 – Figure legend on next page 
  
Empty BirA* N-D1 C-D1 Empty BirA* N-D1 C-D1 
Serum KOSR + 2i 
Myc control N-D1 
Serum KOSR + 2i 








Figure on previous page Figure 4.4 - LFQ Intensity of Dnmt1 calculated by mass spectrometry from A. 
BioID and B. Myc pull-down experiments in the cell lines and media conditions indicated. Numbers 1-
3 under each bar represent the replicates of each group. Red asterixis denote the samples that were 
omitted from subsequent analyses. Empty vector control (Empty), Myc control, BirA* N-terminally 
tagged Dnmt1 (N-D1), BirA* C-terminally tagged Dnmt1 (C-D1) 
 
Similar experiments with the DNMT1-BirA* lines were less successful. In the BioID screen, a 
replicate from each of the experimental lines cultured in KOSR+2i had to be omitted from the 
analysis owing to the large degree of variability. Furthermore, a replicate from the Myc pull-
down in serum media has also been removed from consideration (Figure 4.4). With the 
inclusion of these replicates, a t-test comparing the average LFQ intensities in the 
experimental line and controls would otherwise have removed Dnmt1 itself from the list of 
enriched proteins, reflecting a statistically significant difference between the replicates. 
Therefore, rather than leading with this dataset, it has been used to supplement the findings 
from the Uhrf1 lines.  
To facilitate the data analysis, a t-test was applied, as outlined above, to filter out proteins 
that are significantly (p>0.05) variable between the replicates. Those enriched two-fold over 
either the Empty or free BirA* controls were then isolated.  With this criteria, 818 proteins 
were shown to be enriched over the Empty vector control in the N and C-terminally tagged 
lines collectively. Of this number, 498 were enriched in both the serum and KOSR+2i 
conditions whilst 66 and 254 specifically interacted, respectively. A considerably smaller 
number of 88 proteins were enriched over the free BirA* control. Of these, 26 were shared 
whilst 29 more were found uniquely in the serum condition and 33 in KOSR+2i (Figure 4.5). 
 
Figure 4.5 – The number of proteins from the Uhrf1 BioID and Myc pull-down screens enriched over 
the respective background controls (Empty vector and Free BirA*/Myc pull-down control) in serum 
and KOSR+2i media. Values that were at least 2-fold more abundant and not of a significantly different 
intensity between replicates were considered as enriched.  
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These lists were then ranked according to the average LFQ value in the appropriate 
experimental sample. The series of tables presented below show the fifty most abundant 
proteins that are enriched at least two-fold over the Empty vector controls. The number of 
proteins enriched over the free BirA* in some circumstances did not exceed fifty and they 
are presented in their entirety.  Reassuringly, Uhrf1 was represented close to, if not the top, 
of all these lists (Table 4.1 A-H). Expanded tables detailing the number of peptides detected 
in each sample can be found in Appendix 1. Accompanying volcano plots generated by Jimi 
Wills (IGMM, University of Edinburgh) can be found in Appendix 2.  
The accompanying Myc pull-down experiment yielded 239 proteins over the background 
control, 198 of which were uniquely enriched in serum, 18 in KOSR+2i and 23 were found in 
both conditions (Figure 4.5).  
The data collected from the DNMT1-BirA* lines was also subject to the same processing 
methods. Underlying the deficiency of the dataset is the absence of DNMT1 by these 
measures from the proteins enriched over the BirA* control in the C-terminally tagged line 
cultured in KOSR+2i. Furthermore, the trend of increased bait levels with KOSR+2i culture 
compared to serum, as seen with the Uhrf1 lines, was observed in the Myc pull-down but not 
with BioID, suggesting cells were insufficiently lysed or beads were lost (Figure 4.4). 
Nevertheless, 475 shared proteins cleared the Empty vector background threshold and 239 
and 256 were found specifically in serum and KOSR+2i conditions, respectively. As expected, 
proteins enriched over the BirA* control were fewer: 14 were found in both conditions and 
20 each were unique in serum and KOSR+2i. Meanwhile, 15 and 43 proteins were unique in 
the serum and KOSR+2i Myc pull-down respectively and 10 were shared.   
4.2.2 Visualising the data 
STRING (https://string-db.org/) is an online database into which the names of individual 
proteins are inputted and a web of known or inferred interactors are returned. Interactions 
are depicted by a series of coloured lines, with each line representing a different method that 
was used to demonstrate or infer an interaction occurs. A key describing what the coloured 
lines represent is shown in Figure 4.6.  
Similarly, a list of proteins can also be uploaded and databases are mined to ascertain if there 
are associations between them each. This is particularly useful in proteomic screens as it 
demonstrates whether detected proteins are likely to interact with the bait in a pull-down, 
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or the BirA* fusion protein in BioID, either directly or indirectly as they are a component of a 
larger interacting complex. Handily, functional enrichment analyses are also conducted 
which can be used to summarise the previously described role of the proteins inputted. Each 
of the tables (Table 4.1 A-H) presented were entered into STRING to assist in the visualisation 
of data and the corresponding graphics are shown below (Figure 4.7 A-H). Levels of 
confidence can be changed that may establish a relatively more tenuous association between 
proteins however, I have maintained the default ‘medium’ option throughout. The Gene 





Figure 4.6 – Screenshot from the STRING database of the key for each coloured line that infers or 
denotes an interaction between two proteins.   
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Table 4.1 – The most abundant proteins ranked by average LFQ intensity detected in an N- and C-BirA* 
terminally tagged Uhrf1 line in a BioID experiment with mass spectrometry. Uhrf1 is highlighted in 
each table A-D) The fifty most abundant proteins enriched at least 2-fold over an Empty vector control. 
E-H) All proteins enriched at least two-fold over a free BirA* control. 
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Figure on previous page Figure 4.7 – Visual representation of BioID data generated by STRING for each 
of the noted lines, conditions and enrichment over Empty vector or free BirA* control lines. Inset 
tables are Gene Ontology terms returned for the proteins displayed. Lines are indicative of a report 
from different methods that the proteins labelled above each sphere interact or have the potential to.  
 
In both serum and KOSR+2i, proteins enriched over the Empty vector control are associated 
largely with nuclear processes. These are feasible categories for attempts to identify novel 
interactors that influence the activity of Uhrf1 (Figure 4.7 A-D). Furthermore, the majority of 
proteins have pre-established links and those that lay outside the web of interactions, such 
as the zinc-finger proteins (Zfp), would likely be within close proximity to Uhrf1 as they can 
bind DNA.  
Overall, direct interactors with Uhrf1 are well represented, specifically by Dnmt1, DNA Lig1 
and TopII-α, which appears to be a particularly rich node of interactions (Sharif et al., 2007; 
Lu et al., 2015; Ferry et al., 2017) . In Figure 4.7 A for example, TopII-α has been inferred to 
interact with the RNA helicase Dhx9 as there are putative homologues that demonstrably 
associate in other species. Similarly, homologues of Dhx9 interact with other RNA helicases 
and ribonucleotide proteins, as shown in the vicinity of the Dhx9 node in Figure 4.7 A. As 
BioID biotinylates vicinal proteins, the fact this interacting network has been identified in the 
screen may be a reflection that they share a co-factor in TopII-α and remain associated with 
it, or are in the process of dissociating, when TopII-α facilitates Uhrf1 activity. Histones have 
also been detected in this dataset and in other media and with use of the C-terminal tag. The 
histones are illustrated to interact with numerous other proteins, particularly those 
annotated as helicases or that modify histone tails, such as Artx, Trim28, Smarca5 and 
Jmjd1c. As Uhrf1 engages with histones during DNA methylation maintenance, as covered in 
Chapter 1, this may account for a direct or indirect interaction with these examples.    
As is the case from the serum data, Rif1 is not annotated to interact with Uhrf1 in the network 
displayed in Figure 4.7 B, which shows the fifty most abundant proteins in the N-terminus 
KOSR+2i dataset. Whilst it is shown to likely interact indirectly through Wdhd1, a 
transcription initiation factor, there has been a report that Uhrf1 and Rif1 cooperate in the 
DNA damage response (H. Zhang et al., 2016). This demonstrates that STRING can facilitate 
the processing of data but should not be relied on solely to interpret it.  
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In the C-terminus data in Figure 4.7 C, the presence of DNA Lig1 and TopII-α in the top fifty 
most abundant proteins can account for a number of interactions, similar to the N-terminus 
data. The co-expression of Uhrf1 and Bptf, along with the fact homologues in other species 
reportedly interact, has led to an annotation between these two proteins. This transcription 
factor resides within the centre of various different interactions between multiple other 
proteins, some of which, such as TopII-α and Artx are known or inferred to interact with 
Uhrf1. Despite the annotated role of Brd4 as a reader of acetylated histones, this protein has 
not been associated to interact with Uhrf1 directly, but potentially through Bptf. In both 
cases, the likelihood of Uhrf1 being in proximity to Bptf and Brd4 is high as their functions 
involve chromatin, the substrate for Uhrf1 binding. Furthermore, as Brd4 also mediates the 
DNA damage response (X. Li et al., 2018), this context may provide a route in which Uhrf1 
and Brd4 interact directly, in light of the known function of Uhrf1 in this process as referred 
to earlier with Rif1.  
As for the N-terminus data, the top fifty most abundant proteins in the C-terminus are 
broadly similar between serum and KOSR+2i media. However, in Figures 4.7 E-H, which relate 
to BirA* enriched proteins, the GO terms diverge somewhat between the culture conditions, 
reflecting a change in the protein complexes that Uhrf1-BirA* may interact with or encounter 
in the vicinity. 
The N-terminus serum media BirA* enriched dataset has been presented as having few 
associations (see Figure 4.7 E). Those drawn between Uhrf1 are with a cell-cycle marker, Ki-
67, which coats chromosomes during mitosis, and a DNA damage mediator, Bard1. This 
demonstrates the opportunity to identify novel interactors. Compared to the N-terminus, the 
number of proteins enriched over the free BirA* control in serum media with the C-terminally 
tagged Uhrf1 is less and all but eight proteins are found in the N-terminus dataset also, hence 
the similarity between the STRING plots (see Figure 4.7 G).  
The larger number of proteins enriched over free BirA* in KOSR+2i media has led to a more 
extensive web of inferred interactions emanating from Uhrf1. In the N-terminus data, shown 
in Figure 4.7 F, Tet1 has been inferred to interact with Uhrf1. This may be expected to be 
detected in the BioID data, given the minor role of active mechanisms, mediated by Tet1 for 
example, in the demethylation promoted in 2i media (von Meyenn et al., 2016). 
Furthermore, the SRA domain of Uhrf1 that is typically associated with binding to 5mC, has 
also been shown to have an appreciable affinity for 5hmC, the product of Tet1 activity (Frauer 
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et al., 2011). Perversely, Dnmt3a is also enriched over the BirA* control in KOSR+2i, despite 
the protein declining dramatically in this media, as shown in Chapter 3. However, when 
accounting for the fold-difference in enrichment between serum and KOSR+2i media, this 
does not pass the threshold. Notwithstanding this, there is evidence that Uhrf1 can influence 
de novo methylation in oocytes (Maenohara et al., 2017). 
 The C-terminal data for proteins enriched over the BirA* control in KOSR+2i is largely similar 
to the N-terminal equivalent. Only eight unique proteins were identified using this line and 
none of these may reportedly interact with Uhrf1. Superficially, some examples of these such 
as Zfp563 and Huwe1 could be rationalised to be vicinal to Uhrf1 in mESCs, based on their 
annotations, as they have the capacity to bind DNA and are involved in the DNA damage 
response, respectively.   
Of note are Pcca/b and Mccc1/2, which are present in all datasets. These are mitochondrial 
proteins and in the case of Pcca and Mccc1, they have annotated biotin carboxylase domains 
that transfer CO2 groups from bicarbonate to biotin in an intermediate step of 
macromolecule metabolism. The malonyl-CoA processes in the C-terminal BirA* enriched 
data can also be accounted for by this action as Acaca/b possess a biotin carboxylase domain 
too (Tong, 2013).   
The GO terms of proteins in the Uhrf1 dataset for the serum media Myc pull-down relate to 
metabolic processes associated with nucleic acids, nucleobase-containing compounds, RNA 
and cellular nitrogen compounds, in addition to gene expression. For KOSR+2i, two defined 
categories, regulation of gene expression and nucleobase-containing compound metabolic 
processes, are returned.  
Collectively, this presents a strong case that the Uhrf1-BirA* fusion is localising appropriately 

















Figure 4. 8 – LFQ intensity of Dnmt1 determined by mass spectrometry in the Uhrf1-BirA* lines in 
serum and KOSR+2i medias. Error bars represent the standard deviation from the mean of three 
technical replicates. 
 
The categories for the DNMT1 BioID dataset enriched over the Empty vector control include 
metabolism of nucleic acids, nucleobase-containing and nitrogen compounds. The small 
number of BirA* enriched proteins and those from the pull-down precludes categorisation 
however, ‘small molecule metabolic processes’ has a low false discovery rate for serum BioID 
data. Proteins enriched in the DNMT1 Myc pull-down from serum media are examples of 
chromosome and nucleosome organisation regulators. This may be in part due to the number 
of histone proteins and histone modifying enzymes in the dataset. Known DNMT1 interactors 
Pcna and Usp7, which have been addressed in the introduction, are also found. Proteins in 
the KOSR+2i Myc pull-down dataset are represented by the categories: nucleic acid and RNA 
metabolic processes and regulation of gene expression. Relevant to this former category is 
TSG101 which can interact with DNMT1 through DMAP1 and repress transcription, as 
discussed in the introduction (Rountree, Bachman and Baylin, 2000).  
Of note, Dnmt1 was calculated in the Uhrf1 BioID screen to be enriched over the Empty 
vector control only. Whilst intensity was reduced in the KOSR+2i condition, which is expected 




serum culture was not sufficient for it to be classified as a differential interacting protein. A 
1.97 and 1.82-fold difference was exhibited for the N and C-terminus line respectively (Figure 
4.8). Nevertheless, 29 proteins enriched over the Empty vector control in the Uhrf1 BioID 
data were more abundant in serum than in KOSR+2i, and similarly 185 passed the threshold 
in KOSR+2i. Of proteins enriched over the BirA* control, this was reduced to 10 in serum 
compared to KOSR+2i and 9 in the opposite manner.  
4.2.3 Selecting candidates for functional characterisation 
After surveying the data, five candidates were selected as they showed a different propensity 
to interact with Uhrf1 in the culture conditions, or for scientific curiosity. In all cases, they 
were enriched over the most stringent control in the BioID experiments, free BirA*. 
Furthermore, all were potential novel interacting partners, with the exception of 
Dppa3/Stella (von Meyenn et al., 2016; Mulholland et al., 2018; Du et al., 2019).  
Figure 4.9 and Table 4.2 outline the average LFQ intensities of the proteins across the 
experimental lines in serum and KOSR+2i culture and the fold-differences. Apobec3 
(Apolipoprotein B Editing Complex 3) and Utf1 (Undifferentiated embryonic cell Transcription 
Factor 1) were notable for their relative enrichments in serum media, in contrast to KOSR+2i. 
Conversely, Stella interacted more strongly in KOSR+2i than serum. The fold differences 
between serum and KOSR+2i are presented in Table 4.2 and notably exceed the set 
threshold. Auts2 also displayed variable levels however, a slightly less stringent p value was 
required to be set for the interaction in serum to be accounted for. The N-terminal value was 
otherwise filtered out for having a p value of 0.053 and the C-terminal line at 0.056. 
A number of differential interactors were also found that perform PTMs on other proteins 
(Figure 4.10). Pdk1 (Pyruvate Dehydrogenase Kinase 1) was selected for characterisation as 
this displayed the greatest fold difference in enrichment between serum and KOSR+2i media 
Indeed, Pdk1 was the only example of this class enriched over the free BirA* control and it 
was found exclusively in the serum BioID data. Furthermore, it was also 15.29-fold more 
enriched in the DNMT1 C-terminus BioID data and cleared the threshold set for enrichment 
over the free BirA* control. 
The Uhrf1 Myc pull-down data lends some support to the BioID findings. Whilst Stella was 
not differentially enriched by the criteria imposed, there was concordance with the trend 
observed with BioID. Similarly, Apobec3 and Pdk1 were more enriched in serum, supporting 
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the BioID result, but not over the background values obtained with pull-down of the Myc 
control. Meanwhile, Utf1 was detected in the pull-down from the serum-maintained line only 
and Auts2 was not found in any sample, including the Myc control line (Figure 4.9 and Table 
4.2). 
 
Figure 4.9 – Average LFQ intensity of the candidate proteins in A. N-terminally BirA* tagged Uhrf1, B. 
C-terminally BirA* tagged Uhrf1 and C. Myc mediated pull down of the N-terminally BirA* tagged 




Table 4.2 – Candidates and relative extent of enrichment in BioID and Myc-pull down screens from 




Figure 4.10 – Average LFQ Intensities of differential interacting proteins that mediate post-
translational modifications.  Candidates were found exclusively in the N-terminus data with the 
exception of Pdk1 which was detected at the N-and C-terminus. Pdk1 was the only example enriched 
over the free BirA* control. Error bars represent the standard deviation from the mean of three 
technical replicates. 
  
Kinase Ubiquitin ligase 
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To investigate whether the variable interactions could be explained by differing levels of the 
candidate proteins in the media, I performed a western blot and RT-qPCR for each (Figures 
4.11 and 4.12). I was however unable to validate an antibody for Stella. For all candidates, 
the changes in expression and protein levels correlate with the extent of interaction in the 
different media. Both Utf1 and Pdk1 are subject to downregulation in KOSR+2i and this is 
accompanied by a reduced interaction with Uhrf1. Meanwhile Stella increases in expression 
at the mRNA level in KOSR+2i, matching the more extensive interaction with Uhrf1 that was 
observed. Whilst Apobec3 did not reach the threshold to be defined as a differentially 
interacting protein, the western blot shows levels decline subtly in KOSR+2i and there was a 
trend to reduced binding in the same condition. Lastly, Auts2 levels remain consistent across 
the media and a differential interaction cannot be confirmed as the LFQ intensity fold 
difference (2.78 and 2.88 for N- and C-term lines respectively) falls below the imposed 
threshold. 
 
Figure 4. 11 – Western blot of candidates in mESCs maintained in serum-based media and after 48 
hours in KOSR+2i. The upper band in the Utf1 blot is of a non-specific band reported by the 





















Figure 4.12 – Expression of the selected candidates in serum and KOSR+ 2i media relative to UbqC, as 
determined by RT-qPCR. Error bars represent the standard deviation from the mean of three technical 
replicates. (* = p<0.05) 
 
In an initial attempt to validate the mass spectrometry data, I repeated the BioID and Myc 
pull-down experiments and probed for the proteins of interest in a western blot (Figures 4.13 
and 4.14). In addition, I performed an IP of endogenous Uhrf1 in a WT E14 line (Figure 4.15). 
In all cases, there was no concordance with the dataset as the candidates were not enriched 
in the experimental samples. Whilst interactions may not be preserved by the Myc pull-down 
and IP due to their transient nature, I was unable to recapitulate the BioID data too. One 
possible explanation is that the proportion of Uhrf1 that interacts is low to the extent that it 
152 
 
is below the detection limit of a western blot, meaning alternative methods to validate the 
candidates need to be explored as discussed below. 
 
 
Figure 4.13 – Western blot of candidate interactors following treatment of the Uhrf1-BirA* lines and 
controls with biotin in the respective medias and streptavidin mediated pull-down. Empty vector 
control (E), Free BirA* control (B), BirA* N-terminally tagged Uhrf1 (N) , BirA* C-terminally tagged 















Figure 4.14 – Western blot of the candidate interactors following Myc-tag mediated pull-down of N-
terminally BirA* tagged Uhrf1 and control lines cultured in serum or KOSR+2i media. Myc pull-down 
control (C), N-terminally BirA* tagged Uhrf1 (U)   
 
 
Figure 4.15 – Western blot of candidate interactors after endogenous Uhrf1 immunoprecipitation 






Using a proximity labelling method and a high affinity pull-down, I have generated datasets 
that show the differential interactome of Uhrf1 in medias that maintain a high level of DNA 
methylation or promote a global loss of the mark. As Uhrf1 appears central to this epigenetic 
remodelling, the interacting proteins in these markedly different signalling environments 
may illustrate mechanisms that contribute to this process. Similar attempts to investigate the 
profile of DNMT1 have proven to be less successful and therefore a repeat would be 
necessary to obtain data of comparable quality. Led by the proteomic data, five candidates 
were chosen for further characterisation and to determine whether an interaction with Uhrf1 
is instructive in regulating DNA methylation.  
To this end, initial experiments would investigate the kinetics of DNA demethylation after 
genetic perturbation of each candidate. Proteins that interact more strongly in serum may 
be expected to delay demethylation when overexpressed, with an opposite effect when the 
candidate is knocked down and the cell line transitioned to KOSR+2i, and vice versa. Whether 
knockdown of any of the factors influences demethylation in KOSR+2i in conjunction with 
Uhrf1 perturbation should also be followed. As knockout of Uhrf1 will immediately begin to 
promote DNA hypomethylation (Sharif et al., 2007), a conditional line would prove to have 
more utility for temporal control. Alternatively, a combined knockdown may be sufficient.   
The higher levels of the DNMT1- and Uhrf1-BirA* fusions in KOSR+2i suggest that the media 
promotes a faster rate of proliferation, compared to serum culture (Figures 4.3 and 4.4). 
Although this has not been tested thoroughly, I noticed this when passaging cells maintained 
in KOSR+2i. In order to identify differential interactors, the data from the screens required 
further normalisation and an adjusted threshold limit. To minimise the manipulation of data 
and improve future screens, the protein concentration in the cell lysates could be quantified 
after harvesting the treated cells and then equal amounts from each of the serum and 
KOSR+2i samples taken to perform the respective pull-downs.  
I have made preliminary steps to validate the interactions between Uhrf1 and the candidates 
selected for functional characterisation however, so far this has proven to unsuccessful. In a 
study focussed on core histones, affinity-purification and BioID experiments were performed 
in parallel and both approaches yielded diverse profiles of interacting proteins. BioID was 
notable for detecting lowly abundant proteins, which may partly explain the results of the 
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validation attempts for my screens (Lambert et al., 2015).  An alternative and frequently used 
method to confirm novel interacting partners from BioID datasets is immunofluorescence for 
visualising co-localisation with the protein of interest (Varnaitė and MacNeill, 2016). Whilst 
this does not strictly determine if a protein directly interacts, this can also be argued for BioID 
as this process surveys the vicinity of the tagged protein from which inferences are then 
made. As set out in Table 1.1, overexpression of the protein in an unrelated cell line has 
proven an appropriate method for confirming a functional interaction between Uhrf1 and 
Dnmt1. This approach can be modified by performing sequential co-IPs with truncated 
proteins in order to identify the sites that are important for mediating the interaction. 
Nevertheless, the fulfilment of the five chosen candidates to the strictest control in the BioID 
experiment provides an impetus to investigate them further. The biological roles of the 
candidates are discussed below and their potential relationships with DNA methylation 
maintenance are hypothesised. 
4.3.1. Dppa3/Stella 
The immediate stages of early development that occur after fertilisation are characterised by 
pervasive DNA demethylation. This affects the maternal and paternal genomes 
asymmetrically, as the maternal counterpart demethylates relatively more slowly 
(Smallwood and Kelsey, 2012). One factor that has been suggested to mitigate this effect is 
Stella, also known as Dppa3, which prevents active demethylation mechanisms from 
remodelling the maternal genome (Nakamura et al., 2012). It is therefore surprising that 
Stella has also been shown to disrupt the activity of Dnmt1 and promote demethylation in 
oocytes and mESCs (Mulholland et al., 2018; Y. Li et al., 2018). In the Uhrf1 interactome 
screens, Stella proved to be one of the most robust candidates as it was enriched over the 
free BirA* control and was also detected in the Myc pull-down data. Furthermore, in keeping 
with the notion that Stella is associated with hypomethylation, it was relatively more 
enriched in the KOSR+2i condition.  
It has been shown in oogenesis that Stella is evenly distributed between the nucleus and 
cytoplasm in growing oocytes and is more enriched in the former compartment at later 
stages. Meanwhile, Uhrf1 is mainly maintained in the cytoplasm. In a Stella knockout model 
however, Uhrf1 ectopically accumulates in the nucleus. Subsequently, there is a 
corresponding increase in DNA methylation across a range of genes and repetitive 
sequences, which is most notable in mature (MII) oocytes. As a consequence, the maternal 
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genome is hypermethylated at pronuclei at stages immediately post-fertilisation and the 
two-cell stage, wherein transcriptional defects begin to emerge. Using separate Dnmt3a and 
Dnmt1 null MII oocytes in a Stella null background, over 80% of the aberrantly methylated 
regions that arise in Stella deficient oocytes were shown to be attributable to Dnmt1 activity. 
The influence of Dnmt3b was not tested as it was undetectable at this stage. This study not 
only broadens the role of Stella in pre-implantation development, it also suggests that Dnmt1 
has a de novo methylation function. The typical Dnmt1 substrate is regarded as newly 
synthesised hemi-methylated DNA however, it was shown with Stella-null oocytes that 
aberrant patterns arose when they were mitotically arrested (Y. Li et al., 2018).  
Further evidence of a relationship between Stella and Uhrf1 can be found in a study that 
initially began dissecting the catalytic and catalytically independent roles of Tet1 in mESCs 
(Mulholland et al., 2018). Gene expression analyses in catalytically dead Tet1 and Tet1KO 
mESC lines and a WT EpiLC line, which are all markedly hypermethylated compared to WT 
ESCs, showed that Stella was notably lower compared to WT ESCs. The propensity for Tet1 
to bind to a transcriptional enhancer of Stella and an enrichment of 5hmC at this element 
was later shown. Collectively this suggests that Stella transcription is influenced by Tet1 
activity. One of the main functions of Tet1 in pre-implantation development was therefore 
hypothesised to be to actively demethylate regulatory elements of Stella and promote its 
expression. In turn, deletion of Stella in mESCs was shown to increase 5mC levels by ~25%. 
Analogous to the study above, ectopic expression of Stella was observed to promote the 
translocation of a Uhrf1-GFP fusion protein out of the nucleus and into the cytoplasm in a 
WT line maintained in N2B27+2i. Similarly, a Dnmt1-GFP fusion had disrupted chromatin 
targeting and a small fraction was localised to the cytoplasm (Mulholland et al., 2018). 
Notably, this challenges other reports that have used the same conditions but did not 
observe the redistribution of Uhrf1 (von Meyenn et al., 2016).  
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The evidence presented above strongly suggested that the differential interaction observed 
in the screens I performed is functional, in that Stella may drive Uhrf1 out of the nucleus and 
as a consequence impair Dnmt1 targeting. I therefore tested this by visualising the 
distribution of Uhrf1 in a WT E14 line maintained in serum or KOSR+2i for 48 hours.  
 
Figure 4.16 – Immunofluorescence images of Dnmt1 (green channel) and Uhrf1 (red channel) (and 
DAPI (blue channel)) in mESCs cultured in serum-based or KOSR+2i media for 48 hours. A total of six 




Figure 4.16 shows that the result is inconclusive due to the propensity of the antibodies to 
give a strong background signal however, the localisation of Uhf1 and Dnmt1 does appear to 
be comparable between the different media. Whilst Stella may indeed promote the 
translocation of Uhrf1 at later stages, thus compounding the effect of low Uhrf1 protein 
abundance, other mechanisms may initiate the impairment of DNA methylation 
maintenance. However, aside from an ability to sequester Uhrf1, Stella can reportedly 
influence DNA demethylation independently of this function. From a series of in vitro peptide 
binding assays, the C-terminal end of Stella was shown to compete with histone tails in 
binding the TTD and PHDs of Uhrf1 (Du et al., 2019). A similar effect could be tested in 
KOSR+2i by fractionating WT and Stella knockout mESCs and assaying for the amount of 
Uhrf1 bound to chromatin or free in the nucleoplasm. Experiments from the aforementioned 
studies could also be adopted, including the use of 5-aza-CdR to trap Dnmt1 and quantify the 
amount bound to chromatin in the two culture systems, or Fluorescence Recovery After 
Photobleaching (FRAP) to ascertain whether Dnmt1 and Uhrf1 localisation occurs with similar 
kinetics (Mulholland et al., 2018; Du et al., 2019).  
4.3.2 Utf1 
A candidate that has an inverse profile to Stella in the manner in which it interacts with Uhrf1 
is Utf1. This was initially characterised as transcriptional regulator of high importance in 
development and is expressed in PGCs, the ICM and ESCs. It is transcriptionally regulated by 
Oct4 and Sox2 and as such, this may explain its downregulation in post-implantation 
development (Okuda et al., 1998; van den Boom et al., 2007; Bao et al., 2017). Furthermore, 
knockdown of this factor negatively affects ESC differentiation as exemplified by the 
maintenance of Oct4 and Nanog levels and misexpression of lineage markers when forming 
embryoid bodies. Native ChIP identified genes to which it binds and these are involved in 
chromatin, nucleosome and protein-DNA complex assembly. In addition, it was enriched on 
the Y-chromosome at genes associated with spermatogenesis. Collectively, only ~6% of these 
bound targets were differentially expressed upon Utf1 knockout (Kooistra et al., 2010). 
Another study in ESCs, where biotin-ChIP-seq with a biotin-Utf1 protein was performed, 
noted that the density of CGIs was high at Utf1-bound TSSs, relative to the genome average 
(Jia et al., 2012). 
Utf1 was shown to have an affinity for chromatin comparable to core histones, leading to the 
speculation that it may assist in establishing a permissive epigenetic state to enable 
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differentiation (van den Boom et al., 2007). As set out in the introduction however, DNA 
methylation of genes may only be acquired after transcriptional silencing to lock in this 
regulation. Whether Utf1 therefore sets up a favourable epigenetic state in response to or 
before transcription needs to be temporally dissected (van den Boom et al., 2007). 
Nevertheless, a role in modulating epigenetic marks has been ascribed to Utf1 (Jia et al., 
2012). Utf1 peaks were shown to correlate highly with those of a PRC2 component (Suz12) 
in ChIP-seq experiments in mESCs. Furthermore, PRC2 binding increased up to 4-fold along 
with H3K27me3 deposition upon Utf1 knockout. This led to the conclusion that Utf1 acts to 
regulate the polycomb system by restraining excessive activity. Rescue experiments and in 
vitro assays with PRC2 components and Utf1 demonstrated there is competition for a similar 
DNA motif enriched at bivalent domains, genomic regions at which both Utf1 and PRC2 are 
enriched. Further experiments also showed that Utf1 acts to assist in the efficient loading of 
mRNA decapping components onto nascent mRNAs at these regions, thus pruning the 
expression of bivalently marked genes too. As such, genes that were upregulated upon Utf1 
loss were examples of those escaping pruning whereas downregulated genes, marked by 
higher CpG densities, accumulated PRC2 and were silenced (Jia et al., 2012) .  
Uhrf1 was also shown to have a regulatory role at bivalent domains and therefore the 
interaction detected in the BioID and Myc pull-down screens could reflect a co-occupancy 
with Utf1 (Kim et al., 2018). In a Uhrf1-null mESC line, over half of the bivalent domains that 
were detected in a WT line resolved to either an active or repressed state. Mechanistically, 
the deposition of H3K4me3 borne by active elements and bivalent domains was attributed 
to the direct recruitment of Setd1a by Uhrf1, an interaction I also found to occur in the C-
terminally tagged Uhrf1 in serum media. Furthermore, Uhrf1 was shown to modulate the 
binding of Oct4 at regions marked with H3K4me3. This may account for the observation that 
when Uhrf1 is transduced with OSK into MEFs, the efficiency of reprogramming cells to an 
induced pluripotent state is increased 3-fold, when compared to the use of OSK alone. The 
number of reprogrammed colonies produced by OSK+Uhrf1 is notably comparable to that 
attained using the standard OSKM cocktail (Kim et al., 2018). Of note, Klf4 was found to bind 
to Uhrf1 in my dataset too. This would be an interesting avenue to explore regarding the 
establishment of pluripotency by Uhrf1.   
Aside from histone marks, an association between Utf1 and DNA methylation has also been 
observed. Whether this effect is direct or indirect needs to be determined. When knocked 
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out, H3K9me3 levels, which are highly associated with Uhrf1, remained consistent yet 
demethylation of minor satellite regions was shown (Kooistra et al., 2010). Evidence from the 
BioID and Myc pull-down screens showing Utf1 binds to Uhrf1 suggest that the effect of Utf1 
knockout on DNA methylation may be direct.   
Complicating future experiments to determine a functional relationship with Uhrf1 is the fact 
that knockdown of Utf1 causes cells to proliferate more slowly compared to a WT line. This 
is due to an increase in levels of the tumour suppressor Arf, which is a likely consequence of 
impaired mRNA pruning that Utf1 would otherwise mediate (Jia et al., 2012). When 
maintained in KOSR+2i this may give the impression that demethylation is delayed as DNA 
methylation will be diluted more slowly when the maintenance machinery is impaired. The 
effects on the cell-cycle in this medium will therefore need to be characterised before 
commencing with the experiment. As Arf expression is driven by Myc and levels of Myc were 
shown to dramatically decline in N2B27+2i, the effect may be overcome (Ying et al., 2008; Jia 
et al., 2012). A Utf1 overexpressed line maintained in KOSR+2i, compared to a WT line in the 
same medium, might offer an alternative approach to address the same question.  
Nevertheless, Utf1 knockdown has already been shown to promote hypomethylation and as 
it interacts less extensively in KOSR+2i, evidence suggests it is a robust candidate to follow 
for further mechanistic characterisation.  
4.3.3. Pdk1 
The influence of metabolism on DNA methylation may offer a rich seam to mine for the 
development of novel therapeutics. The generation and recycling of the methyl donor group, 
Adomet, is after all the product of a metabolic pathway (Ulrey et al., 2005; Kim and Yeom, 
2018). In this study, I have found that Pdk1, an enzyme that cooperates with other Pdk 
isoenzymes to modulate the activity of the pyruvate dehydrogenase complex (Pdc) (Behal et 
al., 1993), interacts with Uhrf1 exclusively in serum media. Furthermore, it was shown in the 
DNMT1 C-terminus BioID data to be 15.29-fold more enriched with serum culture compared 
to KOSR+2i. Bearing a catalytic domain with a similar fold as members of the ATPase/kinase 
superfamily, Pdk1 modifies serine residues of Pdc (Bowker-Kinley and Popov, 1999). 
The decarboxylation of three-carbon compounds by Pdc is a prerequisite for further 
metabolic downstream processing and the activity of this enzyme therefore needs to be 
responsive to the requirements of the cell. The role of an inactivating kinase and activating 
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phosphatase is to integrate environmental cues and act on Pdc accordingly. Longer term 
regulation however is mediated by Pdh kinase of which Pdk1 is an isoenzyme (Bowker-Kinley 
and Popov, 1999). A role of Pdc outside of this context has been shown previously in the 
synthesis of acetyl-CoA in the nuclei of A549 renal- and 786-O alveolar- cancer cell lines. Here 
the products are utilised by acetyltransferase enzymes to modify histones (Sutendra et al., 
2014). A redistribution of Pdk enzymes however was not shown to occur similarly to regulate 
Pdc. Taking an unbiased approach with regards to the data from the screen would not 
preclude Pdk1 from consideration as a candidate however.  
As introduced above, a network of metabolic pathways influence DNA methylation and 
therefore perturbations in Pdk1 may indirectly affect the levels of the mark. An approach to 
circumvent this and define whether the influence is direct would be to map the potential 
phosphorylation sites on Uhrf1 and Dnmt1 using overexpression models in cells coupled with 
IPs. This could be followed by a series in vitro assays that were similarly used to characterise 
the modifications set out in Table 1.2. Complementary experiments would be to inhibit the 
phosphorylation or to generate a phosphomimic before observing the impact on DNA 
methylation in a cell line. As the enrichment of Pdk1 is in serum media, phosphorylation by 
this enzyme could be expected to promote DNA methylation, an effect shown to be imparted 
by other phosphorylations (Table 1.2). 
4.3.4 Apobec3 
Apobec3 is demonstrably important for restricting the replication of viruses. The protein can 
be incorporated into viral particles and a DNA editing function is employed to edit cytosine 
bases to uracil on the minus strand of the viral DNA that is produced by reverse transcription. 
This subsequently causes G-to-A mutations in the coding strand which frequently leads to 
missense mutations and the degradation of reverse transcribed DNA (Okeoma et al., 2007; 
Stavrou and Ross, 2015). In addition, Apobec3 may also act on endogenous retroviral 
sequences (Esnault et al., 2005). The role of this candidate however may not be restricted 
solely to this function. 
A contribution of active mechanisms in the epigenetic reprogramming of the zygote was 
assumed due to the faster rate at which the paternal genome is demethylated (Smallwood 
and Kelsey, 2012). As well as the iterative oxidation of 5mC to an extent that DNA repair 
mechanisms are signalled to restore a cytosine base, deamination of 5mC to a thymine by 
Apobec3 has also been implicated to this end. Like oxidation, the aim of this process would 
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be to invoke DNA repair to restore a cytosine (Nabel et al., 2012). It was therefore surprising 
that Apobec3 was more abundant in the serum condition, compared to KOSR+2i, in the BioID 
data. A similar trend was observed in the Myc pull-down but below the value for the 
background. In both cases however, the differing intensities did not reach the threshold to 
be regarded as differentially interacting in the medias (Figure 4.9, Table 4.2). Whilst the lower 
intensity in KOSR+2i could be accounted for by a reduction in Apobec3 levels (Figure 4.11), 
the remaining protein is still highly abundant and could mediate demethylation regardless.  
The function that therefore may appear to unify these roles is the regulation of viral 
sequences by DNA methylation. Apobec3 may promote expression yet minimise the activity 
of viruses to an appropriate level to still increase genetic diversity (Esnault et al., 2005). The 
base media used in the BioID study was composed of 10% KOSR with 1% FCS and the former 
component with 2i has been shown to induce the expression of genes associated with the 2-
cell state, which is partly dependent on endogenous retrovirus activity (Hackett et al., 2017). 
Analysis of the retroviruses in a subpopulation of mESCs expressing 2-cell stage embryo 
markers shows them to be hypomethylated and expressed (Macfarlan et al., 2012). In this 
study, the main driving force for their derepression however was attributed to altered 
histone modifications. Furthermore, there are differing reports on the extent to which DNA 
methylation influences the expression of this class, with family-specific effects likely 
accounting for this and the imposition of stage specific regulatory mechanisms (Karimi et al., 
2011; Schoorlemmer et al., 2014; Schlesinger and Goff, 2015). 
In any case, the association between a co-factor that is involved in maintaining DNA 
methylation and another that may remove it seems contradictory. Apobec3 and Uhrf1 
interplay therefore presents an interesting focus of study.  
4.3.5 Auts2 
The Uhrf1 BioID screen identified a number of proteins that are mutated in disease. The 
nucleosome remodellers Lsh and Cdca7 act in a bipartite complex and influence the 
methylation of DNA satellite sequences. Mutations that prevent their interaction, and that 
are present in the de novo methyltransferase Dnmt3b itself, are attributed to the 
development of ICF syndrome, as set out in the introduction (Jenness et al., 2018). Whilst Lsh 
was detected in both media, a potential interaction with Cdca7 was found exclusively in 
KOSR+2i, suggesting altered cell-signalling had induced a rearrangement of the complex. That 
Uhrf1 may interact with Lsh however may be unsurprising in light of data showing Dnmt1 
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and Lsh can themselves co-IP when overexpressed in a human cell-line (Dunican, Pennings 
and Meehan, 2015). The relationship between Lsh and DNA methylation and the result of a 
neurological deficiency when this is disrupted, provided the motivation to select Auts2 for 
further investigation. 
Auts2 was found in the BioID screen to be enriched over the BirA* control in the N and C-
terminus of Uhrf1, with protein and mRNA consistent between the two media (Figures 4.9, 
4.11 and 4.12, Table 4.2). Although not all of the proteins that reportedly form a stable 
complex with Auts2 were found in the screen, Rybp was a potential interacting partner of 
the C-terminus of Uhrf1 in KOSR+2i.  
As the name suggests, Auts2 is strongly implicated in autism and mental retardation and the 
gene is frequently disrupted through translocations in these disorders (Sultana et al., 2002; 
Kalscheuer et al., 2007). It is highly expressed in the neocortex of mice in early development 
whilst postnatal levels are lower yet more ubiquitous in the brain (Gao et al., 2014).  
Auts2 has been shown to participate in a polycomb PRC1 complex (Gao et al., 2014). Whilst 
PRC1 complexes are typically associated with transcriptional repression, those featuring 
Auts2 were first shown to exhibit transcriptionally activating effects in a GAL4-DNA assay. An 
additional feature of Auts2 containing PRC1 complexes is that they can also operate 
independently of RING1B, a component that would otherwise ubiquitinate histones to 
instigate transcriptional repression. A ChIP-seq analysis in mouse brain showed an 
enrichment of Auts2 at transcriptional start sites, accompanied by PolII and histone marks 
associated with transcriptional activation. However, the overlap with RING1B-bound genes 
and Auts2 was described as poor, with ~36% showing a colocalisation of peaks (Gao et al., 
2014).  
In a Lsh-null neural stem/progenitor cell model, compromised self-renewal and lineage 
commitment along with increased apoptosis have been observed (Han et al., 2017). 
Mechanistically this has been attributed to impaired nucleosome remodelling, an alteration 
in histone marks and a reduced accessibility to underlying chromatin. Ultimately this leads to 
gene expression changes. Aberrant levels of cell cycle regulators and growth factors are likely 
contenders that account for the downstream effects. As histones and their modifications 
instruct DNA methylation, loss of Lsh would disrupt an early stage in the hierarchy of DNA 
methylation control. Nevertheless, reduced DNA methylation was found at an enhancer of 
Bmp4, a regulatory growth factor of neural stem cells (Han et al., 2017). A mESC model 
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expressing a truncated form of Auts2 meanwhile showed a propensity to apoptose more 
frequently when promoted to differentiate down a neuronal lineage (Monderer-Rothkoff et 
al., 2019). The manifestation of this is seen in an Auts2-null mouse model, which exhibits 
developmental delay in a battery of behavioural tests. As nucleosome remodelling activity 
has not been assigned to Auts2, the compromised neural development is therefore most 
likely to be accounted for by an influence on epigenetic marks. Indeed, Gene Ontology terms 
for genes associated with Auts2 ChIP peaks relate to abnormalities in the forebrain and 
cerebellum (Gao et al., 2014). 
The configuration of Auts2 complexes is likely diverse (Gao et al., 2014) and as such, this may 
impose differing outcomes. The positive influence on gene expression in the GAL4 assay 
referred to earlier was shown by ChIP to occur when Auts2 was complexed with RING1B (Gao 
et al., 2014). However as addressed above, evidence suggests that Auts2 can be targeted to 
chromatin independently of RING1B and therefore the transcriptional effects of the complex 
when this component is absent may differ. Recently, different Auts2 isoforms have also been 
identified: a long form is present in mESCs however this is replaced with a shorter version 
when promoted to differentiate down a neural lineage. Both types are present in adult brain 
tissue but the short isoform predominates. In humans, a short transcript is expressed in early 
neurodevelopment and both are detected in the adult brain. Interestingly, assays suggest 
that the longer isoform associates with transcriptional repression, contrasting sharply with 
the shorter protein. Furthermore, overexpression of the long isoform in mESCs delays 
neuronal differentiation, seemingly by promoting Oct4 and Nanog expression (Monderer-
Rothkoff et al., 2019). In light of the above, what could be the implications of an interaction 
with Uhrf1 on DNA methylation?  
It is already known that DNA methylation can act instructively with regards to H3K27me3 
deposition as hypomethylation promotes a dispersal of the mark across the genome (King et 
al., 2016).  Furthermore, a redistribution of H3K27me3 is evident in 2i media with a N2B27 
base (Marks et al., 2012). On the other hand, if Uhrf1 and Auts2 are in a complex with Rybp, 
the presence of this latter partner is associated with an H3K27me3 independent mode of 
chromatin targeting and ChIP analyses have not detected an enrichment of H3K27me3 at 
Auts2 binding sites (Gao et al., 2014). A relationship therefore cannot be drawn directly 
between H3K27me3 and DNA methylation in this context and will require investigation. An 
effect of Auts2 in mESCs may also manifest when cells commit to differentiation: WT and 
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mutant Auts2 lines are initially indistinguishable until promoted to differentiate to cortical 
neurones (Monderer-Rothkoff et al., 2019). As DNA methylation is influenced by 
transcription (Neri et al., 2017), a sequence of which will be set off during this process, 
distinguishing between the direct and indirect effects will be difficult, requiring a specific 
disruption of a potential Uhrf1 and Auts2 interaction in order to do so.  
As a possible complex between Uhrf1 and Auts2 forms in both culture conditions, the rate at 
which hypermethylation is re-established when WT and Auts2 overexpressing lines 
maintained in KOSR+2i are transitioned back to serum-based media could be examined. This 
will determine whether the components in both media impart an Auts2 dependent effect on 
DNA methylation. The observation that Auts2 overexpression induces Nanog and Oct4 levels 
and that an interaction between Auts2 and Uhrf1 is detectable in the KOSR+2i media, a model 
of ground-state pluripotency, is an intriguing correlation. Returning the cells to serum media 
also provides an opportunity to investigate whether overexpressed Auts2 is able to 
counteract the transcriptional heterogeneity associated with Nanog in this medium (Marks 
et al., 2012).  
In summary, five candidate regulators of DNA methylation maintenance have been selected 
based on the proteomic data from Uhrf1 BioID and pull-down experiments. The primary 
focus is to ascertain whether the interactions influence the changes in DNA methylation that 
are observed upon transitioning mESCs from serum media to KOSR+2i. If indeed the 
candidates do, this will illustrate the relationship between a change in protein complex 




Chapter 5 – Investigating the role of citrullination in the regulation of 






Protein function can be influenced by the chemical modification of constituent amino acid 
side chains. These PTMs may occur by default or in response to environmental stimuli 
whereby the cell integrates signalling cues to elicit an effect. Consequently, the stability, 
structure, cellular distribution and activity of a protein can be altered by these chemical 
groups (Knorre, Kudryashova and Godovikova, 2009). In this chapter, I describe the results of 
an investigation into the effects of the relatively understudied PTM citrullination on the 
regulation of DNA methylation in mESCs.   
Citrullination describes the post-translational conversion of protein arginine residues to 
citrullines. Biochemically this equates to the loss of a positive charge and increased 
hydrophobicity. The process is mediated by the highly conserved peptidylarginine 
deiminases (PADI 1-4 and 6) in a Ca2+ dependent manner (Vossenaar et al., 2003; Wang and 
Wang, 2013). 
Whilst PADIs have physiological roles in the adult, they are also a focus of interest in 
inflammation and autoimmune diseases, particularly rheumatoid arthritis, in which there is 
an association with deregulated activity of the enzymes and the generation of autoantigens. 
This precipitates an attack on structural proteins in the synovium and inflammation and 
degradation of the joints  (Reviewed Valesini et al., 2015). 
The PADIs have been shown to regulate gene expression. For example, PADI2 is recruited to 
estrogen receptor α binding sites in response to 17β-estradiol (E2) application in MCF-7 cells. 
Loaded here, PADI2 citrullinates histone 3 at arginine 26 (H3R26) to facilitate the opening of 
chromatin and subsequently transcription (Zhang et al., 2012). Furthermore, the enrichment 
of PADI4 at transcriptional start sites in MCF-7 cells was shown to positively correlate with 
expression and align with other factors associated with activation, such as E2F1 and RNA 
polymerase II. In this study, the target of citrullination was identified as the Elk-1 transcription 
factor, which led to its increased phosphorylation. This is a necessary step to promote an 
interaction with the histone acetyltransferase p300 and activation of gene expression at c-
Fos promoters (Zhang et al., 2011). In a different study, the specific citrullination of H3R8 
(H3R8Cit) by PADI4 was shown to be antagonistic to HP1α binding, resulting in the expression 
of ERVs, satellite repeats and some immune response genes in the MCF-7 cancer cell line and 
Jurkat T cells. This relationship was also observed to an extent in peripheral blood 
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mononuclear cells from multiple sclerosis patients (MS) (Sharma et al., 2012). As a 
consequence of the effects on gene regulation, deregulated PADI activity has an association 
with cancer. PADI2 was notably significantly overexpressed in multiple breast cancer cell lines 
relative to healthy luminal tissue (Mackay et al., 2009). It has also proven to be an effective 
target in supressing the growth of xenografted MCF10DCIS tumorigenesis models in mice 
(McElwee et al., 2012). 
More large-scale chromatin effects are induced by citrullination and this is particularly the 
case with PADI4 mediated activity. In neutrophils, H3/H4Cit promotes expulsion of 
chromatin, termed neutrophil extracellular traps (NETs), to ensnare pathogens (Wang et al., 
2009). The open chromatin structure in mESCs, an important feature of pluripotency, is 
dependent on PADI4 which acts on the linker histone H1 to reduce the binding affinity to 
nucleosomal DNA. Depletion or chemical inhibition of PADI4 in these cells reduces the 
expression of the pluripotency factors Nanog and Tcl1, at whose promoter and enhancer 
regions H3Cit is typically present. This also leads to upregulation of differentiation markers 
such as Prickle and Wnt8a. Conversely, PADI4 overexpression induces pluripotency related 
factors including Tcl1, Tcfap2c and Kit (Christophorou et al., 2014). Accordingly, PADI4 
knockdown or inhibition significantly impairs the reprogramming of a neural stem cell line to 
a pluripotent state and Padi4-knockout mice are born at a lower than expected Mendelian 
ratio (Li et al., 2010; Christophorou et al., 2014).  
PADI activity is also detected throughout pre-implantation development: H3Cit26 is likely 
derived from the oocyte and is enriched in nuclei at the 2-cell stage; H4Cit3 is predominantly 
cytoplasmic, aligning with chromatin at metaphase and H3Cit 2/8/17 is present in the nucleus 
during interphase (Kan et al., 2012). The culture of zygotes in the pan-PADI inhibitor Cl-
amidine arrests development by the 2-4 cell stage and promotes histone hypoacetylation, 
suggesting citrullination has a function in this developmental window (Kan et al., 2012). The 
knockdown of Padi1 recapitulates these results and negatively affects gene expression, 
suggesting that this is the dominant isoform in pre-implantation development. Indeed, it is 
expressed in nuclei of oocytes and from the 2-cell stage onward. This contrasts with PADI2 
and -3 which exhibit weak signals in the oocyte and are largely excluded from the nucleus 
thereafter (X. Zhang et al., 2016). The localisation of PADI4 meanwhile is subject to debate 
with use of different antibodies and controls, regardless of it being unique amongst the PADIs 
in having a nuclear localisation signal (Brahmajosyula and Miyake, 2013; X. Zhang et al., 
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2016). Although PADI6 lacks enzymatic activity, deleterious homozygous or compound 
heterozygous mutations are associated with infertility, likely owing to a failure to maintain 
oocyte cytoplasmic lattices that contain a store of ribosomes. This manifests as dysregulated 
protein synthesis during the 2-cell stage and developmental arrest (Yurttas et al., 2008; Xu et 
al., 2016).  
The examples described above showcase the effects of citrullination on both histone and 
non-histone targets in a physiological context and instances when deregulation leads to 
aberrant cell biological functions. Due to the biochemical effect citrullination imparts, there 
are conceivable implications on the interaction of the protein modified this way with other 
proteins. As more PADI substrates are found and the effects investigated, our understanding 
of the function of citrullination will grow. Identifying novel PADI targets can be facilitated 
with mass-spectrometry however, the small increase in the mass of a citrullinated peptide 
by 0.98 Da poses a challenge (Clancy, Weerapana and Thompson, 2016).  
A previous report has outlined a positive association between PADI4 and DNMT3A protein 
levels in cancerous cell lines and MEFs. Manipulating the levels of PADI4 or inhibiting its 
activity was shown to confer a change in DNA methylation at a number of CpGs across two 
loci tested (Deplus et al., 2014). Furthermore, citrullination is prevalent in pre-implantation 
development, as discussed earlier, and this is also a period in which DNA demethylation 
occurs (Smith et al., 2012). This raises the opportunity to use both serum and 2i media to 
address whether PADI4 is important for DNA methylation in the context of primed and naïve 
pluripotency.  
In this chapter, I describe the results from an investigation into the influence of PADI4 on 
DNA methylation. This study was built on preliminary data from a mass-proteomic screen 
performed by Maria Christophorou in which Dnmt1, Dnmt3b and Uhrf1 were shown to be 
subject to citrullination by PADI4 (unpublished data). Using CRISPR generated Padi4-
knockout and stably overexpressing human PADI4 lines, I aim to outline the influence of 
PADI4 on global methylation levels in serum-based media and during the transition to a more 
naïve state with KOSR+2i. In an attempt to uncover the mechanism through which PADI4 may 
influence DNA methylation, the protein and mRNA of the Dnmts and Uhrf1 were also 





To elucidate the potential influence of PADI4 on DNA methylation, mESCs are suitable 
tractable models to achieve this aim. Firstly, as shown in Chapter 3, DNA methylation of 
mESCs can be modulated by transitioning from serum-based media into alternative tissue 
culture media, KOSR+2i. Whilst there is evidence of PADI4 activity in mESCs cultured in 
serum-based media, work on the reprogramming of neural stem cells to iPSCs suggests PADI4 
activity is responsive to KOSR + 2i (Christophorou et al., 2014). Furthermore, as 2i culture 
systems have been shown to recapitulate the ground-state of pluripotency in vivo to an 
extent, a period in which PADI activity is detectable, findings may help elucidate novel roles 
of citrullination in pre-implantation development (Marks et al., 2012; X. Zhang et al., 2016).  
5.2.1 The effect of Padi4KO on DNA demethylation in KOSR+2i 
For initial experiments, Padi4-null (Padi4KO) mESC clones were used and compared to a 
parental WT E14 line. The Padi4KO lines, Clone 1 and 2, were generated by Abigail Wilson 
using CRISPR. Sequencing revealed Clone 1 has a large deletion between Padi4 exons 7-11. 
Clone 2 has exon 9 deleted and a frameshift in the gene. As shown in Figure 5.1, the lines do 
not have detectable PADI4 protein. The first 5 days of culture in KOSR+2i were the primary 
focus to investigate the influence of PADI4 as this represents the most dynamic period of 
demethylation in the KOSR+2i culture system, as presented in Figure 3.1. Daily collections 
were taken of DNA, protein and mRNA. The first step was to characterise the effect of Padi4 
knockout on DNA methylation using LC-MS.  
 
 
Figure 5.1 – Western blot of whole cell lysates from Padi4 CRISPR targeted E14 cells and the parental 







Figure 5.2 – A. DNA methylation levels of WT and Padi4KO E14 mESCs cultured in KOSR + 2i for the 
days indicated. Values are presented as relative methylation levels to WT E14 serum cultured cells at 
0 days. B. The relative values from days 0-5 of culture presented as natural logs. The slope of the line 
indicates the rate of demethylation, assuming first order rate kinetics. Error bars represent the 






Values presented in Figure 5.2 A are plotted relative to the average value of the WT line 
cultured in full-serum media, this is 0 days. As expected, the WT control underwent changes 
within 1 day of transitioning to KOSR+2i, and methylation was lower at later time points 
assayed. The initial global methylation level of both Padi4KO clones was 17% lower than that 
of the equivalent WT line; it required between 1 and 2 days of culture in KOSR+2i for the WT 
line to be comparably methylated. At all stages thereafter, the knockout clones remained 
more significantly demethylated than the WT counterpart. 
Taking the natural log of the relative values and plotting against time enables the rate of 
demethylation to be determined in KOSR + 2i. Assuming first order kinetics, this will be 
equivalent to the slope of the line. As presented in Figure 5.2 B, the rates of the Padi4KO 
clones are relatively faster than that observed in the WT line, differences which are 
statistically significant (Clones 1 and 2: p≤0.001). Meanwhile, the Padi4KO clones perform 
similarly to each other (p>0.05). 
Collectively, this data demonstrates that PADI4 is important for sustaining DNA methylation 
levels in mESCs maintained in serum media and for counteracting the mechanisms that 
promote demethylation in KOSR+2i.  As discussed earlier, PADI4 has been shown to influence 
both transcription (Christophorou et al., 2014) and in the context of cancer cells and MEFs, 
DNMT3A protein stability (Deplus et al., 2014). Therefore, in order to identify the mechanism 
through which PADI4 modulates DNA methylation in mESCs shown above, protein and mRNA 
levels of DNA methylation regulators were determined in western blots and RT-qPCRs, 
respectively. 
When maintained in serum media, protein levels of the de novo transferases, Dnmt3a and -
b are comparable to the WT line, as is the level of the obligate co-factor of Dnmt1, Uhrf1. 
There is however appreciably less Dnmt1 protein. Dazl is a methylation sensitive gene and its 
expression is influenced directly by its methylation status. Levels can therefore be used as an 
indicator of global methylation (Hackett et al., 2012; Walter et al., 2016). Despite the 
reduction in Dnmt1 protein with Padi4KO, Dazl levels are comparable between the WT and 
Padi4KO clones. More differences emerge when the parental line and the knockout clones 
are transitioned into KOSR + 2i (Figure 5.3). 
The downregulation of Dnmt3a protein proceeds at a similar rate in all lines. However, 
Dnmt3b declines faster and levels in Padi4KO clone 2 after 1 day in KOSR+2i culture are 
comparable to those attained by the WT line in 3 days of culture. Levels of Uhrf1 protein in 
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both knockout clones reach a nadir earlier than the WT line. Whilst clone specific effects on 
Dnmt1 are seen, appreciably lower levels are attained earlier in the KOs with KOSR+2i culture 
also (Figure 5.3). 
Furthermore, Dazl protein is detected after 3 days in KOSR+2i culture whereas it is present 
in the WT line at 5 days. This supports the LC-MS data (see Figure 5.2) which suggests the 
Padi4KO clones demethylate at a faster rate. Noticeably, there is undetectable citrullination, 
as measured by H3 citrullination, in the Padi4KO clones and the WT line too. 
 
Figure 5.3 – Western blot of whole cell lysates from Padi4 CRISPR targeted E14 cells and the parental 
cell line. Gapdh and histone 3 (H3) were used as loading controls. Time above each lane indicates days 
in KOSR+2i culture. Lysates from J1 and TKO cells have been presented to demonstrate the specificity 
of the Dnmt antibodies. The TKO lysate also serves as a positive control for methylation sensitive Dazl 
expression.  
 
To determine whether the differences in the protein levels of the DNA methylation mediators 
are due to post-translational mechanisms or can be accounted for by direct effects on 
transcription, RT-qPCR was performed on samples harvested in parallel with protein (Figure 
5.4). In serum alone, there is increased mRNA for all these genes in at least one knockout 
clone. Most strikingly is the almost 2-fold higher Dnmt3b mRNA in Padi4KO clone 2 however, 
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with the evidence presented above, this does not appear to have implications on the protein 
level. Expression thereafter is comparable between the Padi4KO clones, except at 3 days, 
and the WT line. Whereas there is a highly significant difference (p≤0.001) between Dnmt3b 
expression in Padi4KO clone 2 within serum culture (0 days) and at the end point of 5 days, 
this is not the case for the WT line nor Padi4KO clone 1. Therefore, the effects of KOSR+2i 
overcome the initial influence of Padi4 absence. 
In contrast, Dnmt3a mRNA is more significantly (p≤0.05) abundant in Padi4KO clone 1 in 
serum and remains as such in at least one knockout clone throughout KOSR+2i culture. 
Comparing the high mRNA levels to protein suggests there is again no correlation. 
Throughout KOSR+2i culture, Dnmt3a levels between the WT line and a knockout clone differ 
by 40% at the most, as seen at the 4-day time point. After day 1 however, as mRNA in KOSR+2i 
is significantly less abundant than in serum (p≤0.05) and remains low, it may be unexpected 
for a noticeable effect on protein to be seen despite the differences in mRNA.    
The overall trend in expression of Dnmt3l is similar to Dnmt3a in that levels in the knockout 
clones are initially higher and this remains so in at least one clone at the majority of time 
points in KOSR+2i. At all stages from day 1 however, levels remain significantly (p≤0.05) lower 
than serum culture.  
Regarding the components of the maintenance machinery, there is also a deviation between 
transcript level and protein.  Levels of Dnmt1 mRNA are comparable between lines across 
the time points except in serum and at day 1 where Padi4KO clone 2 expresses 2-fold more, 
a statistically significant amount (p≤0.05). This contrasts to protein which is initially lower in 
both knockout clones. By day 5, the mRNA levels between the three lines are comparable. 
With respect to the Padi4KO clones, this represents a significant (p≤0.05) decline in Dnmt1 
transcription when compared to expression in serum-based media. Fluctuations in Uhrf1 
expression are detected throughout culture in KOSR+2i in all lines at most time points, with 
differences reaching statistical significance (p≤0.05) between the WT and knockout clones on 
occasion. At the latest time point, Uhrf1 expression in Padi4KO clone 2 is comparable to the 
WT E14 line.  
A direct correlation is observed between Dazl mRNA and protein. Both Padi4KO clones 
behave similarly and levels remain significantly (p≤0.05) more abundant than the WT line at 
all time points assayed, including serum. Although Dazl is responsive to demethylation, it will 
also be subject to transcriptional regulation and therefore this alone is an insufficient 
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indicator of methylation. The Padi4KO clones may be more susceptible to demethylation yet 
the transcription of Dazl may be sensitive due to additional signalling mechanisms. 
Nevertheless, there is a positive correlation between the LC-MS data (see Figure 5.2) and 
Dazl levels (See Figures 5.3 and 5.4) 
 
Figure 5.4 – RT-qPCR analysis of DNA methylation mediators in WT E14 cells and two Padi4KO clones 
cultured in KOSR + 2i at the indicated time in days. Dazl expression has been determined to indicate 
the extent of DNA demethylation. Values are presented relative to UbqC expression. Error bars 
represent the standard deviation from three technical replicates. (* = p≤0.05; **= 0.001<p<0.05).  
 
The above data suggests that PADI4 influences the stability of the DNA methylation 
mediators examined. Whilst there are some transcriptional changes upon Padi4KO, the 
extent of which for Dnmt1 and Dnmt3b in particular is lessened with culture in KOSR+2i, the 




5.2.2 The effect of PADI inhibition on DNA demethylation in KOSR+2i 
To account for potential compensatory effects from other PADI enzymes expressed in mESCs, 
such as PADI2 (see Figure 5.5), the level of DNA methylation in KOSR+2i was determined in 
the presence of a pan-PADI inhibitor. 
 
Figure 5.5 – Western blot of whole cell lysates from Padi4KO E14 cells and the parental cell line. Gapdh 
was used as a loading control. Time above each lane indicates days in KOSR+2i culture. 
 
Culturing a WT E14 line in KOSR+2i with the inhibitor promoted demethylation by a further 
10% compared to KOSR+2i alone by 2 days, a statistically significant (p ≤0.00001) difference 
(Figure 5.6). The data from this experiment supports the notion that PADI4 delays 
demethylation.  
  
Figure 5.6 – DNA methylation levels of WT mESCs cultured in KOSR + 2i with or without a pan-PADI 
inhibitor (Cl-amidine) for the days indicated. Values presented as relative levels to WT E14 serum 
cultured cells at 0 days. Error bars represent the standard deviation of the mean from three technical 




5.2.3 The effect of PADI4 overexpression on DNA demethylation in KOSR+2i 
A set of converse experiments were then performed to determine the implications of PADI4 
overexpression. The cell lines used throughout were of a J1 background stably transfected 
with a vector that overexpresses human PADI4, as driven by a CAG promoter. A line 
expressing an empty vector served as the control line (Figure 5.7). 
 
Figure 5.7 – Western blot of whole cell lysates from human PADI4 overexpressing (PADI4) and empty 
vector transfected (CTRL) J1 mESCs. Gapdh was used as a loading control. Time above each lane 
indicates days in KOSR+2i culture. 
 
Assaying for global DNA methylation levels shows that PADI4 overexpression does not impart 
an effect in serum. Initially there is no effect detectable in KOSR+2i either however, a small 
yet statistically significant (p<0.05) divergence at days 2 and 5 is seen, with the PADI4 line 
being 7% and 8% more methylated at these time points (Figure 5.8). This complements the 
experiments with the Padi4KO lines which suggested PADI4 counteracts DNA demethylation. 
In contrast to the Padi4KO lines, the PADI4 overexpressing cells displayed similar levels of 
Dnmt1 protein in serum media and throughout KOSR+2i culture as the control line. 
Furthermore, Uhrf1, Dnmt3a and -b and Dazl protein levels were also comparable between 
the lines. The effects of KOSR+2i on PADI4 activity, using H3 citrullination as an indicator, 









Figure 5.8 – DNA methylation levels of empty vector control (CTRL) and human PADI4 overexpressing 
(PADI4) J1 mESCs cultured in KOSR + 2i for the days indicated. Values presented as relative levels to 
CTRL serum cultured cells at 0 days. Error bars represent the standard deviation of the mean from 
three technical replicates. (* = p≤0.05). 
 
 




Figure on previous page Figure 5.9 – Western blot of whole cell lysates from human PADI4 
overexpressing (PADI4) and empty vector transfected (CTRL) J1 mESCs. Gapdh was used as a loading 
control. Lysates from J1 and TKO cells are presented to demonstrate the specificity of the Dnmt 
antibodies. The TKO lysate also serves as a positive control for methylation sensitive Dazl expression. 
Time above each lane indicates days in KOSR+2i culture. 
 
Analyses of the mRNA show an inverse relationship between PADI4 and the expression of 
the de novo transferases and co-factor Dnmt3l in serum cultured cells. Whilst Padi4KO lines 
have statistically significantly higher levels of these transcripts, PADI4 overexpression has the 
opposite effect (p≤0.05). The changes that KOSR+2i imposes on transcription overcomes the 
influence of PADI4 overexpression as levels of genes tested are not significantly different 
between the control and PADI4 line in this medium, including in the rebound of Dnmt3l and 
-b at day 5. An exception is at 2 days for Dnmt3l however, both lines have lower levels relative 
to serum media-maintained cells (Figure 5.10). Although Dnmt3a is expressed 2-fold higher 
and Dnmt3b 40% higher in the control cell line in serum-based media, this has no bearing on 
protein levels (Figures 5.9 and 5.10).  
Transcriptional regulation of Dnmt1 and Uhrf1 is also comparable between the lines. 
Fluctuations in the expression of these genes are detected throughout KOSR+2i culture but 
this does not reach statistical significance (p>0.05) except at day 5 for Uhrf1, which does not 
have implications on protein abundance. Meanwhile, Dazl increases similarly in the lines 
throughout culture in KOSR+2i and an initial statistically significant difference (p≤0.05) 





Figure 5.10 – RT-qPCR analysis of DNA methylation mediators in human PADI4 overexpressing (PADI4) 
and empty vector transfected (CTRL) J1 mESCs. Time indicates days in KOSR + 2i culture. Values are 
presented relative to UbqC expression. Error bars represent the standard deviation from three 










In this chapter, the relationship between PADI4 and DNA methylation was investigated. The 
potential for PADI4 to disrupt DNA methylation could be inferred from the antagonistic effect 
of citrullination on HP1 binding. As various isoforms of HP1 have been shown to interact with 
and stimulate Dnmt1 activity, hypomethylation could be promoted indirectly through a 
destabilised HP1-Dnmt1 complex (Fuks et al., 2003; Smallwood et al., 2007). PADI4 may also 
influence DNA methylation through the modification of H3R2. This histone residue is 
contacted extensively through intermolecular interactions by the PHD of Uhrf1. Substitution 
of the H3R2 residue for a non-polar alanine residue was shown to significantly impair binding 
affinity, as quantified by isothermal titration calorimetry (ITC). Although a negative effect was 
measured at specific loci, the global impact is nevertheless likely to be slight as H3R2 is 
required for euchromatic targeting only (Rajakumara et al., 2011). Pre-implantation 
development, a period in which epigenetic marks are reprogrammed, is also associated with 
PADI activity (Kan et al., 2012; X. Zhang et al., 2016). However, despite these aforementioned 
observations, data from Padi4KO and PADI4 overexpressed mESC lines suggests citrullination 
facilitates DNA methylation.  
The specific genomic regions that are hypomethylated in the Padi4KO lines can be identified 
with bisulfite sequencing, which determines methylation at the resolution of individual CpGs 
(Li and Tollefsbol, 2011). The biological significance of demethylated repeat elements, which 
may otherwise be supressed by DNA methylation (Walter et al., 2016), could potentially be 
greater than demethylated genes, given the general uncoupling of DNA methylation and 
gene transcription (Hackett et al., 2012). 
5.3.1 Padi4 knockout promotes DNA hypomethylation 
Possible explanations for the variable demethylation rate between Padi4KO and WT E14s 
include an altered cell-doubling time, reduced protein stability of DNA methylation 
regulators and impaired Dnmt recruitment, each of which are addressed below. 
In initial observations, Padi4KO cell counts with a haemocytometer at 2 and 4 days in KOSR+2i 
culture were ~50% more than WT cells, despite equal numbers of all cell lines being seeded 
two days prior. As impaired maintenance is the major mechanism that accounts for 
hypomethylation in 2i (von Meyenn et al., 2016), increased cell proliferation will dilute 5mC 
more quickly. Furthermore, this effect could also account for the relatively lower global 
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methylation levels of the serum maintained Padi4KO lines. It was previously shown that by 
arresting hESCs in pro-metaphase with nocodazole, the proportion of symmetrical CpG 
dinucleotides in a fully methylated configuration increases. These additional sites are 
restored from hemi-methylated regions by mechanisms that act on DNA after replication-
coupled processes. Similarly, when cell division of the highly proliferative HCT116 colon 
cancer cell line was arrested, there was a concurrent increase in global DNA methylation. 
Therefore, if a larger proportion of cells are in S phase at a given time, methylation would be 
notably lower as post-replicative DNA methylation would not have yet occurred (Charlton et 
al., 2018). The implications of these findings on DNA methylation in the Padi4KO lines can be 
tested experimentally by similarly inhibiting cell replication with nocodazole. As a result, I 
hypothesise that global methylation levels in the Padi4KO lines would subsequently be 
comparable to the WT E14 line in serum-based media.  Initially, cell proliferation should also 
be investigated using a more robust method. Flow cytometry could be used to quantify 
nucleoside analogue incorporation, which would be proportional to the number of S phases 
the population completes, or to measure the fluorescence of cytoplasmic dyes that will 
become diluted with each cell division (Romar, Kupper and Divito, 2016).   
An association between citrullination and cell proliferation has been observed previously in 
keratinocytes. Psoriasis is characterised by hyperproliferative keratinocytes with diminished 
levels of citrullinated keratin K1, a process which is typically mediated by PADI1. Whether 
PADI1 activity directly regulates the proliferation of these cells remains to be explored 
(Ishida-Yamamoto et al., 2000; Vossenaar et al., 2003). Furthermore, the LSK fraction of 
haematopoietic cells in Padi4 null mice proliferate more rapidly than in WT mice. The authors 
draw parallels with this phenotype and an elevated c-myc expression, which promotes cell 
proliferation. This was suggested to occur mechanistically by a failure of PADI4 to facilitate 
the recruitment of transcriptionally repressive HDACs to the c-myc promoter (Nakashima et 
al., 2013).  
An increase in cell proliferation may also account for the effect on Dnmt3b protein levels, 
which is regulated at the level of transcription in KOSR+2i. As seen in Figures 5.3 and 5.4, 
Dnmt3b protein declines more quickly in the Padi4KO lines compared to WT however, 
Dnmt3b mRNA levels are comparable throughout KOSR+2i culture. Whilst Uhrf1 protein in 
the Padi4KO clones is lower at early time points in KOSR+2i compared to WT E14s, the 
transcript levels are marginally higher, albeit this is a statistically significance difference. The 
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reduced Uhrf1 protein would further exacerbate demethylation as the maintenance of 5mC 
would occur less efficiently at equivalent time points as a WT line. As Uhrf1 mRNA on the 
whole is not significantly lower in the Padi4KO lines, the post-translation regulation of Uhrf1 
appears to be more acute. Furthermore, Dnmt1 protein is initially lower in Padi4KO lines in 
serum-based media and it declines further in KOSR+2i, despite a comparable effect on 
transcription (see Figures 5.3 and 5.4). Collectively, this suggests that PADI4 may also 
influence protein stability.     
 There has been a report that PADI4 specifically regulates DNMT3A protein levels in multiple 
cell lines (Deplus et al., 2014). In this study, blots of endogenous IPs performed in U2OS cells 
show that the total fraction of DNMT3A associated with PADI4 is modest however, when 
both proteins are overexpressed in a HEK-293T line, DNMT3A stability increases with WT 
PADI4. Conversely, there is no effect on DNMT3A if co-transfected with a catalytically 
impaired PADI4 mutant. Furthermore, endogenous DNMT3A protein was upregulated in 
U2OS cells upon the transient transfection of WT PADI4. This led to an increase in the 
methylation at some CpGs of a DZDT repetitive element. Upon PADI4 knockdown, 
methylation was reduced at the p21 proximal promoter, at which PADI4 has been shown to 
localise (Deplus et al., 2014).  
A pulse-chase assay, as used to illustrate the role of PADI4 in the study above, would also be 
suitable to investigate the effects of citrullination on Dnmt and Uhrf1 stability in mESCs 
(Deplus et al., 2014). For example, cells could be transfected with a vector expressing a 
tagged protein of interest, such as Dnmt1, along with WT or a catalytic mutant Padi4 before 
standard pulse-chase experiment protocols are followed. It could be expected that the WT 
Padi4 may delay the rate at which Dnmt1 is degraded. In addition, Padi4KO mESCs rescued 
with a stably expressed WT or a catalytic mutant Padi4 would also provide a useful tool to 
address the role of citrullination in protein stability. Using these lines, western blots could be 
performed to assess whether protein levels of the DNA methylation mediators are 
comparable to the WT line in serum and throughout KOSR+2i culture. In WT Padi4 rescue 
lines, protein levels of the Dnmts and Uhrf1 would be expected to be comparable to a WT 
E14 line in serum media and subsequently in KOSR+2i. Rescue lines would also address 
whether the effect is directly related to the absence of Padi4. As the two knockout clones 
used in this set of experiments performed similarly in response to KOSR+2i, it would be 
surprising if off-target effects accounted for any of the observations. However, as the 
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Padi4KO lines may adapt to the absence of Padi4 after a prolonged time in culture, rescue 
may not fully reverse the effects on DNA methylation.   
The mechanisms presented above as the potential routes through which PADI4 may 
influence DNA methylation are not mutually exclusive. In addition, PADI4 may also be 
important in regulating the association of the DNA methylation machinery to chromatin by 
facilitating protein-protein interactions between histones or co-factors. To address this, IF 
would be suitable to visualise the localisation of the components. This could be 
complemented with biochemical techniques to trap Dnmts on chromatin, using 5-aza-CdR 
for example. Fractions of the chromatin and nucleoplasm from WT and Padi4KO lines can 
then be prepared and the levels of the Dnmts in each probed for in a western blot. If Dnmt1 
levels are lower on the chromatin in the Padi4KO line, Uhrf1 and Pcna would be the primary 
contenders for assessing whether Dnmt1 recruitment is impaired. One possible experiment 
could be an IP to quantify the extent of interaction between Dnmt1 and these co-factors in 
WT and Padi4KO lines. 
Another possible scenario related to protein interactions involves the association between 
histone citrullination and an open chromatin conformation (Christophorou et al., 2014). As 
has been suggested with TopII-α inhibition, if chromatin is not presented in a favourable 
conformation for the activity of Dnmts, then DNA methylation will be negatively impacted 
(Lu et al., 2015). Likewise, histones have also been shown to be an impediment to DNA 
methylation maintenance. Whilst Uhrf1-null models are embryonic lethal, Uhrf1 mutants 
unable to interact with H3K9me2/3 cause on average a 10% reduction in methylation levels, 
particularly at sequences closest to histones. Mice carrying this mutation are however viable. 
The implication therefore is that H3K9me2/3 enables Uhrf1 to recruit Dnmt1 to sequences 
proximal to histones (Zhao et al., 2016). In this respect, PADI4 may be important to arrange 
chromatin in a conformation that facilitates Dnmt1 association. This possible role would be 
reflected in experiments discussed above that aim to address whether PADI4 in general is 
important for facilitating Dnmt1 and Uhrf1 recruitment to chromatin.  
The conclusions from the Padi4KO lines suggest there is no compensation by other PADI 
enzymes to mitigate the effects on DNA methylation. Furthermore, global 5mC levels in 
KOSR+2i were 10% lower at 2 days with pan-PADI inhibition, whereas the Padi4KO lines had 
around 40% less methylation than the WT line at 48 hours (Figures 5.2 and 5.6). Whilst this 
supports the notion that citrullination positively influences DNA methylation, the discrepancy 
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between Padi4KO and PADI inhibition remains to be investigated. This may be due to the 
effects on the protein levels of the DNA methylation machinery having not yet manifested 
with acute inhibition. The Padi4KO lines meanwhile have been maintained in serum-based 
media for multiple passages prior to the study commencing. The efficiency of the inhibitor in 
ablating PADI4 activity may also be less compared to generating a knockout.  
However, there does appear to be an increase in the expression of PADI2 upon transferring 
the Padi4KO lines to KOSR+2i media (Figure 5.5). Whether this may have implications on DNA 
methylation at the latter stages of KOSR+2i culture could be determined by applying the pan-
PADI inhibitor when PADI2 is upregulated, such as after 3 days. Examining the methylation 
levels of the Padi4KO lines in KOSR+2i with or without Cl-amidine would also illustrate if 
additional PADIs compensate. If the Padi4KO lines do not demethylate in KOSR+2i further 
with Cl-amidine compared to an untreated Padi4KO line, then it could be concluded that 
other PADIs do influence this process.  
5.3.2 PADI4 overexpression promotes the retention of DNA methylation in KOSR+2i media 
Despite the dramatic effects of Padi4 knockout, PADI4 overexpression upregulated Dnmt3a 
and -b transcription in serum only, but this did not impact protein levels. This suggests that 
the influence of endogenous PADI4 on DNA methylation is highly regulated in mESCs as there 
was no striking inverse effect upon introducing exogenous human PADI4, compared to the 
Padi4KO lines. However, at the 2- and 5-day time points, DNA methylation was retained to a 
statistically higher level in the PADI4 line. To investigate the mechanism of this retention, 
analysing the recruitment of the Dnmts to chromatin and the interaction of Dnmt1 with 
Uhrf1, as discussed above in the context of the Padi4KO lines, would be relevant 
experiments.   
5.3.3 Exploring the role of PADI4 in modulating DNA methylation in alternative systems 
A previous study aimed to address the influence of PTMs that may be added or removed 
from Dnmt1 in a 2i system (Habibi et al., 2013). Dnmt1 immunoprecipitated from mESCs 
cultured in N2B27 + 2i was shown to be marginally more efficient in an in vitro catalytic 
activity assay, compared to Dnmt1 from serum-maintained mESCs. In isolating Dnmt1 
however, the interaction between the cofactors required in vivo and the influence that the 
potential disruption of these could have on DNA methylation was not accounted for. The 
choice of substrate in the assay, poly dI-dC, is an unmethylated synthetic DNA duplex and is 
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not a true representative of the hemi-methylated DNA that Dnmt1 has an overwhelming 
preference for (Pedrali-Noy and Weissbach, 1986; Habibi et al., 2013). Whilst biochemical 
assays certainly have their advantages, it is then important to understand the context of 
PTMs in a cellular system. 
The data above represents steps to address the potential role of PADI4 in regulating DNA 
methylation. Whilst Dnmt1, Uhrf1 and Dnmt3b were shown to be citrullinated in mESCs, by 
using Padi4 knockout lines and PADI4 overexpressing systems, the implications on DNA 
methylation outlined above could in fact be due to indirect effects. To deconvolute this, it 
may be necessary to mutate Dnmt1, -3b and Uhrf1 to render them resistant to citrullination 
and conversely, behave biochemically similar to citrullinated proteins. To this end, a previous 
study substituted arginine for lysine and used alanine to mimic the loss of a positive charge 
that occurs with citrullination (Christophorou et al., 2014). These mutated constructs could 
then be transfected to restore proteins in corresponding null cell lines. This will be 
challenging as the screen in which the citrullinated sites were found used only one enzyme, 
Lys-C, to digest proteins into the prerequisite peptides for identification in mass 
spectrometry. As this would only yield suitable peptides that account for a particular 
percentage of a protein of interest, the use of alternative proteases may be necessary to 
capture all residues and therefore all citrullinated sites.  
Notably, I have been unable to present evidence that PADI4 in mESCs is stimulated by 
KOSR+2i at the defined time points analysed (see Figure 5.2). Evidence of PADI4 activity in 
mESCs has been shown with the use of ChIP, which when translated to total protein in the 
context of a western blot may fall below the detection limit (Christophorou et al., 2014). A 
direct relationship between regions at which PADI4 localises and the methylation status of 
the underlying DNA sequence may explain the impact on global methylation levels in the 
absence of PADI4. Locus specific analysis of DNA methylation, for example using bisulfite 
sequencing, cross referenced with ChIP data could be used address this point. This approach 
has already been taken in MCF-7 cells and an inverse relationship between PADI4 bound 
regions and 5mC was noted from ChIP data. In this context, PADI4 was found to be more 
highly enriched at actively transcribed genes (Zhang et al., 2011) and therefore the 
recruitment of transcription factors, facilitated by PADI4, may have inhibited DNA 
methylation. This may therefore suggest that the loss of methylation recorded in the Padi4KO 
mESCs lines occurs at genomic regions that are not enriched for genes, such as at repetitive 
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elements. Whilst a cell specific effect also needs to be considered, given that MCF-7 cells are 
a cancer line, there is also the potential for Padi4 deletion to promote a redistribution of DNA 
methylation in mESCs. For example, if PADI4 does negatively affect the deposition of DNA 
methylation at TSSs in mESCs, its deletion may enable 5mC to be added at regions previously 
refractory to this mechanism. Deconvoluting a direct effect will be difficult however as 
transcriptional changes that arise upon PADI4 deletion will indirectly influence DNA 
methylation.     
A context in which PADI activity is unambiguously detected is throughout the reprogramming 
of pre-iPSCs to iPSCs, a system first discussed in the introduction of Chapter 3. This system 
could be employed to track the relationship between PADI4 activity and DNA methylation, if 
this epigenetic mark is indeed dynamic throughout reprogramming. The availability of a cell 
line in which GFP is expressed as a reporter of endogenous Oct4, as opposed to the Oct4 
initially transduced along with Klf4 and c-Myc, enables the isolation of fully reprogrammed 
cells. Of interest, PADI inhibition reduces reprogramming efficiency. Whether this is partially 
contingent on DNA methylation could be resolved by altering the residues of Dnmt1 for 
example that are substrates for PADI4 so they are resistant to citrullination or to mimic the 
modification, evoking a constitutive citrullinated state (Silva et al., 2008; Christophorou et 
al., 2014). The effect on the reprogramming efficiency could then be determined by GFP 
levels, as a measure of Oct4 expression. Beyond the influence of PADI enzymes specifically, 
these experiments may contribute answers to the question as to whether DNA methylation 
alterations are strictly necessary for reprogramming.   
Collectively, this data suggests that citrullination may not influence DNA demethylation in 
pre-implantation development per se, despite its prevalence throughout this window. 
Nevertheless, PADI4 overexpression was shown to delay demethylation, albeit only 
marginally. Therefore, whether PADI4 contributes towards maintaining the methylation 
status of loci that remain hypermethylated against a background of global reprogramming 
would be intriguing to follow (Smith et al., 2012). Given the different phenotypes of Padi4 
and Dnmt deletion, as addressed above and in the Introduction, the influence of PADI4 may 
be minimal in this regard (Li, Bestor and Jaenisch, 1992; Okano et al., 1999; Li et al., 2010). 
As discussed above, PADI4 has been shown to regulate the stability of DNMT3A in cancer 
lines and MEFs. Whilst the relevance of these findings to mESCs requires thorough 
investigation, overexpression of PADI4 was reported in the same study to increase 
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endogenous DNMT3A protein (Deplus et al., 2014). Notably, this was not evident for this 
particular protein in mESCs (see Figure 5.9) and therefore tissue specific effects need to be 
considered. This also provides further impetus to investigate the role of PADI4 in modulating 
the additional proposed mechanisms, namely the cell cycle or recruitment of Dnmts, which 










6.1 Novel regulatory mechanisms of DNA methylation  
Attempting to explain the molecular mechanisms behind an event that occurs in vivo is often 
an intriguing proposition alone. However, as is the case with DNA methylation 
reprogramming in early development, when the question as to why it is necessary to occur 
in the first place has not been conclusively answered, this provides further stimulus to resolve 
the matter. The aim of my project has been to identify and characterise mechanisms that 
regulate DNA methylation maintenance in mESCs in models of primed and naïve 
pluripotency. Using serum-based media, a condition that sustains DNA methylation at high 
levels, and KOSR+2i, which promotes a global loss of 5mC, the differential interacting profile 
of Uhrf1 has been mapped with BioID, a proximity ligation technique. An attempt was also 
made to conduct a similar BioID experiment to capture interacting partners of DNMT1 in 
these different media however, this proved to be less successful. Nevertheless, on one 
occasion discussed below, the DNMT1 BioID data complemented the Uhrf1 screen.  
Evaluating mechanisms of DNA methylation regulation also led to the role of citrullination 
being considered. Preliminary data showed that this PTM acts on Dnmt1, Uhrf1 and Dnmt3b 
in mESCs.  
The main conclusions from these studies are outlined below: 
• DNA methylation is rapidly lost in KOSR+2i culture conditions, as has been reported 
previously for N2B27+2i. Demethylation is initiated in KOSR+2i before the onset of 
Uhrf1 protein downregulation.  
• Uhrf1 forms alternative protein complexes in serum and KOSR+2i media, as 
determined by BioID and affinity pull-down. Previously known interacting partners 
were found, validating the experimental approach.   
• In the absence of Padi4, mESCs display reduced levels of the DNA methylation 
mediators and are more susceptible to hypomethylation in KOSR+2i media. 
Therefore, PADI4 modulates DNA methylation by promoting the deposition or 
maintenance of 5mC.  
• PADI4 overexpression has a small but statistically significant effect on delaying DNA 





6.2 Characterising the interactome of the DNA methylation maintenance machinery 
The downregulation of Uhrf1 protein reported in the N2B27 system and in Chapter 3 in KOSR 
with 2i, undoubtedly contributes to DNA hypomethylation. As outlined in Chapter 1, there 
are a number of mechanisms that have been shown to regulate Uhrf1 protein stability. It 
would therefore be sensible to ascertain whether they are relevant to the context of Uhrf1 
regulation in 2i media. However, in KOSR+2i, as presented in Chapter 3, DNA demethylation 
proceeded before an appreciable decrease in Uhrf1 protein was evident. This leaves open 
the possibility that alternative mechanisms instigate the hypomethylation.  
My proteomic analyses have yielded an array of proteins that are potential novel regulators 
of the DNA methylation maintenance machinery proteins. These adhere to the strictest 
control in the screen, enrichment over the free BirA*. The initial steps to establish a possible 
role of a candidate in regulating DNA methylation is to perform knockdowns, followed by 
quantification of global 5mC levels. Transient transfections of siRNAs would be suitable for 
assaying levels in serum-based media however, to investigate whether the kinetics of DNA 
hypomethylation are impacted in the absence of the candidate, a constitutive knockout 
would be required. To this end, I have cloned Cas9 into a piggyBac vector and this has been 
transfected into E14 cells in order to generate knockout lines by transfecting specific guide 
oligonucleotides.  
 In the case of Stella, it has since come to light that the role of this protein extends beyond 
protecting the maternal genome from active demethylation mechanisms. It has now been 
shown to promote a dissociation between Uhrf1 and Dnmt1, leading to impaired 
maintenance methylation (Mulholland et al., 2018; Y. Li et al., 2018). This serves as a positive 
control for the proteomic screens I conducted, suggesting that other proteins revealed to 
differentially interact may represent additional mechanisms that influence DNA methylation. 
It also demonstrates that KOSR+2i is a dynamic tool in concert with serum-based media to 
uncover more details about Stella mediated regulation, providing an alternative to N2B27+2i. 
Demethylation in these systems will occur against a background of different signalling and 
transcriptional changes and therefore it will be of interest to dissect the implications of this.  
Previous genetic perturbation studies have already revealed that Utf1 influences DNA 
methylation (Kooistra et al., 2010). As the proteomics screens I conducted have shown Utf1 
interacts more favourably with Uhrf1 in serum media, there is the opportunity to 
demonstrate a biologically relevant context in which a differential interaction leads to 
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changes in DNA methylation. As the Utf1-Uhrf1 interaction is enriched in serum media, 
wherein DNA methylation is high, it may appear to be incompatible with the fact that Utf1 is 
downregulated upon differentiation (Kooistra et al., 2010), which is accompanied by an 
increase in DNA methylation in vivo (Meissner et al., 2008). However, this conclusion would 
be derived from the assumption that there is a clear division between Utf1 downregulation 
in differentiation and the re-methylation of DNA. The stages between a naïve state and a 
committed state are being refined further, with the existence of a formative state being 
postulated (Smith, 2017). This state of exiting pluripotency but not yet fully committing to 
differentiation may represent a window in which DNA methylation increases and Utf1 
remains expressed. Herein, Utf1 may act instructively in regulating DNA methylation. This is 
particularly important as the role of DNA methylation in post-implantation development is 
essential (Li, Bestor and Jaenisch, 1992; Okano et al., 1999). Whilst work is continuing on 
culture conditions that sustain the proposed formative state, characterising the potential 
role of Utf1 on Uhrf1 regulation will serve as a proof of principle study.   
Of the candidates, Pdk1 is unique in having been described previously as carrying out a PTM, 
specifically phosphorylation (Bowker-Kinley and Popov, 1999). The concern with Pdk1 
however is that its localisation has been defined as mitochondrial on databases online. 
However, as it is also similarly enriched in serum-based media in the DNMT1 BioID screen, it 
should not be discounted. As discussed in Chapter 4, other metabolic enzymes such as Pdc, 
to which Pdk1 binds have been shown to translocate to the nucleus wherein histone 
acetylation is modulated (Sutendra et al., 2014). As it may also interact with DNMT1 directly, 
characterising Pdk1 will be facilitated by the array of in vitro assays that have been developed 
to measure the catalytic activity of Dnmt enzymes (Reviewed Poh, Wee and Gao, 2016). 
In a similar regard to Pdk1, Apobec3 is associated with Uhrf1 more robustly in serum media. 
As Apobec3 has been described as a component of the active demethylation pathway (Nabel 
et al., 2012), it may be expected to associate with Uhrf1 more favourably under conditions 
of DNA hypomethylation. Furthermore, levels of Apobec3 decline only slightly in KOSR+2i. 
This may suggest that the signalling changes, rather than the expression changes, that occur 
upon transitioning into different media are the most influential factors dictating an 
interaction. Due to the necessity of normalising LFQ values of proteins in serum media 
however, the fold-difference compared to the average LFQ value in KOSR+2i media did not 
pass the threshold for Apobec3 to be regarded as a differential interactor. Whether a Uhrf1-
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Apobec3 complex instructs DNA methylation in serum and KOSR+2i media can be elucidated 
by genetically perturbing Apobec3 and assaying 5mC levels.  
In the case of Auts2, an interaction was also found in both culture conditions, in which it was 
shown to associate with Uhrf1 to comparable extents. Aberrant epigenetic regulation has 
been observed in neurological conditions (Reviewed Gapp et al., 2014), as discussed in 
Chapter 4 in the context of Lsh and ICF. Whilst there are a small number of reported studies 
into Auts2, which were addressed in Chapter 4, focussing on the potential influence of 
aberrant DNA methylation patterns as a result of Auts2 disruption would be keeping in line 
with the association of epigenetics and disease. 
6.3 Future directions for the interactome screens 
If the results from the genetic perturbations suggest that the associations between the 
candidate regulators and Uhrf1 are functional, and in the case of Pdk1 with DNMT1 also, the 
next step would be to confirm an interaction. In Chapter 4, I presented evidence from an 
endogenous Uhrf1 IP however, I was unable to demonstrate an interaction with any of the 
candidates. A sub stoichiometric or transient interaction were presented as possible 
explanations for this observation. Several alternative approaches, such as those reviewed in 
Phizicky and Fields, 1995 and discussed in the in the context of Dnmt1-Uhrf1 interactions in 
Chapter 1, will be considered to ascertain whether Uhrf1 does indeed interact directly with 
the candidates. However, if the candidate was shown to associate with Uhrf1 in the BioID 
screen only, this may suggest it forms a complex with other proteins but this component 
itself does not bind directly to Uhrf1. In this scenario, immunofluorescence will be a suitable 
tool to ascertain a relationship with the candidate.   
Upon completing the cloning of the BirA* vectors and optimising the necessary procedure to 
conduct a BioID screen, the report on the development of TurboID was released (Branon et 
al., 2018). TurboID is an exciting new tool and its application is already proving fruitful in 
identifying novel interacting partners of signalling mediators (Kim et al., 2019). Furthermore, 
parallel experiments with BioID demonstrates the superiority of TurboID in detecting a larger 
number of interacting candidates within a shorter period of time (Zhang et al., 2019). 
Repeating the DNMT1 interactome screen with the TurboID ligase therefore may prove more 
relevant than using BioID. For this reason, our understanding of the interacting profile of 
Uhrf1 would also benefit from repeating with TurboID.   
194 
 
Whilst this project was concerned with the role of Uhrf1 in regulating DNA methylation, a 
host of other interacting proteins were found in the BioID data that illustrate its diverse roles. 
As discussed in Chapter 4, chromatin remodellers and pluripotency factors, such as Klf4, were 
found. This is in line with the role Uhrf1 plays in regulating bivalent domains and acquisition 
of pluripotency in reprogramming (Kim et al., 2018). Another function of Uhrf1 that was 
represented in the BioID data is the mediation of the DNA damage response. For example, 
phosphorylated UHRF1 was shown to interact with BRCA1 at double-stranded break sites on 
chromatin. Localised here, UHRF1 ubiquitinates RIF1 using its E3 ligase domain and this 
compromises the ability of RIF1 to interact with 53BP1. As a consequence, this promotes DNA 
repair through homologous recombination. This is notably less error prone and mutagenic 
than non-homologous end joining (H. Zhang et al., 2016). In the Uhrf1 BioID screen, both 
53bp1 and Rif1 were detected, along with Rnf169 which also positively influences 
homologous recombination (An et al., 2018). Huwe1, which knockout HeLa models suggest 
promotes 53BP1 recruitment, was also enriched in the Uhrf1 BioID screen (Mandemaker et 
al., 2017). Evidence of DNA damage mechanisms could be expected in mESCs as the lack of a 
G1/S phase checkpoint and basal levels of single stranded breaks and γH2AX have been found 
in this cell line (Chuykin et al., 2008).  
The aforementioned DNA methylation-independent functions, and possibly others not yet 
defined, may explain the discrepancy in the differential gene expression changes seen 
previously upon Uhrf1 knockout in mESCs, compared to Dnmt1 knockout. Accounting for a 
0.05 false discovery rate cut-off, an overlap of only 12.3% of the up-regulated genes and 4.4% 
of the down-regulated genes was recorded (Kim et al., 2018). The specific knockout of 
maternal Uhrf1 also leads to a more severe developmental phenotype. However, it is 
important to note that the demethylation that accompanies Uhrf1 knockout is also more 
severe than Dnmt1 knockout. For example, ICRs are approximately half as much methylated 
in the absence of Dnmt1 compared to controls, whereas they are only a quarter of the level 
methylated with Uhrf1 knockout. A similar effect is also seen with IAP elements (Maenohara 
et al., 2017). With an advancement in tools used for proteomic screens, the route to 
deconvoluting the methylation-dependent and methylation-independent functions of Uhrf1 
would be best served using techniques like BioID and TurboID. Furthermore, consideration 
should also be given to the impact on the methylation independent functions of Uhrf1 when 




6.4 Citrullination as a means to regulate DNA methylation 
Having considered the interactomes of Uhrf1, as was the intention for DNMT1, focus then 
turned to PTMs. This investigation was built on preliminary evidence from a proteomic screen 
in which Dnmt1, Uhrf1 and Dnmt3b were shown to be chemically modified by PADI4 in 
mESCs. Whilst none of the PADIs were detected in any samples in the interactome screens I 
conducted, PADI4 demonstrably influences DNA methylation. Interestingly, when 
hypothesising how PADI4 may affect DNA methylation in the context of previous papers, as 
set out in Chapter 5, it was shown to facilitate DNA methylation. 
Support from the literature that DNA methylation is influenced by PADI4 can be found in a 
study in which PADI4 was genetically perturbed in cancerous and MEF cell lines (Deplus et 
al., 2014). Importantly, the function of PADI4 mediating DNMT3A stability that was proposed 
in this report cannot directly account for the effect I observed in mESCs. Whilst there was no 
effect on Dnmt3a levels in Padi4KO mESCs, Dnmt1 protein was appreciably reduced.  It is also 
conceivable that impaired Dnmt1 activity will impose a greater effect on differentiated cells, 
such as MEFs, in which Dnmt3a and Dnmt3b are lowly expressed (Okano, Xie and Li, 1998). 
However, comparisons between my results and the aforementioned study would have been 
facilitated greatly if global methylation analyses had been conducted as the impact on DNA 
methylation was assayed at two loci only.  
Whether an effect on Dnmt1 protein levels also manifests in cancerous tissue would be an 
interesting avenue to explore. Padi4 is aberrantly expressed in multiple cancers such as 
gastric adenocarcinomas, lung adenocarcinomas and hepatocellular carcinomas (Chang et 
al., 2009). Furthermore, there is a correlation between Padi2 expression and progression 
from normal mammary tissue to fully malignant breast carcinomas, and its inhibition delays 
the growth of tumours in culture and xenografts (McElwee et al., 2012). A similar relationship 
with tumour progression has also been shown in prostate cancer, in which PADI2 is 
associated with activating androgen receptor signalling (Wang et al., 2017). Whilst the 
biological significance of alterations in DNA methylation remains debated (Sproul et al., 
2012), elucidating the mechanism that accounts for these changes would nevertheless be a 
useful contribution, particularly if interventions to restore normal methylation patterns are 
therapeutically beneficial.  
Three non-mutually exclusive and testable hypotheses have been presented to account for 
the methylation changes in the Padi4KO mESCs. Evidently however, the high levels of PADI4 
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that are found in the multiple cancers discussed above do not ensure cell division is 
maintained at a comparable rate to normal tissue. Therefore, the exploration of whether 
PADI4 dependent cell-cycle cycle effects contribute to hypomethylation in cancer will be 
particularly difficult as PADI4-independent mechanisms that maintain the high proliferation 
rate in cancer may continue to promote global hypomethylation upon PADI4 inhibition or 
knockout (Charlton et al., 2018). 
6.5 Implications of findings 
Across these two defined projects, the data I have gathered has the potential to make Figure 
1.8, outlining how DNA methylation maintenance is regulated, even more convoluted yet 
detailed. The BioID screen offers the chance to identify novel regulators of Uhrf1 that may 
indirectly influence DNA methylation. By following the steps outlined above, chiefly 
confirming the interaction and conducting functional assays upon genetic perturbation of the 
candidate regulators, these will define whether the candidate is taken forward to dissect the 
mechanism by which it may influence DNA methylation. For the PADI4 project, there is a 
phenotype, DNA hypomethylation upon Padi4 knockout, and therefore the next steps will be 
to uncover the mechanism that accounts for this effect.  
In the context of 2i media, these projects have aimed to bridge the gap between cell signalling 
changes that occur upon transitioning from serum-based media, and the underlying changes 
to DNA methylation. Whilst 2i media was used as a tool in these projects, it will also be of 
interest to ascertain whether the conclusions drawn from experiments outlined in this thesis 
can be related back to in vivo development. This will add further details to the picture of 
events that occurs in pre-implantation development in the context of DNA methylation and 
inform future studies in which these mechanisms are perturbed to understand the necessity 




Appendix 1- Tables of proteins identified in Uhrf1 BioID screen  
Appendix Table 1.1 – The most abundant proteins ranked by average LFQ intensity detected in A) 
BirA* N-terminally tagged Uhrf1 compared to an Empty vector control line in serum based media 
and B) KOSR+ 2i media; C) C-terminally tagged Uhrf1 compared to an Empty vector control line in 
serum based media and D) KOSR+ 2i media; E) BirA* N-terminally tagged Uhrf1 compared to a free 
BirA* control line in serum based media and F) KOSR+ 2i media; G) C-terminally tagged Uhrf1 
compared to a free BirA* control line in serum based media and H) KOSR+ 2i media 





















Appendix 2-Volcano plots of proteins enriched in the Uhrf1 BioID 








Figure Appendix 2 – Volcano plots illustrating the relative enrichment of each protein detected 
in the Uhrf1 BioID screen for the conditions labelled. Missing values for each protein were 
imputed and p values were calculated using Limma moderated statistics. Plots were generated 
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